Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3024980	s-igg4	g/l (g/l)	5173	8187	0.00%
3024980	s-igg4	— (—)	1881	2565	100.00%	Distribution not available
3024980	s-immunoglobuliinig,alaluokka4	g/l (g/l)	31	33	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Used for control exclusion in common control thyroid runs

1856

3243

2.94

322.13

1.7

1.4

0.79

0.78

g/l

0.10

1406

2448

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1852

4647

2.77

317.62

1.6

0.73

0.76

g/l

0.52

1384

3517

Chronic lower respiratory diseases

2161

4425

2.64

315.89

1.5

1.6

0.77

0.74

g/l

0.39

1650

3318

Examination and observation for other reasons

1189

1878

3.75

310.81

1.7

1.5

0.70

0.85

g/l

2.82

1029

1291

Immunodeficiency with predominantly antibody defects

298

127

33.01

307.65

2.1

1.8

0.29

0.82

g/l

3.51

238

100

Immunodeficiencies

385

245

19.50

307.65

2.0

1.6

0.41

0.87

g/l

4.95

299

189

Asthma (only as main-diagnosis), excluding more controls

1577

1787

5.19

307.65

1.6

0.74

0.76

g/l

0.27

1183

1339

Asthma-related pneumonia or sepsis

887

1906

4.82

307.65

1.6

1.5

0.73

0.77

g/l

0.33

670

1438

Chronic pancreatitis

518

506

11.24

307.65

2.4

1.3

1.04

0.86

g/l

1.03

347

398

Diseases of liver

1084

1984

5.77

307.65

1.7

1.6

0.77

0.81

g/l

0.32

866

1486

Abnormal findings on diagnostic imaging of lung

1037

2461

4.17

307.65

1.6

1.5

0.85

0.79

g/l

0.62

782

1838

Asthma (mode)

1604

1911

4.61

307.65

1.6

0.77

g/l

0.01

1215

1432

GASTRO-related operations

1516

1581

4.91

307.65

1.7

1.3

0.72

0.74

g/l

0.22

1140

1298

Asthma, excluding more controls

1624

1787

4.86

307.65

1.6

0.76

g/l

0.02

1222

1339

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2066

4391

3.32

307.65

1.7

1.5

0.75

g/l

0.01

1546

3337

Autoimmune diseases

1969

3547

2.87

307.65

1.8

1.5

0.76

0.79

g/l

0.40

1516

2647

Fever of other and unknown origin

1330

2785

4.38

307.65

1.6

1.5

0.65

0.78

g/l

3.79

993

2135

L04AX Other immunosuppressants

1385

3655

3.92

307.65

1.9

1.5

0.75

0.74

g/l

0.02

1054

2780

1757

3161

3.44

307.65

1.6

0.72

0.80

g/l

1.29

1315

2367

All pneumoniae

1917

4647

2.81

307.65

1.6

0.73

0.76

g/l

0.56

1428

3521

Acute pancreatitis

1011

858

13.11

307.65

1.8

1.4

0.69

0.84

g/l

1.80

645

664

Azathioprine

549

618

9.54

307.65

2.4

1.3

0.80

0.69

g/l

0.80

436

467

Influenza and pneumonia

2008

4566

2.85

307.65

1.5

1.6

0.72

0.76

g/l

0.63

1504

3458

Certain disorders involving the immune mechanism

716

1145

6.73

307.65

2.1

1.5

0.67

0.81

g/l

1.46

528

870

Autoimmune diseases excluding thyroid diseases

2173

3531

3.43

307.65

1.8

1.5

0.74

0.79

g/l

0.75

1689

2637

5-aminosalicylic acid

582

917

6.65

307.65

2.2

1.3

0.80

0.69

g/l

1.21

477

679

Asthma, hospital admissions , main diagnosis only

1658

4917

3.04

307.65

1.6

0.75

0.74

g/l

0.06

1249

3719

Systemic connective tissue disorders

1007

1972

5.36

307.65

1.9

1.4

0.73

g/l

0.03

762

1474

1153

2716

4.37

307.65

1.6

0.71

0.73

g/l

0.24

887

2066

Asthma, unspecified (mode), excluding more controls

1050

1633

4.94

307.65

1.6

0.79

0.74

g/l

0.46

760

1225

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1757

3161

3.44

307.65

1.6

0.72

0.80

g/l

1.29

1315

2367

Asthma, hospital admission 2, infections

1422

3560

4.04

307.65

1.6

0.72

0.75

g/l

0.50

1088

2697

IBD (strict) with PSC

237

121.58

307.65

3.2

1.3

0.86

0.54

g/l

2.36

221

Noninfective enteritis and colitis

1097

3093

3.66

307.65

2.0

1.5

0.71

0.77

g/l

0.87

875

2329

ILD medications: immunosuppressive drugs

1747

2739

6.16

307.65

1.9

1.3

0.73

0.74

g/l

0.07

1333

2035

Asthma

1662

1895

4.72

307.65

1.6

0.77

g/l

0.02

1252

1420

Asthma (only as main-diagnosis)

1601

1895

5.03

307.65

1.6

0.73

0.77

g/l

0.44

1199

1420

Asthma-related infections

1422

3560

4.04

307.65

1.6

0.72

0.75

g/l

0.50

1088

2697

Autoimmune diseases related-to ILD

1934

4505

3.77

307.65

1.7

1.5

0.70

0.77

g/l

1.54

1492

3371

Asthma (diagnoses ohter than nonallergic)

1772

4850

3.10

307.65

1.6

1.5

0.77

0.74

g/l

0.41

1338

3669

Asthma, unspecified (mode)

1060

1726

4.74

307.65

1.6

1.5

0.79

0.75

g/l

0.38

767

1294

Asthma-related pneumonia

884

1902

4.82

307.65

1.6

1.5

0.73

0.77

g/l

0.32

667

1435

ILD medications

2871

3024

5.31

307.65

1.8

1.3

0.77

0.75

g/l

0.35

2189

2248

Inflammatory bowel disease treatment related agents

3060

3242

5.46

307.65

1.9

1.3

0.77

0.74

g/l

0.63

2354

2389

Asthma, hospital admissions 3, pneumonia

887

1906

4.82

307.65

1.6

1.5

0.73

0.77

g/l

0.33

670

1438

Reimbursement for rheumatic diseases

1430

3546

4.16

307.65

2.0

1.5

0.74

0.75

g/l

0.18

1131

2655

Pneumonias (Asthma/COPD co-morbidities)

1909

4633

2.82

307.65

1.6

0.73

0.76

g/l

0.49

1423

3512

Chronic sinusitis

984

2531

4.01

307.65

1.6

0.75

g/l

0.06

774

1881

Other diseases of biliary tract

411

293

15.67

307.65

2.9

1.4

1.02

0.84

g/l

0.80

317

228

ILD medications: azathioprine

549

600

9.82

307.65

2.4

1.4

0.80

0.70

g/l

0.73

436

455

Oral corticosteroids

2823

3119

5.56

307.65

1.8

1.3

0.76

0.73

g/l

0.50

2138

2292

Colitis, primary sclerosing, strict definition

233

84.09

307.65

3.1

1.3

0.87

0.63

g/l

1.51

216

First line medication for Crohn's disease

2739

2895

5.27

307.65

1.9

1.3

0.78

0.75

g/l

0.50

2102

2147

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1454

3455

3.88

307.65

1.7

1.5

0.85

0.76

g/l

1.23

1087

2596

Disorders of gallbladder, biliary tract and pancreas

2415

3623

4.33

307.65

1.9

1.4

0.77

0.75

g/l

0.25

1762

2807

Cholangitis (primary sclerosing, PSC)

560

207

34.23

307.65

2.8

1.4

0.85

0.92

g/l

0.26

469

163

Autoimmune diseases excluding thyroid diseases, strict definition

2087

3416

3.42

307.65

1.8

1.4

0.75

0.79

g/l

0.60

1629

2562

Other systemic involvement of connective tissue (FG)

699

1258

5.74

307.65

1.9

1.5

0.74

g/l

0.01

528

935

Colitis, primary sclerosing

294

81.76

307.65

3.1

1.5

0.88

0.80

g/l

0.18

271

Cholangitis (primary sclerosing, PSC), with reimbursement 202

344

73.17

307.65

3.2

1.5

0.82

0.66

g/l

0.48

310

Second line medication for Crohn's disease

1452

3747

4.01

307.65

2.0

1.5

0.74

g/l

0.01

1105

2842

Other systemic involvement of connective tissue

718

1465

5.12

307.65

2.0

1.5

0.73

0.72

g/l

0.07

541

1095

Any gastric operation

1516

1581

4.91

307.65

1.7

1.3

0.72

0.74

g/l

0.22

1140

1298

ILD medications: prednisolone, methylprednisolone, prednisone

2821

2964

5.50

307.65

1.8

1.3

0.77

0.74

g/l

0.42

2148

2200

Ulcerative colitis (strict) with PSC

195

126.17

307.65

3.2

1.3

0.89

0.59

g/l

1.54

183

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

392

225

13.17

307.65

1.7

1.3

0.92

g/l

0.01

284

165

Acute pancreatitis (for exclusion)

1011

1064

10.55

307.65

1.8

1.5

0.69

0.86

g/l

2.36

645

828

Pneumonia, organism unspecified

1742

4242

2.94

307.65

1.6

0.72

0.77

g/l

0.65

1300

3200

Bronchiectasis

312

278

12.33

302.86

1.5

1.6

0.66

0.86

g/l

1.70

237

207

General symptoms and signs

1880

3414

2.80

300.02

1.7

1.5

0.74

0.77

g/l

0.40

1427

2591

Undetermined asthma, excluding more controls

367

423

9.14

293.51

1.7

1.5

0.83

0.75

g/l

0.41

268

324

Undetermined asthma

367

437

8.84

286.01

1.7

1.5

0.83

0.76

g/l

0.34

268

339

Gastrointestinal diseases

949

1134

4.26

276.08

1.7

1.4

0.69

0.82

g/l

2.27

718

879

Other pulmonary diagnosis

1269

1915

3.37

272.45

1.6

0.76

0.77

g/l

0.13

954

1435

Asthma, including avohilmo

2042

4662

2.50

271.88

1.6

0.77

0.74

g/l

0.46

1549

3505

Inflammatory bowel disease

801

2078

4.00

270.87

2.1

1.5

0.75

0.76

g/l

0.12

655

1549

Excluding asthma or asthma-COPD overlap

1265

1915

3.36

270.34

1.6

0.76

0.77

g/l

0.11

950

1435

ILD differential diagnosis

1254

1911

3.34

265.37

1.6

0.76

0.77

g/l

0.07

941

1432

COPD differential diagnosis

1253

1912

3.34

264.66

1.6

0.76

0.77

g/l

0.07

941

1432

Ulcerative colitis

664

1534

4.52

262.86

2.2

1.5

0.78

0.77

g/l

0.11

552

1157

Abnormalities of breathing

1560

3301

2.79

259.52

1.5

1.6

0.69

0.80

g/l

2.31

1182

2484

Other diseases of pancreas

289

290

10.82

258.17

2.0

1.4

0.93

0.87

g/l

0.18

192

228

IBD patients in KELA-register

640

1460

4.58

257.63

2.2

1.5

0.77

g/l

0.02

522

1112

COPD/asthma/ILD related infections

1689

3163

2.72

254.74

1.5

1.6

0.68

0.80

g/l

3.07

1281

2368

COPD/asthma related infections

1689

3163

2.72

254.74

1.5

1.6

0.68

0.80

g/l

3.07

1281

2368

Abnormal findings on examination of blood, without diagnosis

942

2571

3.46

253.40

1.8

1.6

0.83

g/l

0.05

713

1918

Budesonide

374

526

7.47

253.10

1.9

1.3

0.74

0.67

g/l

0.43

297

392

Asthma/COPD (KELA code 203)

1642

4411

2.59

249.56

1.6

0.78

0.74

g/l

0.61

1258

3309

Other respiratory diseases principally affecting the interstitium

466

841

5.82

246.89

1.7

1.6

0.94

0.85

g/l

0.53

337

636

Other diseases of liver

515

1020

5.32

246.46

1.6

0.72

0.77

g/l

0.45

418

770

Bacterial infection, other or unspecified

991

2671

3.30

244.41

1.5

1.6

0.70

0.83

g/l

2.16

749

2001

Bacterial infection, other or unspecified

1056

2877

3.17

243.38

1.5

1.6

0.70

0.82

g/l

2.00

801

2157

Inflammatory bowel disease, strict (require KELA)

640

1530

4.37

242.51

2.2

1.5

0.77

0.75

g/l

0.12

522

1166

Mucosal proctocolitis

430

739

6.19

240.72

2.5

1.5

0.83

0.81

g/l

0.09

362

561

Other bacterial diseases

1638

4384

2.55

239.91

1.5

1.6

0.73

0.78

g/l

0.65

1231

3305

ILD, hospital admission 2, with pulmonary infections

294

338

9.27

236.42

1.8

1.6

0.84

0.88

g/l

0.16

215

262

Fibrosis and cirrhosis of liver

290

332

9.55

235.18

1.7

0.83

0.85

g/l

0.08

246

251

Other interstitial pulmonary diseases

412

696

6.25

234.23

1.7

1.6

0.87

g/l

0.01

297

529

Other inflammatory liver diseases

273

292

10.29

233.41

1.9

1.7

0.81

g/l

0.02

203

218

Any reimbursement code in KELA

977

1369

3.64

233.14

1.7

1.4

0.72

0.76

g/l

0.36

745

1036

Interstitial lung disease endpoints

412

703

6.19

231.84

1.7

1.6

0.87

g/l

0.01

297

533

Interstitial lung disease

412

703

6.19

231.84

1.7

1.6

0.87

g/l

0.01

297

533

Pain in joint

1013

1981

3.32

231.74

1.5

1.6

0.62

0.89

g/l

8.14

785

1487

Tramadol

1363

3046

2.80

231.56

1.5

1.6

0.67

0.80

g/l

3.45

1052

2276

1821

3878

2.46

229.55

1.6

0.67

0.80

g/l

3.98

1400

2898

ILD, hospital admissions

407

696

6.18

228.55

1.7

1.6

0.87

g/l

0.01

292

526

Cholelithiasis, broad definition with cholecystitis

1326

3287

2.76

225.97

1.7

1.4

0.69

0.75

g/l

0.93

967

2539

Anaemias

544

692

5.30

223.59

1.8

1.6

0.75

0.77

g/l

0.10

418

549

Ulcerative colitis, NAS

436

814

5.67

223.23

2.2

1.6

0.80

0.77

g/l

0.15

361

614

Other bacterial diseases

1705

4510

2.44

223.22

1.5

1.6

0.72

0.77

g/l

0.68

1293

3396

Symptoms and signs involving the digestive system and abdomen

1588

3093

2.61

222.75

1.7

1.5

0.77

0.81

g/l

0.51

1186

2352

Asthma and opportunity respiratory infection

218

182

13.55

221.71

1.5

0.67

0.79

g/l

0.54

160

139

Other and unspecified immunodeficiencies with predominantly antibody defects

149

34.10

216.43

2.2

1.4

0.27

0.72

g/l

4.06

121

Abdominal and pelvic pain

1569

3093

2.58

216.26

1.7

1.5

0.77

0.81

g/l

0.57

1162

2352

Acute sinusitis

1003

3154

3.01

216.12

1.6

0.64

0.77

g/l

4.03

780

2370

Diseases of oesophagus, stomach and duodenum

1755

4487

2.37

213.97

1.5

1.6

0.70

0.77

g/l

1.52

1342

3365

Cough

766

2151

3.45

207.94

1.5

1.6

0.68

0.83

g/l

2.18

591

1634

ILD, hospital admissions 1, main diag only

367

625

6.21

207.10

1.7

1.6

0.89

g/l

0.01

267

473

ILD, hospital admissions 3, with pneumonia sepsis

257

297

9.25

206.00

1.7

0.81

0.97

g/l

0.73

185

234

Cholelithiasis

1237

3218

2.69

202.71

1.6

1.4

0.68

0.74

g/l

1.13

893

2485

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

469

1024

4.81

199.97

2.3

1.6

0.79

0.78

g/l

0.05

388

774

Chronic hepatitis, not elsewhere classified

182

134

15.58

199.94

2.0

1.7

0.71

0.88

g/l

0.50

142

Ulcerative colitis (strict definition, require KELA)

478

1067

4.70

198.24

2.3

1.5

0.79

0.78

g/l

0.05

394

804

Chronic rhinitis, nasopharyngitis and pharyngitis

659

1864

3.64

195.98

1.7

1.6

0.69

0.76

g/l

0.79

539

1397

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

491

1160

4.43

189.25

2.3

1.5

0.78

0.77

g/l

0.03

404

878

Non-allergic asthma (mode), excluding more controls

363

654

5.66

189.05

1.6

1.5

0.73

0.78

g/l

0.25

278

507

Bronchitis

1716

4863

2.25

188.77

1.5

1.6

0.67

0.78

g/l

3.09

1311

3649

Septicaemia

734

2115

3.32

187.26

1.6

0.75

0.83

g/l

0.81

548

1595

Bacterial pneumonia (organism specified)

786

2278

3.20

187.22

1.5

1.6

0.66

0.81

g/l

2.76

569

1724

L04AA Selective immunosuppressants

558

1459

3.98

187.16

1.8

1.6

0.63

0.75

g/l

1.77

427

1102

Dyspnoea

1463

4646

2.36

186.42

1.5

1.6

0.67

0.77

g/l

2.34

1106

3520

Allergic asthma (mode), excluding more controls

435

918

4.75

185.45

1.6

0.72

0.75

g/l

0.25

359

704

Bacterial pneumoniae

715

1910

3.38

184.36

1.5

1.6

0.68

0.82

g/l

2.19

522

1434

Non-allergic asthma (mode)

363

674

5.49

182.96

1.6

1.5

0.73

0.78

g/l

0.27

278

522

Allergic asthma (mode)

435

932

4.68

182.10

1.6

0.72

0.76

g/l

0.34

359

716

Symptoms and signs involving the circulatory and respiratory systems

1555

3315

2.38

181.60

1.5

1.6

0.69

0.80

g/l

2.50

1161

2491

Certain infectious and parasitic diseases

1494

3140

2.41

179.66

1.6

0.71

0.79

g/l

1.64

1121

2351

Enlarged lymph nodes

383

774

5.15

178.54

1.9

1.4

1.10

0.73

g/l

2.95

294

600

Medical observation and evaluation for suspected diseases and conditions

1048

1882

2.89

178.28

1.7

1.5

0.84

0.85

g/l

0.04

828

1294

Bacterial pneumonia, not elsewhere classified

675

1782

3.41

176.99

1.5

1.6

0.69

0.83

g/l

1.75

493

1342

Acute upper respiratory infections

1615

4477

2.25

176.63

1.5

1.6

0.65

0.79

g/l

4.86

1248

3354

Other necrotizing vasculopathies

237

301

8.50

176.42

1.7

1.6

0.70

0.79

g/l

0.42

172

236

Bacterial Sepsis

786

2225

3.08

173.54

1.5

1.6

0.70

0.85

g/l

1.92

577

1673

Finngen Rheumatological endpoints

1520

3794

2.31

172.42

1.6

1.5

0.71

0.77

g/l

1.12

1157

2846

Other specified/unspecified systemic involvement of connective tissue

221

266

9.07

172.34

2.9

1.5

0.94

0.70

g/l

1.37

180

200

Obesity related asthma

655

2006

3.36

172.04

1.4

1.5

0.66

0.76

g/l

1.48

475

1506

Explicit Sepsis

762

2358

3.08

171.93

1.6

0.74

0.81

g/l

0.74

569

1775

Other septicaemia

647

1883

3.38

171.15

1.5

1.6

0.72

0.84

g/l

1.55

484

1416

Other necrotizing vasculopathies (FG)

203

223

9.84

169.63

1.7

1.6

0.68

0.77

g/l

0.43

147

177

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

234

311

8.03

167.19

1.7

1.6

0.85

0.78

g/l

0.35

160

233

Headache

1019

3137

2.63

166.63

1.6

1.5

0.61

0.75

g/l

5.29

777

2392

Other diseases of pleura

746

2165

3.09

166.05

1.6

0.78

0.85

g/l

0.58

551

1613

Nonhereditary hypogammaglobulinemia

114

32.33

164.64

2.3

2.0

0.21

0.80

g/l

1.61

Other diseases of intestines

1652

4378

2.17

162.65

1.6

0.70

0.78

g/l

1.78

1257

3308

Opioids

1482

3411

2.28

160.08

1.6

0.70

0.78

g/l

1.57

1117

2566

Other acute lower respiratory infections

926

3395

2.65

158.69

1.6

0.71

0.80

g/l

1.17

711

2562

Polyarthropathies

1105

2918

2.51

155.92

1.5

1.6

0.69

0.81

g/l

2.31

845

2211

Implicit bacterial Sepsis

671

1928

3.15

155.23

1.5

1.6

0.69

0.86

g/l

2.91

489

1451

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

501

579

4.40

151.91

1.7

1.5

0.77

0.78

g/l

0.10

383

437

Pain in throat and chest

1243

3209

2.36

149.96

1.6

0.70

0.80

g/l

2.19

952

2407

Acute upper respiratory infections of multiple and unspecified sites

1185

3790

2.35

149.80

1.5

1.6

0.65

0.79

g/l

3.26

905

2847

Implicit bacterial Sepsis

712

2106

2.98

148.74

1.5

1.6

0.69

0.85

g/l

2.81

524

1584

Infections, IBD-co-morbidities

319

409

5.73

148.19

1.6

1.5

0.69

0.85

g/l

0.84

225

313

Selective deficiency of immunoglobulin G [IgG] subclasses

40.40

146.51

2.5

1.7

0.30

0.64

g/l

1.99

Other noninfective gastroenteritis and colitis

502

1443

3.58

145.78

1.8

1.5

0.66

0.79

g/l

2.08

397

1101

Malaise and fatigue

762

2188

2.85

144.99

1.5

0.74

0.78

g/l

0.31

578

1664

Kela reimbursement Agammaglobulinemia (D80-84)

37.03

144.49

2.1

1.6

0.20

0.67

g/l

3.45

Codeine

1361

3339

2.24

142.73

1.5

1.6

0.68

0.78

g/l

2.44

1010

2507

Other specific joint derangements/joint disorders

1175

3292

2.34

142.13

1.5

1.6

0.62

0.80

g/l

7.51

892

2502

Implicit Sepsis

1134

3719

2.33

141.57

1.5

1.6

0.70

0.79

g/l

1.75

830

2807

Other diseases of upper respiratory tract

1576

3954

2.10

139.59

1.6

0.77

0.79

g/l

0.19

1215

2937

Sicca syndrome [Sjögren]

245

415

6.27

139.38

1.6

1.5

0.60

0.66

g/l

0.31

171

315

Acute bronchitis

700

2458

2.85

138.97

1.6

0.68

0.78

g/l

0.92

535

1855

Primary biliary cholangitis (PBC)

116

18.31

138.73

2.0

1.9

0.56

0.98

g/l

1.07

100

Diseases of the respiratory system

865

1585

2.77

136.08

1.6

0.74

0.77

g/l

0.22

649

1179

Suggestive for eosinophilic asthma

245

430

6.02

134.15

2.0

1.6

1.26

0.79

g/l

3.23

193

323

Mixed connective tissue disease

210

319

7.09

133.38

2.4

1.6

0.82

0.73

g/l

0.38

169

238

Other soft tissue disorders, not elsewhere classified

1405

3914

2.13

132.91

1.5

1.6

0.70

0.80

g/l

2.19

1072

2938

Crohn disease

334

771

4.53

132.82

2.0

1.5

0.70

0.79

g/l

0.46

273

586

Implicit viral Sepsis

504

1558

3.31

130.34

1.5

1.6

0.57

0.83

g/l

6.27

372

1193

Nausea and vomiting

444

1241

3.58

129.50

1.7

1.5

0.69

0.77

g/l

0.74

348

967

Hernia of abdominal wall, postoperative

257

488

5.39

128.08

1.7

1.3

0.64

0.79

g/l

1.55

185

410

Early onset COPD, excluding more controls

308

682

4.62

128.02

1.6

1.5

0.69

0.82

g/l

1.06

230

520

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

334

804

4.33

125.72

1.6

0.88

0.86

g/l

0.11

268

612

Ulcerative colitis (strict definition, all Crohn cases excluded)

351

879

4.16

125.23

2.2

1.6

0.79

0.77

g/l

0.11

287

671

Diseases of the digestive system

719

2779

2.62

122.15

1.8

1.6

0.77

0.80

g/l

0.27

535

2080

Eosinophilic disease (BM)

22.15

122.10

2.0

1.3

1.66

0.68

g/l

2.84

Gastro-oesophageal reflux disease

1005

3866

2.27

121.98

1.5

1.6

0.63

0.79

g/l

5.80

738

2906

Other special examinations and investigations of persons without complaint or reported diagnosis

920

1882

2.50

120.30

1.6

1.5

0.75

0.85

g/l

1.34

696

1294

Asthma and allergy, excluding more controls

260

523

5.05

119.28

1.7

1.8

0.68

0.78

g/l

0.91

219

411

Other ulcerative colitis

190

295

6.90

118.12

2.4

1.6

0.86

0.91

g/l

0.13

158

219

Asthma and allergy

260

528

5.00

117.95

1.7

0.68

0.80

g/l

1.07

219

413

Implicit Sepsis

1180

4102

2.13

117.70

1.5

1.6

0.70

0.78

g/l

1.43

859

3115

Other diseases of blood and blood-forming organs, wide

443

1351

3.38

117.68

1.6

0.84

0.77

g/l

0.36

315

1026

Sulfasalazine

414

1209

3.49

117.10

1.6

1.3

0.62

0.72

g/l

1.18

308

893

Viral Sepsis

379

1050

3.72

116.62

1.6

0.57

0.82

g/l

4.86

280

809

Implicit viral Sepsis

378

1046

3.72

116.52

1.6

0.57

0.82

g/l

4.86

279

806

Oedema, not elsewhere classified

478

1510

3.18

116.05

1.7

1.4

0.69

0.78

g/l

1.13

365

1151

Pain (limb, back, neck, head abdominally)

974

2064

2.39

115.38

1.6

0.71

0.89

g/l

3.68

732

1550

Abnormal serum enzyme levels

505

1635

3.09

115.14

1.8

1.6

0.77

0.91

g/l

1.95

405

1224

Unspecified jaundice

144

167

9.17

115.13

2.1

1.5

0.85

0.90

g/l

0.16

101

138

Nonalcoholic fatty liver disease

272

604

4.75

114.05

1.3

1.7

0.71

0.78

g/l

0.49

231

458

Other disorders of white blood cells

173

253

7.35

113.85

1.7

1.28

0.86

g/l

1.42

120

192

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

780

3154

2.44

113.73

1.6

0.66

0.79

g/l

2.93

573

2342

Intestinal infectious diseases

1377

5360

1.97

112.59

1.7

1.5

0.72

0.76

g/l

0.63

1042

4042

Cholecystectomy

1030

4156

2.17

111.14

1.6

1.5

0.69

0.75

g/l

0.86

741

3163

L04AD Calcineurin inhibitors

289

696

4.37

109.14

1.8

1.6

0.66

0.81

g/l

1.35

219

535

Dermatitis

920

4190

2.22

108.24

1.6

0.77

0.74

g/l

0.25

682

3181

Codeine or tramadol medication

1587

4619

1.90

108.19

1.5

1.6

0.69

0.77

g/l

1.74

1179

3475

Cirrhosis of liver, NAS

162

234

7.44

107.84

1.5

1.6

1.02

0.87

g/l

0.58

139

171

Heart failure, not strict

1047

3333

2.16

106.73

1.5

1.6

0.76

0.80

g/l

0.34

788

2493

Intestinal malabsorption

156

219

7.68

106.65

2.3

1.6

0.90

0.80

g/l

0.30

104

174

Certain infectious and parasitic diseases

994

2212

2.27

105.74

1.6

1.5

0.73

0.79

g/l

0.75

769

1634

Diseases of the skin and subcutaneous tissue

1406

3600

1.98

105.52

1.6

0.74

0.78

g/l

0.53

1057

2706

Intestinal infectious diseases

1607

4976

1.86

104.55

1.7

1.5

0.71

0.77

g/l

0.97

1225

3732

Low back pain

1082

3750

2.10

103.48

1.6

0.67

0.79

g/l

3.18

814

2820

Other and unspecified dermatitis

790

3459

2.32

103.35

1.6

0.76

0.75

g/l

0.04

588

2643

Other immunodeficiencies

19.08

102.99

2.3

2.5

0.72

0.99

g/l

0.40

Pain, not elsewhere classified

435

1421

3.12

102.54

1.7

1.5

0.68

0.75

g/l

0.62

348

1085

Pain in limb

1146

3775

2.05

102.30

1.5

1.6

0.71

0.80

g/l

1.56

886

2830

Cardiovascular diseases

941

2254

2.27

101.77

1.6

0.72

0.74

g/l

0.17

695

1768

Dental caries

447

1428

3.08

101.52

1.6

0.61

0.88

g/l

5.79

345

1066

Aplastic and other anaemias

646

2417

2.53

101.14

1.5

1.6

0.76

0.84

g/l

0.67

456

1825

Diarrhoea and gastroenteritis of presumed infectious origin

1041

4583

2.07

100.90

1.7

1.6

0.73

0.78

g/l

0.47

791

3455

Ethmoidectomy

301

792

3.96

100.41

1.9

1.6

1.00

0.78

g/l

1.20

222

606

Exclusions for E4_PCOS_BROAD

372

1125

3.42

100.24

1.6

0.67

0.78

g/l

1.10

214

879

All kidney diseases

1385

5028

1.90

100.00

1.6

0.70

0.75

g/l

1.08

1021

3824

Condition for Implicit Sepsis (Organ dysfunction codes)

1187

4232

2.00

99.98

1.5

1.6

0.69

0.78

g/l

2.11

863

3222

Oxycodone

545

1825

2.75

99.83

1.5

1.6

0.65

0.87

g/l

4.03

404

1349

Irritable bowel syndrome

475

1661

2.92

99.40

1.5

1.6

0.59

0.72

g/l

2.41

359

1253

Vocal cord dysfunction

229

430

4.90

98.59

1.7

1.3

0.62

0.88

g/l

2.17

161

326

Covid-19 confirmed case

577

2242

2.62

98.32

1.8

1.5

0.67

0.79

g/l

1.52

418

1688

Other Crohn's disease

196

375

5.52

97.96

2.0

1.5

0.62

0.83

g/l

1.33

157

284

Cardiovascular diseases (excluding rheumatic etc)

977

2619

2.17

96.82

1.6

0.74

0.72

g/l

0.15

716

2035

Eosinophilia

14.12

96.53

2.0

1.7

1.66

0.76

g/l

2.05

FESS (DNB20)

291

769

3.94

96.51

1.9

1.6

1.03

0.78

g/l

1.43

213

587

General examination and investigation of persons without complaint and reported diagnosis

834

1882

2.34

95.56

1.6

1.5

0.69

0.85

g/l

3.23

688

1294

Diagnoses used for exclusion with ILD

435

1484

3.00

95.32

1.6

0.87

0.80

g/l

0.41

311

1147

Diarrhoea and gastroenteritis of presumed infectious origin

1406

5013

1.87

95.28

1.7

1.5

0.71

0.77

g/l

1.00

1076

3767

Provisional assignment of new diseases of uncertain etiology

805

3670

2.22

95.14

1.8

1.5

0.68

0.76

g/l

1.34

621

2767

Codes for special purposes

805

3673

2.22

94.95

1.8

1.5

0.68

0.76

g/l

1.35

621

2770

Vasomotor and allergic rhinitis

583

2268

2.57

94.83

1.7

1.6

0.74

0.75

g/l

0.09

474

1694

Condition for Implicit Sepsis (Organ dysfunction codes)

1233

4425

1.94

94.80

1.4

1.6

0.68

0.77

g/l

2.09

907

3347

Other anaemias

593

2259

2.54

93.61

1.5

1.6

0.77

0.82

g/l

0.34

420

1701

Persons encountering health services in other circumstances, wide

1593

4570

1.81

92.58

1.6

0.81

0.75

g/l

0.69

1230

3415

Other and unspecified anaemias

587

2246

2.53

92.36

1.5

1.6

0.76

0.83

g/l

0.53

415

1692

Haemorrhage from respiratory passages

468

1504

2.85

92.05

1.7

1.5

0.75

0.90

g/l

1.62

342

1119

Dermatitis and eczema

1519

5253

1.81

91.98

1.6

0.74

0.76

g/l

0.15

1139

3963

Disorders of other endocrine glands

689

2940

2.34

91.97

1.6

0.68

0.73

g/l

0.49

441

2255

Diseases of salivary glands

542

2113

2.62

91.93

1.8

1.5

0.79

0.73

g/l

0.44

413

1577

Complications of surgical and medical care, not elsewhere classified

1353

5055

1.85

90.05

1.5

1.6

0.71

0.75

g/l

0.59

1022

3804

Other disorders involving the immune mechanism, not elsewhere classified

120

152

8.66

90.00

3.3

1.8

1.38

0.88

g/l

0.88

121

Primary_lymphoid and hematopoietic malignant neoplasms

394

1314

3.07

89.95

1.5

1.6

0.58

0.85

g/l

4.35

286

998

Osteoporosis

387

1185

3.12

89.51

1.7

1.5

0.68

0.76

g/l

0.62

277

878

Pleural effusion

259

664

4.01

89.25

1.8

1.7

0.92

0.94

g/l

0.06

190

507

Parasetamol

1026

2516

2.09

89.17

1.6

1.7

0.72

0.85

g/l

2.67

773

1897

Other arthritis (FG)

474

1760

2.74

88.49

1.5

0.70

0.81

g/l

1.12

363

1316

Dorsalgia

1347

3881

1.88

88.44

1.6

0.69

0.79

g/l

2.60

1007

2922

Noninfectious colitis NAS

277

753

3.80

87.98

2.0

1.5

0.66

0.78

g/l

1.14

227

569

Caries of dentine

390

1270

3.06

87.82

1.6

0.61

0.89

g/l

5.46

300

950

Idiopathic pulmonary fibrosis

157

270

6.07

87.70

1.6

0.93

0.90

g/l

0.09

116

208

Other heart diseases

724

2062

2.32

86.98

1.5

1.6

0.73

0.74

g/l

0.13

547

1600

Liquid cancers, helper endpoint

567

1997

2.52

86.64

1.5

1.6

0.67

0.82

g/l

1.82

414

1510

Endocrine, nutritional and metabolic diseases

1139

2943

1.98

86.00

1.6

0.73

0.78

g/l

0.65

835

2300

Disorders of lacrimal system

637

2748

2.35

85.93

1.7

1.5

0.64

0.73

g/l

1.03

471

2072

Adrenocortical insufficiency

127

182

7.57

85.42

1.7

0.58

0.81

g/l

1.11

141

Biological medication for rheuma

362

1198

3.12

84.12

1.6

0.57

0.75

g/l

2.69

269

906

Crohn's disease NAS

173

341

5.34

83.64

2.0

1.6

0.65

0.82

g/l

0.91

148

260

Neoplasms

1084

2925

1.98

83.38

1.7

1.6

0.74

0.76

g/l

0.22

801

2242

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

110

138

8.74

83.15

3.4

1.9

1.41

0.89

g/l

0.82

108

Other disorders of adrenal gland

142

235

6.47

83.07

1.6

0.57

0.80

g/l

1.32

180

Persons encountering health services for examination and investigation

824

1882

2.22

82.93

1.7

1.5

0.78

0.85

g/l

0.72

651

1294

Other functional intestinal disorders

632

2552

2.33

82.69

1.5

1.6

0.63

0.78

g/l

3.66

465

1939

All influenza

392

1370

2.92

82.13

1.5

1.6

0.64

0.84

g/l

3.03

295

1052

Abnormal findings on diagnostic imaging of other body structures

255

687

3.83

82.08

1.8

1.5

0.81

0.74

g/l

0.30

187

521

Implicit fungal Sepsis

156

287

5.70

81.30

1.4

1.7

0.64

0.88

g/l

1.35

107

221

All chronic kidney diseases

736

2781

2.19

81.24

1.7

1.6

0.78

0.81

g/l

0.19

546

2093

Viral pneumonia

240

625

3.96

81.03

1.4

1.7

0.58

0.83

g/l

3.53

174

481

Ulcerative ileocolitis

132

209

6.78

80.69

2.8

1.6

0.88

0.93

g/l

0.12

107

160

Other disorders of lacrimal gland

534

2205

2.47

80.16

1.7

1.5

0.62

0.75

g/l

1.59

389

1660

Persons encountering health services for specific procedures and health care

1457

5009

1.76

79.96

1.5

1.6

0.70

0.77

g/l

1.40

1110

3763

Respiratory disorders in diseases classified elsewhere

14.26

79.69

2.0

1.7

0.75

0.77

g/l

0.03

Other specified/unspecified arthritis

422

1560

2.76

79.58

1.5

1.6

0.73

0.83

g/l

0.81

320

1186

Functional dyspepsia

411

1503

2.79

79.17

1.7

1.5

0.74

g/l

0.02

315

1118

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1468

4568

1.76

79.13

1.6

0.78

0.75

g/l

0.28

1170

3413

Soft tissue disorders

1376

3964

1.80

79.03

1.5

1.6

0.71

0.80

g/l

2.08

1038

2976

Drug-induced adrenocortical insufficiency

11.74

78.75

1.9

2.0

0.46

0.85

g/l

1.06

Lower back pain or/and sciatica

1400

5238

1.76

78.53

1.5

1.6

0.64

0.77

g/l

4.67

1050

3935

Abnormal results of function studies

196

451

4.53

78.45

1.9

1.6

0.76

0.79

g/l

0.14

147

346

Disorders of thyroid, IBD co-morbidities

256

462

3.96

78.44

1.5

0.76

0.80

g/l

0.22

193

353

Osteopathies and chondropathies

783

3537

2.09

78.32

1.6

0.70

0.77

g/l

0.73

576

2689

Renal failure

597

2287

2.34

78.22

1.6

0.73

0.85

g/l

1.27

427

1718

Arthropathies

1232

3380

1.86

78.20

1.5

1.6

0.70

0.81

g/l

2.20

951

2566

Cholecystitis

215

530

4.16

78.12

2.1

1.4

0.89

0.83

g/l

0.21

162

402

Other joint disorders

1185

3363

1.88

77.50

1.5

1.6

0.70

0.80

g/l

2.12

898

2549

Other heart diseases, wide

1271

4326

1.81

77.50

1.5

1.6

0.74

0.75

g/l

0.13

945

3298

Rheumatoid arthritis

463

1612

2.62

77.27

1.6

0.66

0.82

g/l

2.09

350

1225

Nasal polyp

312

995

3.21

77.00

1.8

1.6

1.13

0.82

g/l

2.00

258

742

Metabolic disorders

1264

4299

1.81

76.66

1.5

1.6

0.73

0.77

g/l

0.69

943

3245

Renal tubulo-interstitial diseases

1152

4709

1.84

76.61

1.6

0.68

0.76

g/l

1.57

852

3563

Disorders of eyelid, lacrimal system and orbit

1132

4702

1.85

76.45

1.7

1.5

0.69

0.75

g/l

0.87

850

3560

Other respiratory disorders and diseases

315

1018

3.17

75.97

1.6

0.65

0.87

g/l

2.89

233

769

Other diseases of the respiratory system

315

1018

3.17

75.97

1.6

0.65

0.87

g/l

2.89

233

769

Wegener granulomatosis

12.93

75.73

1.9

1.7

0.67

0.74

g/l

0.14

Nutritional anaemias

668

2987

2.19

75.49

1.7

1.5

0.73

0.78

g/l

0.42

520

2239

Symptoms and signs involving the skin and subcutaneous tissue

959

4978

1.91

74.69

1.8

1.5

0.79

0.73

g/l

0.67

758

3747

Benign neoplasm of colon, rectum, anus and anal canal

810

3504

2.03

74.28

1.7

1.5

0.70

0.81

g/l

2.07

631

2598

COPD (mode)

325

820

3.16

74.07

1.5

0.79

0.81

g/l

0.06

250

608

Neurological diseases, wide definition

425

739

2.92

73.95

1.6

0.74

0.80

g/l

0.33

319

575

Hypothyroidism (congenital or acquired)

377

706

3.06

73.60

1.5

1.6

0.65

0.75

g/l

1.35

273

555

Dysphagia

329

1110

3.02

73.48

1.5

0.76

0.84

g/l

0.50

235

843

Hypothyroidism and >3 levothyroxin purchases

375

702

3.06

73.39

1.5

1.6

0.66

0.76

g/l

1.17

271

551

Hypothyroidism, levothyroxine purchases

375

702

3.06

73.39

1.5

1.6

0.66

0.76

g/l

1.17

271

551

Coagulation defects, purpura and other haemorrhagic conditions

343

1194

2.95

72.75

1.7

1.6

0.71

0.80

g/l

0.62

268

907

Hypertensive diseases (excluding secondary)

738

2012

2.16

72.36

1.6

0.69

0.73

g/l

0.41

531

1556

Pneumonia due to other infectious organisms, not elsewhere classified

126

8.32

72.25

1.4

1.6

0.48

0.92

g/l

2.21

Complications of procedures, not elsewhere classified

1070

4877

1.83

71.86

1.5

1.6

0.72

0.75

g/l

0.29

814

3666

Diverticular disease of intestine

881

2864

1.98

71.18

1.6

0.73

0.81

g/l

1.03

688

2144

Other diseases of pericardium

114

176

6.84

71.16

1.6

1.7

0.77

0.87

g/l

0.30

135

Transplanted organ and tissue status

212

558

3.95

70.83

1.9

1.7

0.61

0.84

g/l

2.29

162

451

Symptoms and signs concerning food and fluid intake

188

452

4.28

70.65

1.7

1.5

0.85

0.78

g/l

0.24

141

362

Collagenous colitis

187

451

4.31

70.41

1.7

1.5

0.64

0.81

g/l

1.14

137

336

Other dorsopathies, not elsewhere classified

1307

3909

1.76

70.33

1.6

0.70

0.79

g/l

1.81

983

2946

Dorsopathies

1347

3942

1.75

70.13

1.5

1.6

0.71

0.79

g/l

1.79

1007

2975

Benign neoplasm: Colon

689

3180

2.10

69.89

1.7

1.5

0.70

0.82

g/l

1.88

538

2372

Iron deficiency anaemia

581

2596

2.24

69.88

1.6

0.68

0.77

g/l

0.96

449

1957

Other disorders of fluid, electrolyte and acid-base balance

429

1616

2.57

69.87

1.4

1.6

0.69

0.84

g/l

1.73

308

1205

Diseases of the musculoskeletal system and connective tissue

718

1667

2.18

69.67

1.6

0.71

0.81

g/l

1.37

542

1274

Total colectomy operation

122

207

6.29

69.58

2.4

1.7

1.02

0.91

g/l

0.24

101

159

Total colectomy

122

207

6.29

69.58

2.4

1.7

1.02

0.91

g/l

0.24

101

159

Neurological diseases

1159

3217

1.83

69.04

1.5

1.6

0.72

0.80

g/l

1.53

860

2480

Benign neoplasm of other and ill-defined parts of digestive system

298

988

3.10

69.00

1.8

1.5

0.70

0.77

g/l

0.50

231

739

Complications of medical and surgical care

965

4825

1.86

68.83

1.5

1.6

0.72

0.75

g/l

0.26

722

3646

Biological medicines for asthma

9.75

68.64

1.6

1.9

1.27

0.80

g/l

1.41

Other and unspecified iron deficiency

472

1980

2.42

68.32

1.5

0.66

0.75

g/l

0.91

362

1486

Methotrexate

202

525

3.94

68.27

1.5

1.3

0.60

0.65

g/l

0.29

143

397

Spondylopathies

993

3175

1.89

68.25

1.5

1.6

0.66

0.82

g/l

4.36

718

2372

Other headache syndromes

602

2798

2.18

68.10

1.5

1.6

0.63

0.72

g/l

1.90

453

2140

Diseases of the eye and adnexa

1102

3014

1.85

68.08

1.6

1.5

0.70

0.80

g/l

1.84

830

2284

Constipation

1146

4494

1.78

67.74

1.5

1.6

0.66

0.78

g/l

3.35

836

3435

Hypopituitarism

183

449

4.28

67.58

1.6

1.7

0.70

0.86

g/l

0.89

362

Fibromyalgia

184

452

4.21

67.52

1.5

1.6

0.56

0.70

g/l

1.16

140

343

Chronic kidney disease

397

1516

2.61

67.22

1.6

0.77

0.87

g/l

0.62

287

1149

Anxiety disorders, excluding more controls

1117

4081

1.80

67.17

1.6

0.67

0.78

g/l

2.40

867

3071

6-mercaptopurine

131

7.78

67.13

2.4

1.4

0.71

0.67

g/l

0.16

100

Benign neoplasms

1280

4088

1.74

66.57

1.6

1.5

0.75

0.77

g/l

0.28

947

3085

Crohn's disease of large intestine

138

275

5.29

66.02

2.2

1.5

0.80

0.84

g/l

0.09

114

213

Dialysis, with operation codes

239

714

3.46

65.96

1.4

1.7

0.60

0.86

g/l

3.04

180

550

Candidiasis

440

1823

2.46

65.72

1.5

0.69

0.73

g/l

0.27

335

1370

ILD-related respiratory insufficiency

120

8.12

65.70

1.4

1.5

0.67

0.91

g/l

0.65

Sarcoidosis

250

771

3.34

65.55

1.6

0.77

0.82

g/l

0.27

173

595

Tumor necrosis factor alpha inhibitors

309

1078

2.95

65.48

1.5

1.6

0.57

0.76

g/l

2.65

228

808

Polymyalgia rheumatica

192

498

3.96

65.19

1.5

0.70

0.80

g/l

0.69

149

373

Chronic hepatitis NAS

13.02

65.13

1.9

1.7

0.75

0.82

g/l

0.11

COPD

515

1844

2.31

64.81

1.5

1.6

0.77

0.81

g/l

0.30

389

1362

Alcohol-induced chronic pancreatitis

155

348

4.68

64.27

1.5

1.7

0.85

0.91

g/l

0.22

271

Other gastritis (incl. Duodenitis)

322

1165

2.82

63.44

1.7

1.6

0.67

0.85

g/l

2.61

254

865

SLE (Finngen)

122

7.82

63.31

1.7

1.8

0.53

0.89

g/l

1.38

Abnormalities of heart beat

443

1832

2.40

63.08

1.4

1.6

0.69

0.82

g/l

1.72

321

1393

9.89

63.02

1.6

1.3

0.83

0.86

g/l

0.06

Malignant neoplasm of pancreas, including Hilmo

155

353

4.54

62.80

1.8

1.7

0.77

0.96

g/l

0.96

114

272

Episodal and paroxysmal disorders

1410

4318

1.67

62.74

1.5

1.6

0.72

0.78

g/l

1.15

1033

3310

Acute renal failure

314

1131

2.83

62.45

1.4

1.6

0.65

0.91

g/l

3.70

213

858

Other chronic obstructive pulmonary disease

491

1779

2.30

61.40

1.5

1.6

0.77

0.82

g/l

0.38

369

1310

Mycoses

409

1692

2.46

61.38

1.6

0.72

0.78

g/l

0.34

299

1281

Purpura and other haemorrhagic conditions

247

787

3.23

61.37

1.8

1.6

0.73

0.78

g/l

0.27

191

602

Other intervertebral disc disorders

1033

3495

1.79

60.95

1.5

1.6

0.70

0.80

g/l

1.91

756

2618

Anxiety disorders

1196

4933

1.70

60.73

1.6

0.67

0.76

g/l

2.21

927

3698

Chronic laryngitis and laryngotracheitis

222

667

3.41

60.57

1.5

1.6

0.70

0.77

g/l

0.43

169

498

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

108

186

6.10

60.47

1.5

1.8

0.57

1.01

g/l

2.61

149

Neurotic, stress-related and somatoform disorders

1183

4895

1.71

60.30

1.6

0.67

0.76

g/l

2.01

919

3666

Alcohol-induced acute pancreatitis

109

191

6.11

60.27

1.4

1.7

0.72

0.95

g/l

0.91

146

Ulcerative enterocolitis

148

6.94

60.24

2.5

1.6

0.92

0.90

g/l

0.02

110

Nephropathy related operations

225

687

3.38

60.03

1.5

1.6

0.62

0.88

g/l

2.65

167

529

Fungal Sepsis

102

169

6.38

59.50

1.5

1.6

0.61

0.89

g/l

1.02

131

Ascites

132

278

4.91

58.90

1.6

1.4

0.88

0.80

g/l

0.26

218

Rheumatoid arthritis, including avohilmo

520

2422

2.18

58.86

1.6

1.5

0.66

0.76

g/l

1.52

390

1808

Cardiac arrhythmias

808

2777

1.91

58.84

1.4

1.6

0.71

0.74

g/l

0.37

592

2142

Antihypertensive medication - note that there are other indications

846

2373

1.91

58.54

1.5

1.6

0.69

0.77

g/l

1.20

628

1833

Seropositive rheumatoid arthritis

332

1266

2.66

58.50

1.7

1.4

0.73

0.75

g/l

0.15

250

944

Bleeding

1032

4219

1.76

58.49

1.6

0.74

0.80

g/l

0.75

776

3174

Spondyloarthritis

266

908

2.99

58.38

1.5

0.60

0.83

g/l

3.14

195

691

Unspecified acute lower respiratory infection

258

869

3.04

58.17

1.6

0.65

0.80

g/l

1.37

194

667

Sleep disorders (combined)

1413

4576

1.63

57.56

1.5

1.6

0.75

0.76

g/l

0.13

1034

3484

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

598

1802

2.12

57.56

1.7

1.6

0.77

0.73

g/l

0.44

445

1388

Implicit fungal Sepsis

157

6.48

56.77

1.5

1.7

0.63

0.87

g/l

0.73

121

Erysipelas

839

3506

1.84

56.75

1.6

0.79

0.80

g/l

0.07

639

2628

Depression medications

394

765

2.62

56.61

1.5

1.7

0.65

0.78

g/l

1.74

293

606

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

124

258

4.99

56.22

2.1

1.7

0.77

0.94

g/l

0.77

201

Oesophageal varices

104

187

5.88

55.81

2.1

1.7

0.82

0.93

g/l

0.30

151

Mood disorders, excluding more controls

1193

4278

1.68

55.57

1.5

1.6

0.68

0.78

g/l

1.96

903

3218

Osteoporosis with pathological fracture (FG)

115

227

5.23

55.33

1.8

1.5

0.74

0.69

g/l

0.11

174

Hypertension, essential

998

3223

1.77

55.31

1.6

0.69

0.77

g/l

1.58

726

2446

Depression

1232

5104

1.65

55.06

1.5

1.6

0.68

0.76

g/l

1.88

933

3834

Diaphragmatic hernia

467

2145

2.21

54.78

1.6

1.5

0.68

0.77

g/l

1.07

373

1610

Migraine

678

2854

1.95

54.75

1.5

1.6

0.60

0.70

g/l

1.82

515

2212

Hepatic failure, not elsewhere classified

143

6.65

54.71

1.6

1.8

0.82

0.88

g/l

0.12

108

Myalgia

344

1394

2.51

53.99

1.5

1.6

0.58

0.75

g/l

3.13

262

1045

Pulmonary heart disease, diseases of pulmonary circulation

409

1791

2.32

53.84

1.6

0.75

0.83

g/l

0.48

318

1340

Other bacterial intestinal infections

267

958

2.84

53.59

1.6

1.5

0.65

0.81

g/l

1.16

197

715

Adalimumab

202

621

3.37

53.45

1.6

1.7

0.54

0.76

g/l

2.51

157

474

Infection due to other mycobacteria

12.25

53.37

1.5

1.4

0.63

g/l

0.00

Drug-induced osteoporosis with pathological fracture

10.86

53.36

2.2

2.1

0.75

0.98

g/l

0.34

Mood disorders

1299

5239

1.62

53.23

1.5

1.6

0.68

0.77

g/l

2.17

982

3944

Crohn disease (strict definition, require KELA)

151

385

4.09

52.98

1.9

1.7

0.69

0.79

g/l

0.31

119

297

Rheumatism, unspecified

217

699

3.18

52.89

1.8

1.6

0.65

0.74

g/l

0.75

162

520

Mood [affective] disorders

1295

5238

1.61

52.82

1.5

1.6

0.68

0.77

g/l

2.15

980

3941

Infections of the skin and subcutaneous tissue

784

4320

1.82

52.78

1.6

0.76

0.79

g/l

0.17

614

3244

Chronic gastritis

331

1331

2.52

52.74

1.4

1.6

0.67

0.82

g/l

1.87

278

989

Viral infections characterized by skin and mucous membrane lesions

1091

5652

1.66

52.63

1.6

0.69

0.76

g/l

1.11

815

4281

Crohn disease (strict definition, require KELA, min 2 HDR)

149

379

4.10

52.46

1.9

1.7

0.69

0.80

g/l

0.33

117

292

Allergic rhinitis

479

2239

2.15

52.18

1.6

0.74

0.71

g/l

0.24

398

1696

Urticaria and erythema

525

2572

2.07

52.09

1.6

0.70

g/l

0.03

409

1958

Giant cell arteritis

157

6.17

52.07

1.3

1.6

0.78

0.80

g/l

0.04

120

COPD, hospital admission 2, with asthma infections

387

1421

2.37

52.01

1.5

1.6

0.69

0.89

g/l

2.65

288

1067

Sleep apnoea

1165

4605

1.65

51.92

1.4

1.6

0.75

0.77

g/l

0.17

831

3509

Hypertensive diseases

1017

3358

1.72

51.69

1.6

0.70

0.76

g/l

0.90

742

2557

Other antidepressants

1280

4056

1.63

51.44

1.5

1.6

0.70

0.81

g/l

2.60

942

3074

Hypertension

1015

3355

1.72

51.36

1.6

0.69

0.76

g/l

1.03

740

2555

Pneumocystosis

8.45

50.63

1.5

1.8

0.36

0.88

g/l

2.26

Other bacterial intestinal infections

321

1299

2.51

50.59

1.5

0.69

0.78

g/l

0.50

243

975

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

155

416

3.88

50.58

2.0

1.7

0.70

0.78

g/l

0.26

123

323

Pulmonary eosinophilia, not elsewhere classified

13.31

50.55

2.0

1.9

1.70

0.91

g/l

0.86

Continuous positive airway pressure

256

766

2.86

50.21

1.5

0.65

0.91

g/l

3.18

223

594

Systemic lupus erythematosus

157

6.06

49.88

1.7

1.5

0.53

0.74

g/l

1.08

124

Care involving use of rehabilitation procedures

810

4243

1.77

49.74

1.5

1.6

0.66

0.79

g/l

2.77

602

3189

Respiratory insufficiency

104

207

5.12

49.24

1.4

1.5

0.64

0.88

g/l

1.32

161

Sciatica+with lumbago

630

3070

1.91

49.06

1.4

1.6

0.59

0.81

g/l

6.95

473

2304

Viral infections characterized by skin and mucous membrane lesions

571

2941

1.96

49.05

1.6

0.65

0.79

g/l

1.61

429

2223

Syncope and collapse

485

1997

2.10

48.97

1.6

1.5

0.70

0.79

g/l

0.83

354

1515

Simple and mucopurulent chronic bronchitis

139

6.29

48.90

1.3

1.6

0.49

0.91

g/l

2.50

105

Heart failure,strict

587

2109

1.98

48.80

1.4

1.6

0.77

0.86

g/l

0.77

430

1557

Disorders of conjunctiva

1053

5165

1.65

48.75

1.6

1.5

0.66

0.75

g/l

2.34

827

3890

Non-invasive ventilation

296

1036

2.59

48.59

1.6

0.72

0.85

g/l

0.72

119

799

COPD, hospital admissions 3, with asthma pneumonia sepsis

323

1124

2.49

48.49

1.5

1.6

0.69

0.89

g/l

2.23

244

845

Explicit bacterial Sepsis

169

493

3.52

48.41

1.6

1.7

0.80

0.85

g/l

0.11

122

389

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1209

4939

1.61

48.36

1.5

1.6

0.73

0.75

g/l

0.24

883

3800

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

9.11

48.30

2.1

1.7

0.92

0.97

g/l

0.07

Other disorders of skin and subcutaneous tissue

834

4287

1.74

48.24

1.6

0.70

0.77

g/l

0.85

624

3237

Diseases of arteries, arterioles and capillaries (FINNGEN)

313

851

2.58

48.12

1.6

0.83

0.86

g/l

0.07

231

643

Glomerular diseases

277

1074

2.63

47.91

1.8

1.6

0.63

0.83

g/l

1.81

199

823

Pericarditis

139

6.27

47.87

1.3

1.8

0.65

0.89

g/l

0.94

110

Sleep apnoea, including avohilmo

1214

4726

1.60

47.74

1.4

1.6

0.75

0.76

g/l

0.09

870

3590

Erysipelas

626

2947

1.90

47.72

1.6

0.79

0.83

g/l

0.21

476

2198

Childhood asthma (age<16), excluding more controls

189

451

3.36

47.67

1.5

1.8

0.69

0.81

g/l

0.76

145

349

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

747

4170

1.79

47.60

1.5

1.6

0.73

0.76

g/l

0.18

564

3149

Other diseases of the digestive system

385

1735

2.25

47.38

1.6

0.75

0.85

g/l

0.74

294

1305

Other general symptoms and signs

107

225

4.89

47.28

1.9

1.4

0.60

0.68

g/l

0.45

178

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

470

2294

2.08

47.23

1.7

1.5

0.72

0.71

g/l

0.12

311

1750

Pulmonary embolism

370

1643

2.28

47.22

1.6

0.77

0.81

g/l

0.22

283

1232

Malignant neoplasm of pancreas

114

256

4.60

47.11

1.4

1.7

0.75

0.92

g/l

0.60

200

Childhood asthma (age<16)

189

456

3.32

46.90

1.5

1.8

0.69

0.81

g/l

0.75

145

352

Persons encountering health services in other circumstances

523

2642

1.99

46.87

1.5

1.6

0.69

0.74

g/l

0.67

343

1974

Spondylopathies (FG)

220

766

2.94

46.81

1.6

0.58

0.77

g/l

2.18

162

575

Crohn's disease of small intestine

140

370

3.92

46.66

1.9

1.5

0.73

0.82

g/l

0.23

115

281

Other pleural conditions

146

396

3.78

46.66

1.6

0.82

0.90

g/l

0.30

108

309

Protozoal diseases

144

6.16

46.41

1.5

1.7

0.37

0.78

g/l

2.63

113

Anxiety (asthma-related co-morbidities)

807

3595

1.75

46.38

1.5

1.6

0.67

0.73

g/l

0.89

643

2731

GI-bleeding

381

1725

2.24

46.35

1.6

0.75

0.85

g/l

0.77

289

1296

Pulmonary heart disease

370

1658

2.26

46.21

1.6

0.77

0.81

g/l

0.21

283

1246

Atrial fibrillation and flutter

396

1138

2.28

46.15

1.5

1.6

0.75

0.81

g/l

0.43

301

870

Streptococcal septicaemia

139

369

3.87

45.88

1.7

0.82

0.84

g/l

0.05

299

Bacterial intestinal infections, IBD co-morbidities

259

992

2.66

45.86

1.6

0.64

0.78

g/l

0.99

192

749

Mycoses

1053

5702

1.62

45.81

1.5

1.6

0.72

0.76

g/l

0.52

809

4286

Other symptoms and signs involving the digestive system and abdomen

213

738

2.94

45.61

1.6

1.5

0.67

0.74

g/l

0.31

145

577

Voice disturbances

367

1652

2.26

45.46

1.5

0.60

0.74

g/l

2.33

280

1239

Hypothyroidism, drug reimbursement

194

426

3.27

45.43

1.9

1.5

0.65

0.72

g/l

0.58

148

341

Heart failure and antihypertensive medication

326

873

2.48

45.41

1.5

1.6

0.77

0.91

g/l

0.67

245

666

Early onset COPD

308

1287

2.44

45.39

1.6

0.69

0.86

g/l

1.69

230

962

Polyneuropathies and other disorders of the peripheral nervous system

298

1228

2.47

45.29

1.5

1.6

0.62

0.88

g/l

4.43

236

930

Atypical mycobacterium lung infection

13.93

44.96

1.4

1.3

0.77

0.59

g/l

0.53

Other and unspecified polyneuropathies, also in other diseases

263

1029

2.61

44.64

1.5

1.6

0.62

0.90

g/l

4.16

207

771

Lumbar disc prolapse

761

3340

1.76

44.64

1.5

1.6

0.67

0.81

g/l

2.78

556

2501

Depression or dysthymia

853

2732

1.74

44.46

1.5

1.6

0.71

0.84

g/l

2.59

636

2065

Follow-up examination after treatment for conditions other than malignant neoplasms

480

1547

2.07

44.43

1.5

0.69

0.80

g/l

1.21

382

1077

All anxiety disorders

821

3805

1.72

44.40

1.5

1.6

0.67

0.73

g/l

1.00

653

2875

Hypothyroidism, strict autoimmune

732

2715

1.79

43.69

1.5

1.4

0.66

0.77

g/l

1.88

538

2050

Conjunctivitis

949

4880

1.64

43.00

1.6

1.5

0.66

0.73

g/l

1.43

758

3670

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

176

5.25

42.88

1.9

1.8

0.70

1.01

g/l

1.23

138

Recurrent or chronic depression

547

2001

1.94

42.83

1.5

1.6

0.71

0.79

g/l

0.92

417

1531

Symptoms and signs involving speech and voice

429

2107

2.06

42.43

1.5

0.63

0.76

g/l

1.88

330

1581

Gout

304

1132

2.39

42.31

1.4

1.7

0.68

0.99

g/l

3.57

226

845

Ulcerative rectosigmoiditis

152

453

3.46

42.31

1.9

1.5

0.75

0.82

g/l

0.21

114

339

Other specified/unspecified necrotizing vasculopathies

10.32

42.20

2.0

1.8

0.58

0.81

g/l

0.41

Non-Hodgkin lymphoma, all, including Hilmo

192

660

2.98

41.90

1.5

1.6

0.59

0.82

g/l

1.66

138

499

Visual disturbances and blindness

635

3562

1.80

41.78

1.7

1.6

0.79

0.76

g/l

0.24

483

2692

Symptoms and signs involving the nervous and musculoskeletal systems

701

4048

1.75

41.67

1.6

0.66

0.77

g/l

1.96

527

3081

Other chronic obstructive pulmonary disease, including avohilmo

595

2682

1.85

41.60

1.5

1.6

0.77

0.84

g/l

0.69

445

2001

DVT of lower extremities and pulmonary embolism

481

2472

1.96

41.20

1.6

0.75

0.81

g/l

0.50

364

1857

Hypo-osmolality and hyponatraemia

224

837

2.71

41.18

1.4

1.6

0.62

0.82

g/l

1.86

151

622

Disorders of orbit

219

4.68

40.98

2.1

1.7

0.77

0.81

g/l

0.12

170

Insulin, combination of fast acting with intermediate-acting or long-acting

723

3868

1.72

40.38

1.8

1.6

0.84

0.79

g/l

0.29

513

2917

Exposure to unspecified factor

1202

5677

1.53

40.33

1.5

1.6

0.76

0.75

g/l

0.11

858

4334

Nerve, nerve root and plexus disorders

1248

5035

1.53

39.98

1.6

0.69

0.76

g/l

1.24

912

3802

Chronic diseases of tonsils and adenoids

893

3446

1.65

39.77

1.5

1.6

0.61

0.77

g/l

4.57

696

2560

Venous thromboembolism

612

3324

1.79

39.76

1.6

0.75

0.80

g/l

0.43

462

2493

L04AC Interleukin inhibitors

127

352

3.75

39.66

1.6

1.7

0.55

0.78

g/l

1.75

268

Thrombocytopenia, unspecified

126

347

3.75

39.60

2.0

1.6

0.66

0.87

g/l

1.08

261

Factors influencing health status and contact with health services

338

726

2.36

39.57

1.6

1.7

0.79

0.99

g/l

1.78

266

524

Urticaria

418

2087

2.03

39.56

1.6

0.70

g/l

0.05

326

1591

Gastroduodenal ulcer

285

1219

2.36

39.49

1.4

1.6

0.78

0.91

g/l

0.94

210

898

Hard cardiovascular diseases

991

3703

1.61

39.35

1.6

0.78

0.77

g/l

0.05

763

2775

Visual disturbances

595

3342

1.80

39.11

1.7

1.6

0.81

0.76

g/l

0.36

450

2519

Heart failure, strict

620

2441

1.81

39.05

1.4

1.6

0.77

0.86

g/l

0.78

453

1818

COPD, hospital admissions

491

2176

1.93

39.04

1.5

1.6

0.77

0.87

g/l

0.99

368

1608

Adenocarcinoma and ductal carcinoma of pancreas

125

5.95

38.95

1.3

1.6

0.75

0.94

g/l

0.41

Percutaneous Coronary Intervention

919

3483

1.63

38.77

1.6

0.74

0.80

g/l

0.76

701

2634

COPD, early/later onset

492

2185

1.92

38.49

1.5

1.6

0.77

0.87

g/l

0.96

369

1616

Panniculitis, unspecified

13.02

38.20

1.6

2.8

0.60

1.20

g/l

0.58

Diseases of arteries, arterioles and capillaries

723

3145

1.71

38.13

1.5

1.6

0.75

0.83

g/l

0.88

536

2354

Ischemic heart diseases

969

3659

1.60

38.02

1.6

0.74

0.79

g/l

0.61

714

2766

Enterocolitis due to Clostridium difficile

147

458

3.28

38.00

1.6

0.54

0.85

g/l

3.21

103

353

Insulin medication

723

3608

1.70

37.99

1.8

1.6

0.84

0.81

g/l

0.20

513

2724

Coronary revascularization (ANGIO or CABG)

916

3484

1.62

37.92

1.6

0.74

0.80

g/l

0.72

699

2635

Migraine without aura

290

1278

2.30

37.89

1.4

1.6

0.58

0.67

g/l

1.30

218

1008

Any mental disorder

1309

4374

1.51

37.82

1.5

1.6

0.74

0.78

g/l

0.56

990

3295

Later onset COPD, excluding more controls

172

437

3.08

37.80

1.3

1.4

0.86

0.82

g/l

0.13

131

329

Other diseases of intestine

194

709

2.79

37.79

1.6

0.75

0.86

g/l

0.59

138

529

Glomerulonephritis

163

543

3.08

37.75

2.0

1.7

0.69

0.79

g/l

0.35

110

420

Candidiasis

208

789

2.69

37.75

1.6

0.74

0.75

g/l

0.01

150

607

Other/unspecified dorsalgia

446

2294

1.95

37.64

1.4

1.6

0.71

0.82

g/l

1.14

332

1726

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

675

3969

1.71

37.53

1.5

1.6

0.72

0.75

g/l

0.24

506

2989

All-cause Heart Failure

604

2393

1.80

37.40

1.4

1.6

0.77

0.87

g/l

0.82

443

1782

Aspergillosis

11.16

37.38

1.5

1.9

0.69

0.99

g/l

0.45

SLE, ICD10

179

4.94

37.34

1.6

0.54

0.84

g/l

1.60

138

SLE, strict definition

179

4.94

37.34

1.6

0.54

0.84

g/l

1.60

138

Nonsuppurative otitis media

333

1337

2.19

37.31

1.7

1.6

0.72

0.74

g/l

0.10

248

1039

Benign neoplasm: Colon, unspecified

301

1362

2.24

36.91

1.7

1.6

0.71

0.85

g/l

1.09

228

1025

Malignant neoplasm of other and unspecified parts of biliary tract

9.22

36.64

2.0

1.3

0.86

0.65

g/l

0.53

Cerebrovascular diseases (FINNGEN)

370

1253

2.11

36.60

1.6

0.85

0.79

g/l

0.29

293

956

UC patients in KELA-register (code 208), prior to 1994

210

4.52

36.58

2.3

1.6

0.72

0.92

g/l

0.63

163

Seropositive rheumatoid arthritis, wide

332

1569

2.15

36.50

1.7

1.5

0.73

0.75

g/l

0.12

250

1169

Paralytic ileus and intestinal obstruction

293

1316

2.25

36.45

1.5

1.6

0.66

0.86

g/l

1.67

211

980

Alcoholic liver disease

149

482

3.17

36.27

1.3

1.6

0.86

g/l

0.00

111

367

Emergency coronary revascularization (for ACS)

964

3726

1.58

36.21

1.6

0.74

0.80

g/l

0.75

734

2802

Inflammatory diseases of the central nervous system

143

453

3.25

36.12

1.6

1.7

0.59

0.81

g/l

1.81

111

344

Hypermobility syndrome

106

277

3.97

36.01

1.6

1.5

0.45

0.58

g/l

1.34

213

Disturbances of skin sensation

374

1858

2.04

35.97

1.4

1.5

0.62

0.71

g/l

1.35

291

1390

Spondylosis

592

2749

1.77

35.82

1.5

1.6

0.69

0.84

g/l

2.46

418

2057

Other diseases of lip and oral mucosa

501

2747

1.84

35.78

1.6

1.5

0.72

0.75

g/l

0.19

370

2067

Corticotropin deficiency

11.09

35.53

2.0

2.1

0.68

0.86

g/l

0.24

Polyarthrosis

239

918

2.45

35.52

1.8

1.6

0.64

0.78

g/l

1.41

167

700

Atrial fibrillation and flutter with reimbursement

296

826

2.31

35.30

1.5

1.6

0.74

0.86

g/l

0.75

223

625

Hypokalaemia

168

591

2.90

35.22

1.4

1.6

0.78

0.79

g/l

0.02

125

444

Migraine with aura

327

1559

2.13

35.11

1.4

1.6

0.60

0.68

g/l

0.64

257

1208

Other reaction to severe stress, and adjustment disorders

480

2614

1.86

35.03

1.7

1.6

0.67

0.70

g/l

0.37

362

1979

All influenza (not pneumonia)

206

809

2.59

34.80

1.4

1.6

0.71

0.85

g/l

0.89

150

620

Drug-induced cataract

111

6.04

34.71

1.8

0.48

0.88

g/l

1.53

Multiple myeloma, including Hilmo

170

4.82

34.56

1.5

1.9

0.37

1.02

g/l

4.69

136

Other disorders of urethra and urinary system

791

3532

1.63

34.43

1.4

1.5

0.66

0.74

g/l

1.36

572

2696

COPD related to multimorbidity

409

1778

1.96

34.40

1.5

1.6

0.79

0.87

g/l

0.60

303

1308

Other nutritional deficiencies

795

4698

1.61

34.11

1.4

1.6

0.70

0.74

g/l

0.53

606

3570

Viral pneumonia (unknown virus, not influenza)

120

354

3.49

34.04

1.4

1.8

0.55

0.83

g/l

2.83

280

Intracranial trauma

670

2797

1.70

34.01

1.5

1.6

0.76

0.79

g/l

0.19

496

2155

Symptoms and signs involving cognition, perception, emotional state and behaviour

1122

5125

1.50

33.93

1.5

1.6

0.71

0.76

g/l

0.74

832

3880

Disorders of oesophagus in diseases classified elsewhere

7.45

33.83

1.7

1.2

0.66

0.75

g/l

0.24

Weight loss

150

508

3.03

33.77

1.6

0.90

0.79

g/l

0.35

109

392

Abnormal weight loss

139

451

3.16

33.73

1.7

1.5

0.95

0.77

g/l

0.59

100

346

Psoriatic and enteropathic arthropathies

171

622

2.81

33.71

1.5

1.6

0.61

0.76

g/l

1.27

132

467

Colectomy operation

218

894

2.48

33.65

2.0

1.6

1.00

0.82

g/l

0.84

167

664

Use of hypnotics and sedatives

1241

4851

1.48

33.57

1.5

1.6

0.71

0.77

g/l

0.98

951

3637

Major coronary heart disease event

946

3681

1.56

33.46

1.6

0.75

0.80

g/l

0.68

720

2772

688

3780

1.66

33.40

1.5

1.6

0.78

0.81

g/l

0.26

484

2853

Cutaneous abscess, furuncle and carbuncle

349

1740

2.03

33.29

1.5

1.6

0.74

0.77

g/l

0.13

267

1331

Temporal arteritis

137

5.25

33.23

1.4

1.7

0.78

0.82

g/l

0.09

103

Disorders of sclera, cornea, iris and ciliary body

657

3970

1.67

33.23

1.7

1.6

0.72

0.77

g/l

0.38

494

3005

Alcohol use disorder, Swedish definition

649

3572

1.68

33.18

1.5

1.6

0.74

0.82

g/l

1.23

454

2696

Thyroiditis, ILD-related definition

162

580

2.85

32.91

1.6

1.5

0.62

0.75

g/l

1.02

122

437

Other complications of surgical and medical care, not elsewhere classified

150

516

2.98

32.84

1.4

1.6

0.57

0.78

g/l

2.70

117

398

Other and unspecified disorders of white blood cells

182

4.58

32.76

1.4

1.6

0.72

0.84

g/l

0.32

139

Other/unspecified seropositive rheumatoid arthritis

320

1555

2.09

32.75

1.6

1.5

0.73

0.74

g/l

0.09

243

1160

Diseases of middle ear and mastoid

708

3553

1.64

32.65

1.6

0.78

0.74

g/l

0.28

523

2679

196

777

2.57

32.55

1.7

1.6

0.65

0.72

g/l

0.32

131

572

Disorders of skin appendages

598

3541

1.70

32.55

1.5

1.6

0.62

0.76

g/l

3.86

456

2665

Diseases of the ear and mastoid process

1363

4748

1.45

32.51

1.6

0.76

0.75

g/l

0.06

1009

3621

Multiple myeloma and malignant plasma cell neoplasms

187

4.49

32.50

1.5

1.7

0.36

0.93

g/l

4.29

143

Secondary hypertension

115

335

3.47

32.43

1.3

1.5

0.90

0.88

g/l

0.03

258

Herpesviral [herpes simplex] infections

179

681

2.69

32.40

1.6

1.7

0.79

0.76

g/l

0.08

136

525

Gout, FINNGEN

304

1450

2.12

32.37

1.4

1.7

0.68

0.94

g/l

3.13

226

1093

Other specified/unspecified inflammatory spondylopathies

235

4.05

32.28

1.7

1.9

0.46

0.80

g/l

2.79

179

COPD, hospital admissions 1, only main diagnosis

358

1543

2.01

32.23

1.4

1.6

0.69

0.88

g/l

2.61

271

1148

Other anxiety disorders

585

2978

1.72

32.20

1.5

1.6

0.68

0.73

g/l

0.59

474

2251

Acute tubulo-interstitial nephritis

686

3625

1.64

32.11

1.5

0.62

0.76

g/l

3.43

527

2751

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

316

1541

2.08

32.05

1.6

0.72

0.75

g/l

0.13

241

1154

Idiopathic thrombocytopenic purpura

143

5.07

31.72

1.9

1.7

0.83

g/l

0.01

109

Insulin, fast-acting

441

2415

1.84

31.62

1.8

1.6

0.80

0.81

g/l

0.02

317

1851

Concussion

577

2763

1.72

31.51

1.5

1.6

0.75

0.79

g/l

0.33

425

2130

Other viral diseases

497

2803

1.78

31.50

1.5

1.6

0.59

0.75

g/l

4.08

381

2147

Pain in thoracic spine

201

820

2.49

31.39

1.4

1.6

0.66

0.80

g/l

0.78

163

617

Special screening examination for infectious and parasitic diseases

286

972

2.19

31.38

1.6

1.5

0.67

0.77

g/l

1.23

229

679

Gastric ulcer

192

766

2.54

31.37

1.5

1.6

0.82

0.88

g/l

0.25

145

569

Other (seronegative) rheumatoid arthritis, wide

239

1055

2.30

31.25

1.5

0.57

0.75

g/l

2.24

188

788

Disorders of lens

745

2887

1.62

31.19

1.5

0.72

0.80

g/l

0.82

539

2205

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

661

3950

1.64

31.10

1.7

1.5

0.66

0.70

g/l

0.53

539

3002

711

3907

1.61

31.01

1.5

1.6

0.78

0.81

g/l

0.25

501

2946

Migraine with aura and triptan purchases

233

1022

2.32

30.96

1.4

1.6

0.62

0.68

g/l

0.29

183

778

Giant cell arteritis with polymyalgia rheumatica

146

4.93

30.89

1.4

1.6

0.78

0.86

g/l

0.20

112

Polypectomy (DHB20)

113

342

3.40

30.84

2.3

1.8

1.04

0.88

g/l

0.74

263

Agranulocytosis

163

607

2.75

30.81

1.4

1.6

0.53

0.78

g/l

2.90

119

456

Cystitis

954

3733

1.53

30.69

1.6

1.5

0.66

0.75

g/l

1.89

726

2851

Polyarteritis nodosa and related conditions

7.77

30.54

1.7

1.8

1.38

0.82

g/l

0.54

COPD-related respiratory insufficiency

141

488

2.94

30.50

1.4

1.6

0.62

0.91

g/l

2.62

105

376

Psychiatric diseases

1159

3953

1.48

30.48

1.5

1.6

0.72

0.79

g/l

1.31

864

2982

Other medical care

504

2599

1.76

30.44

1.3

1.6

0.75

0.80

g/l

0.39

385

1924

Pneumonia derived septicemia

144

4.92

30.40

1.8

1.9

0.51

0.86

g/l

1.63

116

Other CVD (FINNGEN)

137

350

3.09

30.25

1.5

0.60

0.84

g/l

1.65

260

Insulin, intermediate and long-acting

613

3626

1.66

30.02

1.7

1.6

0.82

0.80

g/l

0.14

444

2743

Benzodiazepine use

1148

5456

1.46

30.00

1.5

1.6

0.70

0.76

g/l

1.00

844

4124

ILD and respiratory illness in diseases classified elsewhere

13.54

29.89

1.9

1.3

0.96

0.68

g/l

0.36

Cervical disc disorders

402

2179

1.86

29.86

1.6

0.65

0.86

g/l

4.52

293

1632

Shoulder lesions

817

3170

1.57

29.83

1.5

1.6

0.67

0.82

g/l

2.43

627

2357

Sequelae of external causes of morbidity and mortality

313

1572

2.02

29.32

1.5

1.6

0.82

0.79

g/l

0.09

237

1179

Diabetes, varying definitions

1181

4801

1.45

29.31

1.6

0.74

0.75

g/l

0.16

857

3664

Heart failure and coronary heart disease

419

1608

1.86

29.27

1.4

1.6

0.74

0.92

g/l

2.36

315

1185

Paroxysmal tachycardia

262

1017

2.18

29.27

1.5

1.6

0.75

0.79

g/l

0.21

192

772

Other symptoms and signs involving the nervous and musculoskeletal systems

499

2904

1.73

29.15

1.6

1.5

0.64

0.76

g/l

1.77

367

2196

Congenital malformations of the respiratory system

108

5.65

29.14

1.7

1.8

0.63

0.75

g/l

0.27

Atopic dermatitis, strict definition with reimbursement

390

2035

1.87

29.12

1.5

1.6

0.73

0.71

g/l

0.15

316

1556

Diabetes mellitus

1185

4813

1.45

29.07

1.6

0.73

0.75

g/l

0.23

862

3673

Other diseases of hard tissues of teeth

643

2004

1.67

29.05

1.6

0.77

0.84

g/l

0.64

475

1501

Glomerular disorders in diseases classified elsewhere

163

628

2.65

28.82

1.4

1.6

0.55

0.86

g/l

3.67

118

486

Other overlap syndromes

7.34

28.72

2.1

1.3

0.88

0.53

g/l

0.80

Other symptoms and signs involving the circulatory and respiratory systems

283

3.55

28.72

1.5

1.6

0.64

0.86

g/l

1.24

220

Other diseases of gallbladder

143

4.75

28.62

1.6

1.5

0.71

0.82

g/l

0.41

118

Other or unspecified ileus, impaction or obstruction

205

880

2.36

28.56

1.4

1.6

0.66

0.87

g/l

1.11

141

654

Crohn disease (strict definition, all UC cases excluded)

285

3.56

28.56

1.7

1.6

0.64

0.80

g/l

0.64

215

Symptoms and signs involving the urinary system

843

4224

1.53

28.55

1.6

0.78

0.77

g/l

0.05

627

3172

Pain and other conditions associated with female genital organs and menstrual cycle

258

1113

2.16

28.54

1.4

1.5

0.68

0.62

g/l

0.32

190

848

Insulin, fast-acting or short human

442

2500

1.78

28.52

1.8

1.6

0.80

0.81

g/l

0.03

318

1907

Arthrosis

753

2612

1.59

28.49

1.5

1.6

0.74

0.82

g/l

1.23

567

1970

Systemic sclerosis (FG)

5.93

28.46

1.7

1.8

0.56

0.70

g/l

0.33

Spinal stenosis

505

2228

1.73

28.30

1.5

1.6

0.70

0.87

g/l

2.72

369

1649

Type 2 diabetes

1112

4487

1.46

28.18

1.6

1.5

0.73

0.75

g/l

0.22

817

3407

Hypoparathyroidism

146

4.70

28.01

2.3

1.7

0.62

0.83

g/l

0.55

111

Other diseases of urinary system

1118

4343

1.45

28.00

1.5

1.6

0.70

0.77

g/l

1.41

825

3310

Coeliac disease

172

690

2.54

27.97

1.9

1.6

0.64

0.73

g/l

0.54

126

520

Other arthrosis

549

2258

1.70

27.94

1.5

1.6

0.71

0.85

g/l

2.39

417

1708

Other abnormal immunological findings in serum

6.07

27.89

1.8

1.6

1.13

0.73

g/l

0.58

Allergic conjunctivitis

682

4231

1.58

27.81

1.7

1.5

0.64

0.69

g/l

0.71

558

3201

Zoster [herpes zoster]

536

3170

1.68

27.74

1.6

0.68

0.79

g/l

1.01

401

2395

Deviated nasal septum

361

1936

1.88

27.69

1.5

1.6

0.75

0.84

g/l

0.83

263

1413

Congenital malformations, deformations and chromosomal abnormalities

771

4645

1.54

27.67

1.5

1.6

0.66

0.75

g/l

1.63

566

3526

Pollen allergy

280

1364

2.06

27.58

1.6

0.81

0.71

g/l

0.94

241

1049

Drug-induced osteoporosis

7.95

27.57

2.1

1.9

0.58

0.75

g/l

0.31

Other and unspecified vasculitis limited to skin

5.63

27.41

1.7

1.6

0.77

0.76

g/l

0.01

Hernia

1056

4893

1.45

27.34

1.7

1.5

0.76

0.75

g/l

0.09

794

3667

Benign neoplasm: Pancreas

122

5.08

27.25

1.7

0.48

0.88

g/l

1.69

Postviral fatigue syndrome

9.37

27.13

2.0

1.7

0.54

0.47

g/l

0.25

Intestinal stricture

346

1847

1.89

27.06

1.5

1.6

0.67

0.82

g/l

1.44

253

1385

Obesity and other hyperalimentation

730

4577

1.55

26.98

1.4

1.6

0.68

0.74

g/l

1.07

557

3477

Internal derangement of knee

411

2304

1.79

26.91

1.5

1.7

0.74

0.84

g/l

1.11

304

1753

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1069

4751

1.45

26.90

1.7

1.5

0.77

0.75

g/l

0.17

795

3583

Seronegative rheumatoid arthritis

141

524

2.74

26.75

1.4

1.5

0.53

0.72

g/l

1.53

104

381

Vasculitis limited to skin, not elsewhere classified

109

5.28

26.63

1.7

1.8

0.75

0.94

g/l

0.39

Pneumonia due to Streptococcus pneumoniae

173

4.23

26.60

1.9

1.7

0.59

1.00

g/l

1.34

138

Convulsions, not elsewhere classified

254

1209

2.10

26.54

1.4

1.5

0.61

0.80

g/l

3.14

191

924

Non-rheumatic valve diseases

482

2027

1.73

26.52

1.4

1.6

0.77

0.85

g/l

0.73

339

1522

Valvular heart disease excluding rheumatic fever

486

2051

1.72

26.48

1.4

1.6

0.77

0.85

g/l

0.75

342

1541

Papulosquamous disorders

454

2647

1.73

26.44

1.6

0.65

0.79

g/l

1.81

343

1978

Acute suppurative otitis media

357

1804

1.87

26.43

1.6

0.76

0.72

g/l

0.25

275

1393

Congenital malformations, deformations and chromosomal abnormalities

705

4358

1.55

26.33

1.5

1.6

0.64

0.74

g/l

2.28

519

3310

Obesity

725

4573

1.54

26.27

1.4

1.6

0.67

0.74

g/l

1.09

552

3475

Migraine without aura and triptan purchases

231

1082

2.17

26.22

1.5

1.6

0.53

0.68

g/l

2.61

177

827

Non-selective monoamine reuptake inhibitors

419

2304

1.77

26.17

1.5

0.62

0.79

g/l

3.57

312

1749

Temporomandibular joint disorders, including avohilmo

530

3183

1.66

26.08

1.6

1.5

0.59

0.68

g/l

1.79

375

2437

Other inflammation of eyelid

180

764

2.40

25.91

1.6

0.69

0.75

g/l

0.35

140

580

Other diseases of arteries and capillaries

116

396

2.99

25.83

1.7

1.6

0.74

0.80

g/l

0.10

305

Care involving dialysis

121

424

2.92

25.77

1.4

1.7

0.62

0.90

g/l

1.71

325

Volume depletion

115

391

2.99

25.75

1.5

1.6

0.69

0.89

g/l

1.02

289

Non-follicular lymphoma

128

463

2.83

25.67

1.5

1.6

0.50

0.87

g/l

4.49

353

Congenital malformations of the respiratory system

102

5.45

25.63

1.7

1.8

0.67

0.75

g/l

0.15

Iridocyclitis

284

1448

1.99

25.59

1.7

1.6

0.65

0.78

g/l

1.25

215

1108

Viral pneumonia (known virus, not influenza)

113

5.09

25.57

1.4

1.6

0.72

0.77

g/l

0.10

Gonarthrosis [arthrosis of knee](FG)

727

2729

1.56

25.50

1.5

0.74

0.82

g/l

1.09

556

2044

Systemic lupus erythematosus, unspecified

154

4.42

25.41

1.4

1.7

0.52

0.77

g/l

1.13

117

Other skin changes

216

1000

2.19

25.25

1.9

1.5

0.66

0.74

g/l

0.76

161

753

Other disorders of eye and adnexa

196

874

2.28

25.18

1.7

1.6

0.57

0.75

g/l

2.92

156

661

Ovarian cyst

406

1301

1.82

25.14

1.4

1.5

0.62

0.63

g/l

0.06

305

971

Disorders of lipoprotein metabolism and other lipidaemias

860

3588

1.49

25.10

1.5

1.6

0.79

0.80

g/l

0.09

652

2691

Other viral diseases, not elsewhere classified

351

1920

1.84

25.03

1.5

1.6

0.60

0.75

g/l

2.75

279

1482

Cervicalgia

235

1129

2.11

24.93

1.7

1.6

0.71

0.82

g/l

0.89

182

846

Other viral diseases, not elsewhere classified

255

1262

2.04

24.83

1.6

0.60

0.81

g/l

3.11

203

976

Disorders of the thyroid gland

1036

4732

1.43

24.75

1.6

1.5

0.69

0.75

g/l

0.86

746

3615

Unspecified kidney failure

116

406

2.91

24.68

1.4

1.6

0.57

0.90

g/l

3.51

314

Ulcerative proctitis

100

323

3.18

24.61

1.8

1.6

0.69

0.85

g/l

0.95

248

Disorders of parathyroid gland

219

1016

2.16

24.60

1.6

1.5

0.68

0.73

g/l

0.23

159

749

Exophthalmic conditions

7.65

24.57

2.2

1.8

1.02

0.88

g/l

0.19

Other encephalitis

129

4.70

24.54

1.3

1.8

0.43

0.92

g/l

2.36

Dizziness and giddiness

813

4353

1.49

24.48

1.4

1.6

0.69

0.76

g/l

1.20

610

3294

Viral hepatitis, IBD co-morbidity

197

3.83

24.47

1.5

1.7

0.79

0.77

g/l

0.04

155

Chronic apical periodontitis

1260

5196

1.39

24.45

1.5

1.6

0.72

0.76

g/l

0.58

914

3955

Other metabolic disorders

180

784

2.33

24.45

1.9

1.6

0.73

0.71

g/l

0.06

127

589

Herpesviral [herpes simplex] infections

311

1662

1.89

24.36

1.5

1.6

0.76

0.71

g/l

0.24

236

1248

Somatoform disorder

215

1009

2.16

24.32

1.4

1.6

0.66

0.76

g/l

0.78

157

753

Extracorporeal dialysis

305

3.24

24.32

1.4

1.7

0.57

0.92

g/l

1.67

237

Other viral diseases

384

2184

1.77

24.24

1.6

0.59

0.75

g/l

3.07

295

1685

Other diseases of anus and rectum

305

1617

1.90

24.23

1.5

1.6

0.71

0.82

g/l

1.10

233

1218

Heart failure and bmi 25plus

340

1236

1.88

24.14

1.4

1.6

0.85

0.86

g/l

0.06

237

882

Other diseases of stomach and duodenum

256

3.44

24.12

1.3

1.5

0.58

0.86

g/l

1.97

192

Suppurative and unspecified otitis media

452

2383

1.70

24.03

1.6

0.76

0.73

g/l

0.22

339

1829

Diseases of spleen

6.06

23.96

1.6

1.9

0.54

0.91

g/l

0.87

Triptan medication for migraine, single purchase ok

904

4221

1.46

23.93

1.5

0.65

0.72

g/l

1.52

687

3198

Migraine, single triptan purchase ok & required. ICD-code if available is included

904

4221

1.46

23.93

1.5

0.65

0.72

g/l

1.52

687

3198

Encephalitis

140

4.47

23.90

1.3

1.8

0.42

0.89

g/l

2.41

107

Myocarditis

210

3.71

23.87

1.4

1.5

0.92

0.83

g/l

0.17

161

Disorders of synovium and tendon

571

3157

1.59

23.87

1.6

0.63

0.79

g/l

3.72

420

2362

Selective serotonin reuptake inhibitors

1105

4091

1.42

23.81

1.5

1.6

0.69

0.81

g/l

3.17

815

3105

Enteropathic arthropathies

5.28

23.77

1.9

2.0

0.53

0.87

g/l

1.07

Other and unspecified tonsillitis

394

1899

1.76

23.72

1.5

1.7

0.74

0.81

g/l

0.62

299

1428

Other peripheral vascular diseases

112

394

2.90

23.69

1.3

1.6

0.59

0.75

g/l

1.05

304

Genitourinary diseases

691

2236

1.56

23.59

1.6

0.80

0.84

g/l

0.41

519

1702

Ocular pain

127

480

2.71

23.47

1.6

1.7

0.59

0.76

g/l

1.62

360

Pneumococcal septicemia

159

4.18

23.47

1.8

0.52

0.85

g/l

1.44

123

Personal history of allergy to drugs, medicaments and biological substances

6.99

23.38

1.9

1.7

0.98

0.80

g/l

0.32

Cervicobrachial syndrome

253

1279

2.00

23.37

1.6

1.5

0.64

0.82

g/l

1.46

209

955

Multiple myeloma

5.37

23.34

1.5

1.9

0.35

1.11

g/l

2.82

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

5.37

23.34

1.5

1.9

0.35

1.11

g/l

2.82

Hypogonadotropic hypogonadism

187

3.93

23.33

1.4

1.8

0.71

0.92

g/l

0.75

146

Triptan medication for migraine, min. 3 purchases

668

3339

1.54

23.25

1.5

0.62

0.66

g/l

0.56

525

2531

Suppurative and necrotic conditions of lower respiratory tract

243

3.47

23.23

1.5

1.6

0.68

0.92

g/l

1.02

186

Systemic sclerosis

111

4.91

23.15

1.7

1.6

0.56

0.73

g/l

0.47

Exposure to other specified factors

854

5433

1.45

23.06

1.6

0.80

0.75

g/l

0.46

635

4127

Panhypopituitarism

5.48

22.99

1.7

1.8

0.61

0.86

g/l

0.56

Gout, idiopatic and unspecified

256

1308

1.98

22.96

1.5

1.7

0.67

0.96

g/l

3.63

189

998

Falls/tendency to fall

1252

4566

1.38

22.91

1.5

1.6

0.75

0.76

g/l

0.10

956

3437

Exclusions for E4_PCOS_CONSORTIUM

827

3531

1.48

22.90

1.5

0.64

0.67

g/l

0.31

562

2730

Type 2 diabetes, wide definition

744

3179

1.51

22.89

1.7

1.5

0.77

0.80

g/l

0.23

572

2462

Emphysema

240

3.44

22.86

1.5

1.6

0.88

0.92

g/l

0.10

187

Haemolytic anaemias

158

4.13

22.81

2.3

1.7

0.81

0.89

g/l

0.16

121

Enthesopathies of lower limb, excluding foot

257

1319

1.97

22.75

1.6

0.60

0.83

g/l

3.50

209

986

Rotator cuff syndrome

620

2873

1.56

22.72

1.5

1.6

0.72

0.84

g/l

1.33

481

2134

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

123

465

2.70

22.70

1.5

0.63

0.75

g/l

0.84

356

Other arrhythmias

681

3396

1.52

22.65

1.5

1.6

0.70

0.76

g/l

0.67

493

2579

Recurrent aphthous stomatitis , including avohilmo

186

849

2.23

22.63

1.5

1.6

0.70

0.74

g/l

0.18

147

638

Non-ischemic cardiomyopathy

302

1303

1.88

22.55

1.4

1.6

0.78

0.89

g/l

0.73

227

977

Benign neoplasm: Stomach

127

490

2.65

22.52

1.9

1.6

0.71

0.79

g/l

0.40

107

361

Nephrotic syndrome

160

4.10

22.47

2.4

1.6

0.78

0.72

g/l

0.08

122

Zoster [herpes zoster]

207

989

2.12

22.38

1.6

0.46

0.79

g/l

7.98

162

742

Stomatitis and related lesions

249

1274

1.98

22.31

1.5

1.6

0.74

0.75

g/l

0.02

194

965

Nonorganic sleeping disorders, excluding more controls

238

1201

2.01

22.15

1.4

1.6

0.66

0.75

g/l

0.69

178

910

Other infectious diseases

119

448

2.71

22.15

1.6

0.58

0.83

g/l

2.50

340

Other CVD

196

920

2.15

22.14

1.6

1.5

0.65

0.85

g/l

1.89

134

695

Atopic dermatitis

660

3580

1.52

22.13

1.5

1.6

0.74

0.72

g/l

0.19

521

2745

Localized swelling, mass and lump of skin and subcutaneous tissue

353

2019

1.77

22.13

2.2

1.5

1.09

0.75

g/l

2.62

298

1504

Sequelae with surgical and medical care as external cause

238

1202

2.01

22.13

1.5

1.6

0.88

0.81

g/l

0.16

181

896

Diseases of oral cavity, salivary glands and jaws

612

2010

1.57

22.04

1.6

0.76

0.83

g/l

0.69

460

1507

Unspecified chronic bronchitis

111

4.71

22.04

1.4

1.6

0.79

0.87

g/l

0.11

Acute and subacute iridocyclitis

238

1207

2.00

21.88

1.6

0.65

0.79

g/l

1.32

174

928

Lung diseases due to external agents

151

641

2.39

21.76

1.5

1.7

0.72

0.88

g/l

0.95

110

499

Acquired haemolytic anaemia

109

4.80

21.72

2.1

1.6

0.73

0.83

g/l

0.18

Adverse effects, not elsewhere classified

252

1307

1.95

21.71

1.7

1.6

0.71

g/l

0.04

194

996

Hypothyroidism, other/unspecified

953

4440

1.42

21.68

1.5

0.67

0.74

g/l

1.34

685

3395

Haemorrhoids and perianal venous thrombosis

315

1748

1.81

21.68

1.5

1.6

0.73

0.84

g/l

0.55

224

1310

Pruritus

137

559

2.49

21.60

1.6

0.66

0.73

g/l

0.38

108

423

Persons encountering health services for specific procedures, not carried out

123

478

2.63

21.52

1.4

1.7

0.69

0.82

g/l

0.69

102

365

Other specified/unspecified soft tissue disorders

178

3.80

21.51

1.5

1.8

0.58

0.89

g/l

1.40

137

Behavioural syndromes associated with physiological disturbances and physical factors

1029

5257

1.39

21.51

1.5

1.6

0.72

0.75

g/l

0.48

773

3981

Adenocarcinoma of pancreas

5.08

21.50

1.3

1.6

0.80

1.05

g/l

0.38

Hypothyreosis and Thyroxine purchase for inclusion criteria

987

4622

1.41

21.49

1.5

0.67

0.74

g/l

1.30

712

3533

Anterior Iridocyclitis

249

1291

1.95

21.48

1.6

0.65

0.78

g/l

1.21

183

981

Myositis

102

4.89

21.45

1.2

1.9

0.52

1.04

g/l

2.11

Other enthesopathies

323

1817

1.79

21.44

1.6

0.64

0.81

g/l

2.57

248

1370

Lung cancer and mesothelioma

140

487

2.48

21.44

1.2

1.4

0.74

0.83

g/l

0.37

367

Subjective visual disturbances

291

1588

1.85

21.41

1.6

1.5

0.65

0.73

g/l

0.89

219

1179

Vascular disorders of the intestines

226

3.42

21.35

1.5

1.6

0.87

0.92

g/l

0.13

175

Ulcer of lower limb, not elsewhere classified

159

697

2.31

21.31

1.3

1.6

0.89

g/l

0.01

124

529

Fissure and fistula of anal and rectal regions

262

1384

1.91

21.31

1.4

1.6

0.58

0.84

g/l

4.36

191

1024

Misadventures to patients during surgical and medical care

173

788

2.23

21.18

1.4

1.5

0.78

g/l

0.01

122

603

Diseases of tongue

273

3.18

21.14

1.6

1.7

0.62

0.86

g/l

1.43

209

Other diseases of oesophagus

109

403

2.75

20.99

1.5

0.76

0.85

g/l

0.48

302

Type 2 diabetes, definitions combined

1016

4283

1.40

20.97

1.6

1.5

0.75

0.76

g/l

0.03

744

3258

Inflammatory diseases of female pelvic organs

648

3168

1.51

20.93

1.5

0.59

0.61

g/l

0.26

487

2399

Non-Hodgkin lymphoma, all

150

4.04

20.92

1.4

1.5

0.75

1.01

g/l

0.47

119

Other infectious diseases

101

360

2.86

20.90

1.5

0.53

0.84

g/l

3.12

275

Benign neoplasm: Transverse colon

132

540

2.49

20.75

1.9

1.7

0.58

0.87

g/l

3.15

105

412

Fall on same level

1285

5230

1.35

20.70

1.5

1.6

0.71

0.76

g/l

0.92

980

3940

Other external causes of accidental injury

937

3313

1.42

20.66

1.5

1.6

0.73

0.76

g/l

0.39

711

2516

Heartburn

124

493

2.55

20.64

1.3

1.4

0.80

0.76

g/l

0.08

374

Excessive, frequent and irregular menstruation

418

1357

1.70

20.62

1.5

0.55

0.64

g/l

1.62

301

1017

Radiculopathy

171

784

2.21

20.56

1.5

1.6

0.70

0.89

g/l

1.32

126

594

Ankylosing spondylitis

121

477

2.58

20.56

1.6

1.7

0.60

0.86

g/l

1.93

370

Systemic sclerosis, icd10

123

4.43

20.44

1.7

1.8

0.56

0.87

g/l

0.95

Diseases of the myoneural junction and muscle

148

643

2.34

20.32

1.6

0.58

0.84

g/l

2.96

115

499

Unknown and unspecified causes of morbidity

295

3.04

20.32

1.4

0.46

0.75

g/l

3.54

236

Gingivitis and periodontal diseases

1125

4245

1.37

20.29

1.6

0.72

0.79

g/l

1.20

872

3159

Disorders of mineral metabolism

111

424

2.67

20.13

1.5

1.7

0.85

0.82

g/l

0.05

322

Pure hypercholesterolaemia

733

3275

1.47

20.09

1.5

1.6

0.80

0.81

g/l

0.10

552

2454

Disorders of optic nerve and visual pathways

133

555

2.44

20.05

1.5

1.7

0.54

0.76

g/l

2.26

426

Soft tissue disorders related to use, overuse and pressure

283

1563

1.83

20.03

1.5

1.6

0.71

0.87

g/l

1.84

230

1161

STROKE

575

2553

1.54

19.95

1.6

0.83

0.79

g/l

0.21

447

1908

Other and unspecified effects of external causes

335

1948

1.74

19.90

1.6

0.75

0.71

g/l

0.27

256

1487

Senile cataract

618

2505

1.52

19.82

1.4

1.5

0.70

0.82

g/l

1.51

448

1917

Dermatitis due to substances taken internally

258

3.18

19.81

1.5

1.7

0.47

0.82

g/l

3.26

197

Deforming dorsopathies

297

1672

1.79

19.72

1.5

1.6

0.62

0.81

g/l

2.44

226

1251

Algoneurodystrophy

162

3.83

19.65

1.4

1.7

0.69

0.74

g/l

0.13

124

Hypotension

163

747

2.21

19.63

1.5

1.6

0.65

0.89

g/l

1.95

108

565

Disease of hard tissues of teeth, NOS

581

1974

1.55

19.61

1.5

1.6

0.75

0.84

g/l

0.85

430

1479

Gout, unspecified

208

1047

2.01

19.57

1.5

1.6

0.69

0.98

g/l

2.70

155

802

Type 2 diabetes, strict (exclude DM1)

1016

4335

1.38

19.57

1.6

1.5

0.75

0.76

g/l

0.05

744

3289

Diabetes medication

1136

4989

1.36

19.45

1.6

0.75

g/l

0.00

825

3799

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

159

3.83

19.36

1.7

0.60

0.84

g/l

0.90

119

Reactive arthropathies, FINNGEN

353

2.80

19.35

1.4

1.7

0.53

0.76

g/l

2.03

265

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1019

4476

1.38

19.34

1.7

1.6

0.74

0.76

g/l

0.23

730

3412

Obesity, other/unspecified

397

2433

1.65

19.32

1.5

1.6

0.71

g/l

0.03

323

1844

Substance abuse, excluding more controls

592

3368

1.51

19.29

1.4

1.7

0.74

0.82

g/l

0.78

433

2525

Psoriasis

325

1893

1.73

19.21

1.5

1.6

0.61

0.79

g/l

2.90

247

1420

Acetic acid derivatives and related substances

294

829

1.85

19.18

1.6

1.7

0.73

0.83

g/l

0.81

226

631

Lymphoid leukaemia

239

3.21

18.97

1.4

1.6

0.43

0.87

g/l

3.17

181

Seropositive rheumatoid arthritis, strict definition

177

851

2.11

18.94

1.6

0.80

0.74

g/l

0.26

138

633

Persons with potential health hazards related to communicable diseases

458

2893

1.58

18.92

1.7

1.6

0.63

0.72

g/l

1.33

319

2234

Other coagulation defects

105

403

2.66

18.91

1.7

1.6

0.66

0.77

g/l

0.47

302

Cellulitis

254

1383

1.86

18.90

1.6

0.70

0.77

g/l

0.55

211

1058

Hyperlipidaemia, other/unspecified

365

2020

1.68

18.88

1.5

1.6

0.68

0.88

g/l

3.08

282

1498

External causes of morbidity and mortality

746

2575

1.46

18.81

1.6

0.70

0.77

g/l

0.81

558

1960

Sleep disorders

966

5106

1.37

18.56

1.4

1.6

0.72

0.75

g/l

0.26

728

3859

Type 2 diabetes, definitions combined, including avohilmo

1016

4338

1.37

18.53

1.6

1.5

0.77

0.75

g/l

0.16

752

3291

Accidents

921

3313

1.40

18.48

1.5

1.6

0.73

0.76

g/l

0.37

705

2516

Pyogenic arthritis

290

2.95

18.47

1.3

1.7

0.73

0.86

g/l

0.50

224

Gonarthrosis

614

2339

1.50

18.46

1.5

1.6

0.74

0.85

g/l

1.48

471

1768

Cluster headache, strict

174

3.61

18.42

1.3

1.8

0.69

0.84

g/l

0.57

137

Other pulmonary heart/vessel disease

169

3.64

18.42

1.6

1.7

0.68

0.88

g/l

0.56

131

Dentofacial anomalies [including malocclusion]

785

4476

1.42

18.36

1.5

1.6

0.61

0.72

g/l

3.30

561

3432

Endocarditis

142

3.91

18.34

1.4

1.6

0.76

0.81

g/l

0.10

115

Other/unspecified rheumatoid arthritis

135

590

2.32

18.32

1.5

0.55

0.77

g/l

2.06

105

427

Ischaemic heart disease, wide definition

777

3387

1.43

18.29

1.6

0.77

0.81

g/l

0.43

564

2553

Irregular menses

519

2687

1.54

18.25

1.5

0.56

0.61

g/l

0.95

398

2057

Other and unspecified urticaria

242

1315

1.86

18.17

1.5

1.6

0.66

0.71

g/l

0.34

179

994

Secondary right heart disease

152

3.78

18.17

1.6

1.7

0.67

0.92

g/l

0.70

120

Diabetes insipidus

7.18

18.14

1.8

1.3

0.82

0.61

g/l

0.42

Coxibs

291

848

1.82

18.01

1.4

1.7

0.68

0.83

g/l

1.57

219

648

Chronic tubulo-interstitial nephritis

153

3.76

17.99

1.4

1.8

0.96

0.84

g/l

0.22

118

Otitis media, unspecified

152

645

2.20

17.90

1.5

1.6

0.75

0.76

g/l

0.06

107

523

Coronary atherosclerosis

621

2664

1.48

17.86

1.6

0.80

0.84

g/l

0.24

454

1992

Diseases of pulp and periapical tissues, including avohilmo

1150

4465

1.34

17.78

1.5

1.6

0.76

0.77

g/l

0.13

861

3385

Iron deficiency anaemia secondary to blood loss (chronic)

166

798

2.10

17.77

1.7

1.5

0.70

0.79

g/l

0.45

131

590

Cardiomyopathy

180

892

2.04

17.74

1.5

1.6

0.75

0.90

g/l

0.81

134

676

Abnormal findings on diagnostic imaging of central nervous system

244

3.11

17.72

1.9

1.6

0.70

0.81

g/l

0.28

192

Panic disorder

192

977

1.99

17.60

1.6

0.67

0.73

g/l

0.31

149

738

Conjunctivitis (acute, non atopic)

323

1920

1.69

17.51

1.6

0.71

0.75

g/l

0.38

247

1468

Dental operations

620

2150

1.49

17.45

1.6

0.80

0.82

g/l

0.09

452

1650

Personality disorders, excluding more controls

289

1674

1.74

17.44

1.4

1.6

0.72

0.73

g/l

0.05

208

1261

Chronic iridocyclitis

252

3.05

17.39

1.6

1.7

0.62

0.79

g/l

0.72

191

Reactive arthropathies

113

469

2.45

17.29

1.4

1.7

0.50

0.81

g/l

4.04

347

Pneumothorax

290

2.88

17.29

1.4

1.6

0.83

0.88

g/l

0.12

228

Viral and other specified intestinal infections

320

1841

1.69

17.27

1.8

1.6

0.70

0.75

g/l

0.22

240

1408

Psoriatic arthropathies

128

562

2.31

17.24

1.4

1.7

0.64

0.84

g/l

1.29

425

Benign neoplasm: Small intestine

187

3.42

17.23

1.5

1.8

0.81

0.89

g/l

0.12

144

Hepatocellular carcinoma, including Hilmo

100

4.43

17.22

2.0

1.7

0.66

1.12

g/l

1.57

Disorders of muscles

120

513

2.37

17.17

1.3

1.7

0.65

0.81

g/l

0.89

389

Other neurological diseases

716

3980

1.42

17.09

1.5

1.6

0.69

0.79

g/l

2.20

534

2976

Fentanyl

388

2.58

16.99

1.5

1.6

0.59

0.89

g/l

2.44

296

Cytomegalovirus infection, IBD co-morbidity

106

4.33

16.92

1.4

1.6

0.53

0.76

g/l

0.65

Postprocedural endocrine and metabolic disorders, not elsewhere classified

151

715

2.14

16.88

1.9

1.6

0.74

0.70

g/l

0.12

110

539

Raynaud syndrome

116

493

2.40

16.88

1.4

1.7

0.56

0.73

g/l

1.58

381

Dermatopolymyositis (FG)

5.71

16.86

1.2

1.9

0.39

0.80

g/l

1.05

Cluster headache, wide

190

3.35

16.78

1.3

1.8

0.67

0.80

g/l

0.46

149

Dermatopolymyositis

5.51

16.75

1.3

1.7

0.50

0.78

g/l

0.60

Other and unspecified coagulation defects

274

2.92

16.73

1.8

1.6

0.73

0.75

g/l

0.06

205

Benign neoplasm: salivary glands, exclude unknown (D119)

106

434

2.49

16.73

2.1

1.6

1.02

0.82

g/l

0.44

331

Chronic ulcer of skin, not elsewhere classified

279

2.88

16.71

1.9

1.6

0.91

0.89

g/l

0.03

216

Invasive ventilation

358

2.65

16.70

1.3

1.7

0.50

0.88

g/l

3.27

276

Benign neoplasm of major salivary glands

114

483

2.40

16.68

2.1

1.6

0.99

0.81

g/l

0.43

369

Presence of other functional implants

552

2581

1.49

16.66

1.5

0.75

0.80

g/l

0.32

335

1994

Meniscus derangement

531

2390

1.50

16.64

1.5

1.6

0.69

0.85

g/l

2.83

374

1804

Insomnia

935

5048

1.36

16.64

1.5

1.6

0.72

0.74

g/l

0.17

712

3816

Small fibre neuropathy

134

3.87

16.62

1.6

0.59

0.86

g/l

1.02

101

Tuberculosis, IBD comorbidity

259

2.94

16.51

1.7

0.82

0.88

g/l

0.15

200

Secondary and unspecified malignant neoplasm of lymph nodes

100

402

2.53

16.42

1.4

1.6

0.65

0.91

g/l

1.29

306

Malignant neoplasm of digestive organs

361

1763

1.63

16.37

1.5

1.6

0.88

0.86

g/l

0.07

258

1319

Fenamates

160

516

2.13

16.33

1.5

0.75

0.85

g/l

0.52

134

394

Other disorders of bone

231

1281

1.82

16.29

1.5

1.6

0.78

0.73

g/l

0.24

181

979

Obesity due to excess calories

514

3475

1.49

16.24

1.3

1.6

0.68

0.75

g/l

0.93

388

2616

Oter anti-inflammatory and antirheumatic agents, non-steroids

216

625

1.92

16.04

1.5

1.6

0.75

0.85

g/l

0.43

167

464

Disorders of plasma-protein metabolism, not elsewhere classified

7.45

15.98

1.8

1.5

0.64

0.62

g/l

0.03

Congenital malformations of the musculoskeletal system, not elsewhere classified

4.46

15.92

1.4

0.65

0.57

g/l

0.20

Injuries to the knee and lower leg

1273

5469

1.30

15.91

1.5

1.6

0.74

0.76

g/l

0.15

975

4109

Other and unspecified drugs and medicaments

107

451

2.42

15.88

1.4

1.7

0.65

0.79

g/l

0.87

335

Cluster headache, strict, including avohilmo

283

2.83

15.79

1.3

1.8

0.60

0.79

g/l

1.17

215

Injuries to the ankle and foot

774

5017

1.38

15.75

1.6

0.77

0.74

g/l

0.18

602

3780

Cytomegaloviral disease

112

4.08

15.74

1.4

1.7

0.53

0.82

g/l

0.92

Hyperkalaemia

213

3.11

15.72

1.5

1.7

0.56

0.97

g/l

2.24

163

Other cataract

426

2091

1.55

15.71

1.7

1.5

0.74

0.82

g/l

0.53

309

1606

Other disorders of skin and subcutaneous tissue, not elsewhere classified

154

756

2.06

15.67

1.9

1.6

0.85

0.80

g/l

0.18

110

575

Faecal incontinence

352

2.59

15.62

1.3

1.4

0.58

0.69

g/l

0.56

261

Asthma mixed form (mode), excluding more controls

168

3.39

15.61

1.6

1.5

0.61

0.82

g/l

1.16

131

Thyroiditis

395

2.51

15.55

1.5

1.7

0.72

0.75

g/l

0.09

298

Diabetes, insulin treatment (Kela reimbursement)

1056

4841

1.32

15.53

1.7

1.6

0.75

0.77

g/l

0.18

761

3679

Malignant neoplasm, wide definition for exclusion

941

4118

1.35

15.46

1.5

1.6

0.69

0.75

g/l

1.03

697

3116

Dermatographic urticaria

379

2.53

15.40

1.9

1.6

0.71

0.74

g/l

0.11

285

Psoriasis vulgaris

215

1189

1.83

15.35

1.5

1.6

0.62

0.80

g/l

1.94

167

907

Etanercept

386

2.51

15.33

1.5

1.7

0.72

0.76

g/l

0.09

299

Tuberculosis, wide

276

2.80

15.28

1.7

1.6

0.81

0.86

g/l

0.12

212

Coxarthrosis [arthrosis of hip](FG)

460

2143

1.52

15.23

1.5

0.72

0.83

g/l

1.26

362

1588

Complications of internal orthopaedic prosthetic devices, implants and grafts

205

1119

1.85

15.23

1.4

1.6

0.67

0.83

g/l

1.85

155

829

Paralytic ileus

142

3.60

15.22

1.5

1.7

0.53

0.97

g/l

2.18

114

Metatarsalgia

109

473

2.34

15.14

1.6

0.58

0.77

g/l

1.47

358

Other enthesopathy of foot (+metatarsalgia)

116

517

2.28

15.13

1.6

0.59

0.75

g/l

1.28

392

Postprocedural disorders of nervous system

414

2.44

14.99

1.5

1.7

0.63

0.73

g/l

0.50

322

Other and unspecified acquired haemolytic anaemias

6.50

14.87

2.4

1.9

0.81

0.92

g/l

0.11

Cluster headache, wide,, including avohilmo

298

2.71

14.86

1.3

1.8

0.59

0.81

g/l

1.52

228

Gout, strict definition

172

895

1.94

14.85

1.4

1.6

0.54

0.99

g/l

7.07

128

683

Postprocedural disorders of digestive system, not elsewhere classified

140

3.60

14.82

2.0

1.5

0.83

0.81

g/l

0.03

107

Acute pharyngitis

173

895

1.94

14.80

1.4

1.7

0.85

0.82

g/l

0.05

130

681

Asthma mixed form (mode)

174

3.27

14.79

1.6

1.4

0.61

0.83

g/l

1.27

135

Retention of urine

316

1597

1.64

14.76

1.6

0.87

g/l

0.02

231

1191

Benign neoplasm: Ascending colon

144

706

2.07

14.75

1.8

1.6

0.67

0.83

g/l

1.31

115

528

Injuries to the abdomen, lower back, lumbar spine and pelvis

392

2531

1.54

14.68

1.4

1.6

0.79

g/l

0.01

301

1898

Chronic nephritic syndrome

191

3.17

14.66

1.8

1.6

0.60

0.80

g/l

0.82

147

Other meningitis

4.63

14.64

1.9

1.5

0.57

0.56

g/l

0.03

Golimumab

202

3.11

14.61

1.5

1.8

0.60

0.80

g/l

0.78

159

Hypertensive heart and/or renal disease

231

974

1.78

14.57

1.3

1.6

0.75

0.95

g/l

0.98

176

706

Missing teeth due to accident, extraction or parodontitis

577

3830

1.43

14.57

1.5

1.6

0.70

0.80

g/l

1.68

409

2886

Acute lymphadenitis

348

2.55

14.53

2.3

1.7

1.07

0.76

g/l

0.63

275

Substance use, excluding alcohol

236

1365

1.75

14.48

1.4

1.6

0.61

0.77

g/l

1.95

174

1044

Viral infections of the central nervous system

103

446

2.35

14.44

1.5

1.7

0.50

0.79

g/l

3.23

339

Disorders of calcium metabolism

291

2.70

14.40

1.5

1.7

0.99

0.85

g/l

0.19

217

Atopic dermatitis, strict definition

351

2200

1.58

14.39

1.5

1.6

0.73

0.70

g/l

0.20

287

1686

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

291

1774

1.65

14.37

1.4

1.6

0.65

0.70

g/l

0.52

212

1351

Ankylosing spondylitis, ICD10

118

543

2.21

14.31

1.6

0.60

0.80

g/l

1.39

417

Dental caries, including avohilmo

758

2821

1.38

14.30

1.6

0.75

0.80

g/l

0.54

561

2146

Polyarthritis, unspecified

154

3.39

14.18

1.7

1.8

0.51

0.87

g/l

1.85

122

Other and unspecified rosacea

110

494

2.27

14.16

1.3

1.6

0.64

0.75

g/l

0.55

370

Tongue abnormality

294

2.67

14.14

1.6

1.7

0.62

0.83

g/l

1.10

227

Polyuria

221

1263

1.77

14.14

1.4

1.6

0.78

0.84

g/l

0.29

168

950

Disorders of vestibular function (Vertigo)

453

3022

1.48

14.12

1.4

1.6

0.64

0.78

g/l

2.67

329

2281

Benign neoplasm: Duodenum

117

3.81

14.03

1.5

1.6

0.84

0.77

g/l

0.07

Fracture of rib(s), sternum and thoracic spine

296

1832

1.63

14.02

1.5

1.6

0.71

0.86

g/l

1.84

232

1373

Ehlers-Danlos syndrome

4.95

13.97

1.5

0.69

0.49

g/l

0.48

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

113

516

2.22

13.96

1.7

1.6

1.08

0.80

g/l

0.53

399

Phlebitis and thrombophlebitis (not including DVT)

235

1374

1.73

13.88

1.6

0.68

0.76

g/l

0.50

180

1048

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

104

3.96

13.88

1.2

1.5

0.31

1.00

g/l

3.56

Chronic lymphocytic leukaemia

104

3.96

13.88

1.2

1.5

0.31

1.00

g/l

3.56

Chronic lymphocytic leukaemia, helper endpoint

104

3.96

13.88

1.2

1.5

0.31

1.00

g/l

3.56

Rosacea

139

689

2.05

13.87

1.4

1.6

0.65

0.74

g/l

0.54

110

517

Pyothorax

182

3.15

13.82

1.5

1.8

0.75

0.89

g/l

0.34

139

Other obstetric conditions, not elsewhere classified

353

1430

1.58

13.77

1.5

0.54

0.59

g/l

0.64

277

1099

Menorrhagia

344

1200

1.60

13.76

1.6

1.5

0.56

0.63

g/l

0.91

246

896

Rash and other nonspecific skin eruption

114

526

2.20

13.73

1.6

0.52

0.74

g/l

2.49

405

Adjustment and management of implanted device

164

863

1.92

13.71

1.4

1.7

0.78

0.82

g/l

0.20

119

653

Nonorganic sleeping disorders

238

1402

1.71

13.70

1.4

1.6

0.66

0.74

g/l

0.58

178

1060

Injuries to the head

1172

5644

1.28

13.69

1.6

0.77

0.75

g/l

0.14

882

4264

Other and unspecified types of non-Hodgkin lymphoma, hilmo

178

3.17

13.68

1.7

0.58

0.94

g/l

1.34

139

Injury, poisoning and certain other consequences of external causes

590

2076

1.43

13.66

1.7

1.6

0.68

0.77

g/l

1.01

447

1546

Keratitis

372

2443

1.53

13.63

1.7

1.6

0.75

0.77

g/l

0.11

271

1822

Carrier of infectious disease

129

3.61

13.62

1.9

1.6

1.17

0.78

g/l

0.80

Cerebral cysts

289

2.65

13.53

1.8

1.7

0.76

0.79

g/l

0.08

225

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

344

1389

1.58

13.52

1.5

0.55

0.59

g/l

0.51

269

1069

Diseases of external ear

348

2259

1.55

13.47

1.5

1.6

0.71

0.78

g/l

0.53

262

1704

Other disorders of ear

940

4702

1.31

13.46

1.6

1.5

0.72

0.76

g/l

0.41

686

3581

Viral infections of the central nervous system

405

2.36

13.37

1.5

1.7

0.50

0.81

g/l

3.17

307

Aortic aneurysm

200

1107

1.79

13.33

1.7

0.81

0.97

g/l

0.87

136

850

Other autoimmune haemolytic anaemias

5.36

13.33

2.5

1.8

0.91

0.92

g/l

0.01

Viral and other specified intestinal infections

231

1326

1.71

13.32

1.9

1.5

0.72

0.76

g/l

0.12

166

1020

Disorders of ocular muscles, binocular movement, accommodation and refraction

501

3475

1.44

13.31

1.5

1.6

0.59

0.76

g/l

5.05

375

2648

Hernia of abdominal wall

449

3081

1.47

13.27

1.6

0.71

0.82

g/l

1.56

335

2320

Injuries to the thorax

439

2997

1.47

13.27

1.6

0.73

0.83

g/l

1.16

344

2238

Acute laryngitis and tracheitis

142

708

2.00

13.26

1.5

1.7

0.68

0.84

g/l

1.21

106

540

Unspecified haematuria

390

2145

1.52

13.25

1.7

1.6

0.82

0.83

g/l

0.07

302

1598

Benign neoplasm: Caecum

114

534

2.17

13.24

1.9

1.6

0.73

0.86

g/l

0.56

406

Polycystic ovarian syndrome, consortium definition

713

3099

1.37

13.22

1.5

0.57

0.61

g/l

0.72

532

2351

Cardiomyopathy, other and unspecified

358

2.44

13.18

1.5

1.6

0.57

0.86

g/l

2.35

280

Rare circulating lymphoid malignancy, including Hilmo

122

3.62

13.18

1.8

1.6

0.40

0.88

g/l

1.95

Other/unspecified reactive arthropathies

377

2.41

13.17

1.3

1.7

0.54

0.80

g/l

2.22

290

Other postsurgical states

323

2.52

13.12

1.7

1.6

0.78

0.82

g/l

0.09

259

Coxarthrosis

434

1933

1.49

13.09

1.4

1.6

0.72

0.87

g/l

1.71

340

1461

Hyperkinetic disorders, excluding more controls

145

711

1.97

13.08

1.5

1.8

0.74

0.77

g/l

0.12

111

552

Diplopia

142

725

1.98

13.05

1.9

1.6

0.92

0.79

g/l

0.48

102

551

Sacroiliitis, not elsewhere classified

243

2.77

13.04

1.4

1.9

0.53

0.75

g/l

0.99

187

Generalized skin eruption due to drugs and medicaments

200

2.97

12.96

1.6

1.7

0.42

0.76

g/l

2.41

148

Secondary uncertain malignant neoplasm

129

638

2.05

12.95

1.4

1.6

0.70

0.84

g/l

0.71

477

Dipeptidyl peptidase 4 (DPP-4) inhibitors

515

2900

1.43

12.92

1.6

0.80

0.83

g/l

0.28

390

2166

Benign neoplasm: Rectum, anus and anal canal

195

1106

1.78

12.87

1.5

1.6

0.78

0.85

g/l

0.30

155

832

Caries of dentine, including avohilmo

811

3101

1.34

12.84

1.6

0.71

0.80

g/l

1.45

598

2375

Acute generalized exanthematous pustulosis

234

2.80

12.84

1.5

1.6

0.44

0.79

g/l

3.03

175

Endometriosis

338

1266

1.58

12.83

1.5

0.67

0.63

g/l

0.36

258

942

Vitamin B12 deficiency anaemia

418

2.30

12.82

1.8

1.6

0.93

0.87

g/l

0.09

311

Elevated blood glucose level

413

2.31

12.78

2.1

1.6

1.04

0.80

g/l

0.58

308

Trochanteric bursitis

138

705

1.98

12.66

1.6

0.64

0.76

g/l

0.74

111

520

Operations 2 for CAVS

231

1337

1.69

12.58

1.4

1.6

0.84

0.88

g/l

0.18

171

1010

Calcific aortic valvular stenosis, diagnosis (helper)

231

1337

1.69

12.58

1.4

1.6

0.84

0.88

g/l

0.18

171

1010

Calcific aortic valvular stenosis, operated

232

1345

1.68

12.56

1.4

1.6

0.84

0.88

g/l

0.19

172

1018

Calcific aortic valvular stenosis

232

1345

1.68

12.56

1.4

1.6

0.84

0.88

g/l

0.19

172

1018

Other embolism and thrombosis

137

701

1.98

12.53

1.8

1.6

0.89

0.83

g/l

0.18

101

532

Oesophagitis

220

2.82

12.52

1.4

1.5

0.61

0.88

g/l

1.26

164

Other and unspecified visual disturbances

115

553

2.11

12.50

1.9

1.7

0.94

0.78

g/l

0.42

417

Other/unspecified cytomegaloviral diseases

3.98

12.50

1.4

1.6

0.55

0.84

g/l

0.80

Scleritis and episcleritis

337

2.45

12.50

1.5

1.7

0.71

0.78

g/l

0.30

260

Synovial cyst of popliteal space [Baker]

301

2.53

12.45

1.3

1.7

0.63

0.81

g/l

0.95

227

Lichen simplex chronicus and prurigo

290

2.56

12.41

1.2

1.7

0.90

0.83

g/l

0.20

224

Calcific aortic valvular stenosis, including rheumatic fever

231

1341

1.68

12.40

1.4

1.6

0.84

0.88

g/l

0.18

171

1012

Other disorders of kidney and ureter

138

711

1.97

12.39

1.4

1.6

0.74

0.80

g/l

0.30

102

541

Other follicular disorders

445

2.24

12.36

1.5

1.7

0.58

0.80

g/l

1.58

340

Myelodysplastic syndrome, including Hilmo

3.88

12.24

1.5

1.8

0.96

1.05

g/l

0.12

Pyoderma gangrenosum

5.61

12.24

1.2

1.9

0.62

0.85

g/l

0.33

Other bursopathies

132

673

1.98

12.20

1.5

1.6

0.83

0.82

g/l

0.03

507

Congenital malformations of the musculoskeletal system, not elsewhere classified

4.09

12.17

1.4

0.68

0.57

g/l

0.23

Atherosclerosis, excluding cerebral and coronary sclerosis

327

1683

1.55

12.16

1.4

1.6

0.74

0.89

g/l

0.93

246

1260

Myocardial infarction

422

2027

1.47

12.15

1.5

1.6

0.78

0.90

g/l

1.05

320

1497

Abscess of lung

4.37

12.13

1.3

1.8

0.51

0.88

g/l

0.99

Cerebral palsy and other paralytic syndromes

129

655

1.99

12.09

1.5

1.7

0.69

0.80

g/l

0.47

502

Other or ill-defined heart diseases

247

2.68

12.08

1.5

1.7

0.83

0.84

g/l

0.04

188

Other noninfective disorders of lymphatic vessels and lymph nodes

165

3.10

12.08

1.5

1.7

0.76

0.89

g/l

0.31

124

Duodenal ulcer

423

2.25

12.05

1.4

1.6

0.73

0.86

g/l

0.84

326

Cardiac murmurs and other cardiac sounds

450

2.20

12.03

1.4

1.7

0.78

0.80

g/l

0.06

359

Allergic urticaria

100

463

2.19

12.01

1.5

1.7

0.82

0.74

g/l

0.23

352

Other abnormalities of plasma proteins

4.84

12.00

2.0

1.8

2.04

0.89

g/l

0.47

Covid-19 suspected case

246

1516

1.64

11.97

1.7

1.6

0.67

0.74

g/l

0.47

214

1147

Dental pulpitis, including avohilmo

983

4984

1.28

11.95

1.5

1.6

0.73

0.74

g/l

0.11

719

3779

Benign neoplasm: other/unspecified salivary gland

111

3.61

11.93

2.6

1.7

1.47

0.84

g/l

0.66

Other disorders of optic [2nd] nerve and visual pathways

326

2.44

11.93

1.6

1.7

0.57

0.79

g/l

1.24

255

Diseases of inner ear

514

3565

1.40

11.89

1.4

1.6

0.65

0.79

g/l

3.03

372

2690

Abscess of anal and rectal regions

102

478

2.16

11.88

1.5

1.6

0.69

0.86

g/l

0.91

364

Abnormal findings on examination of urine, without diagnosis

210

2.82

11.88

1.7

1.6

0.82

g/l

0.00

160

Marginal zone B-cell lymphoma, including Hilmo

4.40

11.87

1.7

1.6

0.39

1.05

g/l

1.99

Arthropathic psoriasis

132

681

1.96

11.84

1.3

1.6

0.63

0.78

g/l

0.99

516

Hypertensive Heart Disease

198

896

1.74

11.78

1.4

1.6

0.65

0.97

g/l

3.19

149

659

Procreative management

381

2155

1.48

11.73

1.6

0.67

0.72

g/l

0.51

274

1629

Other retinal disorders

584

3324

1.37

11.71

1.5

1.6

0.76

0.80

g/l

0.25

419

2507

Hyperparathyroidism

158

856

1.84

11.70

1.4

1.5

0.70

0.73

g/l

0.12

120

630

Presence of cardiac and vascular implants and grafts

374

1872

1.49

11.68

1.5

1.6

0.80

0.89

g/l

0.72

287

1425

Otitis externa

239

1472

1.64

11.68

1.5

1.6

0.68

0.77

g/l

0.60

194

1130

Peripheral artery disease

351

1862

1.51

11.66

1.4

1.6

0.76

0.88

g/l

0.66

266

1386

Phobic anxiety disorders

159

875

1.83

11.62

1.7

1.6

0.68

0.75

g/l

0.50

122

670

Any death

581

3037

1.38

11.58

1.3

1.6

0.79

0.83

g/l

0.22

438

2246

Meningitis

265

2.58

11.54

1.9

1.7

0.68

0.85

g/l

0.61

204

Mental and behavioural disorders due to psychoactive substance use

612

4200

1.36

11.54

1.4

1.6

0.74

0.80

g/l

0.65

445

3163

Paracetamol or NSAID medication

176

483

1.85

11.53

1.6

1.8

0.82

0.92

g/l

0.43

132

388

Other specified/unspecified bacterial intestinal infections

319

2.42

11.52

1.4

1.7

0.84

0.85

g/l

0.02

246

Pacemaker

257

1546

1.60

11.50

1.4

1.6

0.76

0.85

g/l

0.69

186

1170

Nummular dermatitis

388

2.28

11.46

1.8

1.6

0.99

0.87

g/l

0.35

299

Demyelinating diseases of the central nervous system

109

532

2.08

11.45

1.5

1.7

0.58

0.73

g/l

1.00

409

Diffuse large B-cell lymphoma

192

2.87

11.44

1.6

1.8

0.63

1.00

g/l

1.44

154

Diffuse large B-cell lymphoma, helper endpoint

192

2.87

11.44

1.6

1.8

0.63

1.00

g/l

1.44

154

Diffuse large B-cell lymphoma, including Hilmo

192

2.87

11.44

1.6

1.8

0.63

1.00

g/l

1.44

154

Other congenital malformations

112

552

2.06

11.44

1.4

1.6

0.69

0.72

g/l

0.08

432

Postmenopausal osteoporosis with pathological fracture

231

2.68

11.44

1.4

1.6

0.70

0.71

g/l

0.01

173

Barrett oesophagus

203

2.81

11.44

1.7

1.5

0.79

0.87

g/l

0.21

155

Bronchitis, not specified as acute or chronic

395

2.26

11.40

1.6

0.92

0.80

g/l

0.22

298

Benign neoplasm: Rectum

173

984

1.78

11.38

1.5

0.77

0.83

g/l

0.23

140

735

Pleural plaque

345

2.35

11.37

1.4

1.5

0.80

1.06

g/l

1.00

262

Spondylolisthesis/Spondylolysis

173

985

1.77

11.33

1.7

1.6

0.68

0.83

g/l

0.99

128

744

Open wound of lower leg

161

898

1.81

11.32

1.5

1.6

0.86

0.81

g/l

0.12

125

681

Substance abuse

592

4113

1.36

11.32

1.4

1.7

0.74

0.80

g/l

0.58

433

3102

Anaemia in chronic diseases classified elsewhere

101

3.67

11.28

1.6

1.7

0.72

0.76

g/l

0.06

Mouth breathing

415

2896

1.44

11.25

1.6

0.78

0.82

g/l

0.22

307

2192

Oxicams

216

723

1.71

11.24

1.7

1.6

0.69

0.83

g/l

1.17

173

543

Unspecific neurodegenerative disorder

113

1492

0.51

11.20

1.5

1.6

0.66

0.89

g/l

1.56

1109

Major coronary heart disease event excluding revascularizations

527

2534

1.39

11.14

1.5

1.6

0.78

0.86

g/l

0.73

391

1881

Subacute thyroiditis

168

2.98

11.10

1.6

1.7

0.73

0.84

g/l

0.27

133

Psoriatic arthropathies, ICD10

127

662

1.95

11.10

1.4

1.7

0.64

0.78

g/l

0.81

506

Diseases of peritoneum

107

525

2.06

11.08

1.5

1.6

0.55

0.81

g/l

2.26

395

Intestinal adhesions without obstruction

362

2.29

11.07

1.9

1.7

0.69

0.88

g/l

0.67

275

Adhesive capsulitis of shoulder

159

890

1.80

11.05

1.4

1.6

0.59

0.82

g/l

3.44

126

668

Disorders of vitreous body and globe

471

3239

1.40

11.04

1.6

1.5

0.77

0.78

g/l

0.06

368

2434

Disorders of vitreous body

459

3161

1.41

11.04

1.6

1.5

0.77

0.78

g/l

0.09

357

2374

Speech therapy

259

1650

1.58

11.02

1.4

1.6

0.77

g/l

0.01

235

1231

Vascular diseases of the intestine

132

3.24

10.99

1.5

1.7

0.97

0.90

g/l

0.10

100

Erythema multiforme

103

3.60

10.96

1.5

1.6

0.67

0.76

g/l

0.18

CR(E)ST syndrome

4.34

10.93

1.4

1.3

0.37

0.56

g/l

1.10

Disorders of choroid and retina

765

4169

1.31

10.93

1.6

0.76

0.78

g/l

0.11

557

3140

Unspecified fall

490

3489

1.39

10.91

1.6

0.66

0.80

g/l

2.38

355

2638

Other demyelinating diseases of the central nervous system

215

2.72

10.85

1.6

1.7

0.64

0.78

g/l

0.45

161

Autoimmune hyperthyroidism

261

2.53

10.84

1.5

1.6

0.74

0.76

g/l

0.05

197

Acute peritonitis

286

2.45

10.77

1.6

1.7

0.60

0.89

g/l

1.38

222

Chorioretinal inflammation

124

3.31

10.75

1.7

1.6

0.53

0.75

g/l

0.84

Otalgia

458

2.13

10.74

1.8

1.6

0.64

0.76

g/l

0.59

358

Other disorders of conjunctiva

139

754

1.86

10.73

1.5

1.6

0.58

0.82

g/l

2.72

566

Combined immunodeficiencies

5.49

10.70

1.4

0.31

0.61

g/l

1.32

Allergic purpura

141

3.12

10.55

1.5

1.4

0.84

0.65

g/l

0.37

107

Benign neoplasm: Descending colon

326

2.34

10.55

1.5

1.7

0.66

0.90

g/l

1.32

243

Disorder of lipoprotein metabolism, unspecified

121

631

1.94

10.54

1.4

1.6

0.77

0.90

g/l

0.56

100

468

Hyperhidrosis

111

3.40

10.45

1.4

0.60

0.81

g/l

0.79

Malignant neoplasm

865

3998

1.28

10.44

1.4

1.6

0.68

0.75

g/l

1.07

647

3023

Cutaneous lupus erythematosus

3.60

10.40

1.4

1.7

0.78

0.85

g/l

0.10

Neuromuscular dysfunction of bladder

457

2.11

10.40

1.3

1.6

0.82

0.84

g/l

0.07

351

Other psoriatic arthropathies

121

636

1.93

10.35

1.4

1.7

0.65

0.76

g/l

0.58

483

Other and unspecified disorders of vitreous body

385

2658

1.44

10.34

1.6

1.5

0.75

0.76

g/l

0.01

305

1992

Bullous disorders

256

2.50

10.29

1.8

1.7

0.81

0.87

g/l

0.14

193

Caries of enamel

927

5300

1.27

10.28

1.6

0.69

0.75

g/l

0.83

752

3952

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

444

2.11

10.27

1.6

1.7

0.86

0.91

g/l

0.11

337

Erythema nodosum

133

3.16

10.25

1.8

1.7

0.78

0.80

g/l

0.05

101

Optic neuritis

251

2.53

10.25

1.6

1.8

0.50

0.75

g/l

1.77

191

Congenital malformations and deformations of the musculoskeletal system

114

587

1.96

10.19

1.5

1.7

0.66

0.73

g/l

0.30

467

Other disorders of eyelid

377

2509

1.44

10.15

1.6

1.5

0.77

0.79

g/l

0.07

293

1899

Benign neoplasm of other and unspecified endocrine glands

142

790

1.82

10.15

1.5

1.6

0.63

0.77

g/l

1.27

107

594

Arthropathies in other diseases classified elsewhere

155

2.96

10.14

1.3

1.9

0.62

0.96

g/l

0.93

121

Artrosis, including avohilmo

846

3615

1.29

10.13

1.5

1.6

0.74

0.76

g/l

0.20

644

2702

Injuries to the shoulder and upper arm

836

5292

1.28

10.12

1.5

1.6

0.70

0.79

g/l

1.45

637

3975

Conduction disorders

250

1297

1.57

10.12

1.5

1.6

0.78

0.87

g/l

0.54

173

978

Colonic or urogenital fistula

270

1772

1.53

10.10

1.4

1.6

0.60

0.82

g/l

3.68

198

1334

Superficial injury of lower leg

251

1625

1.56

9.99

1.4

1.6

0.73

0.72

g/l

0.02

198

1229

Failure and rejection of transplanted organs and tissues

4.06

9.99

1.5

0.57

0.75

g/l

0.31

Primary adrenocortical insufficiency

4.45

9.98

1.6

1.9

0.64

0.69

g/l

0.06

Tuberculosis

218

2.60

9.97

1.6

1.7

0.80

0.91

g/l

0.24

166

Tonsillectomy and adenotomy

623

3278

1.33

9.91

1.5

1.6

0.52

0.72

g/l

8.41

477

2495

Special screening examination for other diseases and disorders

479

2.04

9.87

1.5

0.70

0.85

g/l

0.62

326

Acute gastritis

323

2.29

9.85

1.6

0.62

0.80

g/l

1.03

240

Benign paroxysmal vertigo

270

1782

1.53

9.85

1.4

1.6

0.62

0.77

g/l

2.24

194

1340

Kidney transplant status

305

2.34

9.85

1.6

1.7

0.53

0.85

g/l

1.67

241

Maternal care for other conditions predominantly related to pregnancy

224

1390

1.59

9.84

1.4

1.5

0.50

0.62

g/l

1.90

173

1055

Myocardial infarction, strict

379

1885

1.44

9.83

1.5

1.6

0.78

0.91

g/l

1.01

288

1390

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

303

2025

1.49

9.80

1.5

1.6

0.65

0.69

g/l

0.31

240

1551

Artificial opening status

238

2.52

9.80

1.5

1.8

0.91

0.89

g/l

0.02

192

Malignant neoplasm of liver and intrahepatic bile ducts

3.51

9.80

1.8

1.7

0.81

1.10

g/l

0.44

Osteonecrosis

293

2.36

9.79

1.3

1.6

0.50

0.81

g/l

1.79

225

Abnormalities of gait and mobility

114

599

1.92

9.76

1.5

1.6

0.69

0.90

g/l

1.46

466

Congenital malformations and deformations of the musculoskeletal system

137

759

1.82

9.76

1.5

1.6

0.70

0.72

g/l

0.07

101

604

Other obstructive and reflux uropathy

192

2.70

9.74

1.6

1.7

0.97

0.78

g/l

0.40

148

Diseases of pulp and periapical tissues and dental caries

651

2524

1.33

9.72

1.6

0.74

0.81

g/l

0.82

476

1915

ILD medications: pirfenidone

8.76

9.69

1.3

1.0

0.55

0.79

g/l

0.60

Pure hyperglyceridaemia

102

3.43

9.67

1.4

1.8

0.64

0.81

g/l

0.40

Hodgkin lymphoma, hilmo

138

3.05

9.66

1.5

0.72

0.84

g/l

0.27

103

Fibroblastic disorders

196

1207

1.63

9.65

1.4

1.6

0.74

0.89

g/l

1.39

149

908

Unspecified privation

115

609

1.91

9.63

1.7

0.83

0.79

g/l

0.09

468

Atypical facial pain

259

2.44

9.58

1.8

1.6

0.67

0.75

g/l

0.30

200

Isolated proteinuria

155

2.92

9.58

1.5

0.67

0.79

g/l

0.38

119

Autoimmune thyroiditis

3.55

9.56

1.3

1.7

0.56

0.79

g/l

0.50

Nonspecific lymphadenitis

347

2.23

9.56

1.6

1.02

0.77

g/l

0.72

272

Superficial injury of abdomen, lower back and pelvis

156

908

1.73

9.55

1.4

1.6

0.72

0.78

g/l

0.35

120

693

Umbilical hernia

262

1731

1.52

9.53

1.7

1.6

0.77

0.86

g/l

0.71

196

1313

Amyloidosis

3.77

9.50

1.6

1.8

0.63

0.85

g/l

0.34

Other and unspecified follicular disorders

207

2.61

9.45

1.8

0.74

0.85

g/l

0.28

158

Other specified and unspecified disorders of eye and adnexa

184

2.72

9.44

1.8

1.7

0.59

0.79

g/l

0.75

142

Idiopathic gout

421

2.09

9.42

1.4

1.6

0.71

0.88

g/l

0.54

319

Haemorrhage, not elsewhere classified

124

3.12

9.39

1.6

1.4

0.71

0.89

g/l

0.39

Neuralgia and neuritis, unspecified

231

2.51

9.39

1.4

1.6

0.61

0.86

g/l

0.67

171

Other (not insulin) diabetes medications

954

4534

1.25

9.39

1.6

0.75

0.76

g/l

0.08

700

3431

Post-traumatic stress disorder

462

2.04

9.38

1.4

1.7

0.59

0.74

g/l

1.07

345

Pneumonitis due to solids and liquids

324

2.25

9.35

1.5

1.7

0.63

0.89

g/l

1.19

249

Other and unspecified nerve root and plexus disorders, also in other diseases

202

1267

1.61

9.28

1.5

0.68

0.75

g/l

0.40

115

961

Infliximab

105

3.35

9.28

1.5

1.9

0.60

0.85

g/l

0.55

Type 1 diabetes

260

1727

1.51

9.18

1.8

1.6

0.71

0.80

g/l

0.34

191

1329

Brachial plexus disorders

109

577

1.91

9.17

1.4

1.6

0.48

0.75

g/l

3.52

446

Viral warts

110

584

1.91

9.17

1.6

0.66

0.74

g/l

0.38

440

Vitamin deficiency, wide

228

2.50

9.16

1.3

1.7

1.03

0.81

g/l

0.26

171

Vitamin deficiency

228

2.50

9.16

1.3

1.7

1.03

0.81

g/l

0.26

171

Hypersensitivity pneumonitis due to organic dust

3.88

9.15

1.2

1.6

0.63

0.83

g/l

0.40

Carpal tunnel syndrome

577

3870

1.32

9.12

1.6

0.68

0.76

g/l

1.19

431

2931

Other and unspecified myopathies

401

2.10

9.04

1.7

0.60

0.89

g/l

2.08

303

Injuries to the wrist and hand

1018

5731

1.23

9.03

1.5

1.6

0.75

g/l

0.02

768

4324

Unspecified/other endometriosis

100

517

1.96

9.02

1.5

1.6

0.49

0.59

g/l

0.79

387

Acute posthaemorrhagic anaemia

122

3.09

9.01

1.8

1.6

0.60

0.74

g/l

0.41

Extreme obesity with alveolar hypoventilation

183

2.67

8.99

1.4

1.6

0.63

0.88

g/l

0.76

135

Acute bronchiolitis

354

2.12

8.98

1.6

1.7

0.85

0.84

g/l

0.02

293

Non-allergic asthma

449

2.03

8.98

1.8

1.7

0.71

0.84

g/l

0.52

338

Other symptoms and signs involving cognitive functions and awareness

396

2600

1.39

8.95

1.5

1.6

0.75

0.82

g/l

0.65

288

1942

Generalized anxiety disorder

170

1032

1.66

8.93

1.5

1.6

0.62

0.72

g/l

0.96

142

777

Smoking dependency

499

1.97

8.91

1.3

1.6

0.49

0.79

g/l

3.30

374

Disorders of continuity of bone

107

569

1.90

8.89

1.4

1.6

0.55

0.74

g/l

1.37

427

Angina pectoris

477

2348

1.36

8.87

1.6

0.75

0.85

g/l

1.10

335

1745

Cardiomyopathies, Primary/intrinsic

112

605

1.87

8.85

1.6

1.7

0.80

0.99

g/l

0.72

471

Other congenital malformations

145

846

1.73

8.84

1.4

1.6

0.76

0.71

g/l

0.21

112

655

Noninflammatory disorders of female genital tract

386

1370

1.42

8.83

1.5

0.61

0.65

g/l

0.36

287

1028

Cardiomyopathy (excluding other)

115

627

1.85

8.82

1.6

1.7

0.81

0.99

g/l

0.64

485

Intracranial injury

564

4071

1.32

8.82

1.5

1.6

0.77

0.79

g/l

0.08

420

3073

Other diseases of blood and blood-forming organs

333

2.19

8.80

1.7

0.81

g/l

0.01

253

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

453

2.01

8.76

1.4

1.8

0.59

0.73

g/l

0.66

366

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

233

1357

1.54

8.76

1.4

1.7

0.69

0.73

g/l

0.24

176

1054

Mental and behavioural disorders due to tobacco

502

1.96

8.76

1.3

1.6

0.49

0.78

g/l

3.13

376

Abnormality of white blood cells, not elsewhere classified

4.79

8.72

1.3

2.0

0.47

0.95

g/l

0.79

Other juvenile arthritis

228

2.46

8.69

1.6

1.8

0.46

0.70

g/l

1.32

176

Other/unspecified enthesopathies, not elsewhere classified

402

2.06

8.61

1.8

1.6

0.77

0.82

g/l

0.16

307

Preparatory care for dialysis

205

2.54

8.60

1.3

1.7

0.60

0.83

g/l

0.85

157

Dystonia

285

2.28

8.60

1.4

1.7

0.77

0.79

g/l

0.04

210

conjunctival haemorrhage

356

2.13

8.59

1.5

1.6

0.57

0.88

g/l

2.89

274

Unspecified misadventure during surgical and medical care

260

2.35

8.58

1.5

1.7

0.97

0.86

g/l

0.28

197

Other/unspecified enthesopathies of lower limb, excluding foot

376

2.10

8.58

1.4

1.7

0.66

0.83

g/l

0.89

294

Olecranon bursitis

285

2.28

8.58

1.3

1.6

0.80

0.90

g/l

0.28

218

Benign neoplasm: Pituitary gland, craniopharyngeal duct

279

2.30

8.58

1.5

1.7

0.78

0.85

g/l

0.19

214

Episcleritis

279

2.30

8.57

1.6

1.7

0.76

0.79

g/l

0.09

217

Other localized connective tissue disorders

3.51

8.57

2.1

1.9

0.80

0.90

g/l

0.16

Adult respiratory distress syndrome

4.30

8.54

1.4

1.8

0.54

0.91

g/l

0.60

Appendectomy

648

4838

1.29

8.54

1.4

1.6

0.60

0.75

g/l

3.08

478

3655

Dermatophytosis

127

722

1.78

8.52

1.6

0.66

0.86

g/l

1.45

102

552

Juvenile arthritis (FINNGEN)

255

2.35

8.50

1.6

0.54

0.66

g/l

0.50

197

KRA_PSY_EATING, excluding more controls

436

2.01

8.47

1.4

1.7

0.62

0.68

g/l

0.27

334

Disorders of adult personality and behaviour

305

2129

1.44

8.47

1.5

1.6

0.74

0.71

g/l

0.22

221

1625

Personality disorders

289

1999

1.46

8.43

1.4

1.6

0.72

0.71

g/l

0.05

208

1517

Disorders resulting from impaired renal tubular function

178

2.64

8.40

1.3

1.7

0.63

0.87

g/l

0.64

139

Benign neoplasm: Parotid gland

386

2.07

8.40

1.8

1.6

0.77

0.85

g/l

0.22

295

Trigger finger

133

770

1.74

8.36

1.6

0.70

0.77

g/l

0.33

102

581

Ventral hernia

213

1387

1.55

8.36

1.5

0.63

0.80

g/l

1.98

165

1042

Fracture of lumbar spine and pelvis

182

1141

1.60

8.35

1.5

1.6

0.85

0.80

g/l

0.16

136

858

Cardiodefibrillation

290

2006

1.45

8.34

1.4

1.6

0.75

0.88

g/l

1.11

204

1499

Other aneurysm

214

2.46

8.33

1.7

1.6

0.82

0.90

g/l

0.15

163

Other noninflammatory disorders of vulva and perineum

497

1.93

8.32

1.4

1.5

0.58

0.63

g/l

0.20

371

Hypothyroidism, strict autoimmune, 3 medication purchases required

793

4275

1.26

8.30

1.5

0.66

0.73

g/l

1.16

587

3272

Spontaneous rupture of synovium and tendon

361

2.10

8.28

1.6

1.7

0.61

0.82

g/l

1.07

278

Impingement syndrome of shoulder

213

1390

1.54

8.28

1.5

1.6

0.59

0.88

g/l

5.26

168

1046

Other bullous disorders

129

2.94

8.24

1.6

0.78

0.75

g/l

0.08

101

Allergic colitis

129

2.94

8.23

1.3

1.4

0.55

0.67

g/l

0.58

108

Other abnormal findings of blood chemistry

210

2.47

8.19

1.9

1.7

0.49

0.78

g/l

1.36

157

Amiodarone users

472

1.95

8.18

1.2

1.6

0.73

0.93

g/l

1.04

363

IgA nephropathy (IgA glomerulonephritis)

119

3.02

8.16

1.3

1.9

0.68

0.94

g/l

0.49

Type 1 diabetes, wide definition, subgroup 1

199

1283

1.56

8.14

1.6

0.66

0.82

g/l

0.57

151

1017

Viral meningitis

199

2.51

8.12

1.5

1.8

0.54

0.78

g/l

1.08

159

Visual impairment including blindness (binocular or monocular)

292

2.22

8.11

1.4

1.6

0.57

0.80

g/l

1.31

227

Endometriosis of pelvic peritoneum

160

934

1.65

8.10

1.5

0.62

0.63

g/l

0.03

106

712

Familial hypercholesterolemia

125

718

1.75

8.09

1.8

1.6

0.65

0.85

g/l

1.61

101

533

Other hearing loss

221

1429

1.52

8.07

1.6

0.67

0.82

g/l

1.69

152

1069

Other disorders of nervous system

332

2.14

8.07

1.4

1.8

0.43

0.86

g/l

4.44

259

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

475

1.94

8.05

1.4

1.6

0.61

0.82

g/l

1.21

362

Autonomic disorders

3.21

8.02

1.3

1.8

0.67

0.83

g/l

0.29

Sequelae of other external causes

281

2.24

8.01

1.4

1.6

0.67

0.86

g/l

0.97

220

Abnormal involuntary movements

131

766

1.73

7.99

1.5

1.6

0.63

0.78

g/l

1.14

107

586

Vasomotor rhinitis (mode)

367

2.07

7.97

2.0

1.6

0.80

0.82

g/l

0.04

277

Infections with a predominantly sexual mode of transmission

315

2235

1.42

7.95

1.6

0.68

g/l

0.04

245

1677

Other specified and unspecified retinal disorders

154

2.71

7.95

1.7

0.52

0.86

g/l

1.61

120

Myocardial infarction, without ST-elevation

307

1974

1.42

7.94

1.6

0.74

0.88

g/l

1.36

244

1471

Other extrapyramidal and movement disorders in other diseases

216

1429

1.52

7.91

1.6

0.65

0.78

g/l

1.33

168

1072

Disturbance of activity and attention

141

826

1.69

7.91

1.5

1.8

0.77

0.72

g/l

0.17

107

634

Hidradenitis suppurativa

214

2.43

7.89

1.2

1.7

0.37

0.77

g/l

3.23

160

Ganglion

193

1247

1.56

7.87

1.5

1.6

0.60

0.72

g/l

1.39

148

943

Cervicocranial syndrome

528

1.87

7.86

1.4

1.6

0.69

0.78

g/l

0.39

404

Thoracic aortic aneurysm

127

740

1.73

7.85

1.8

1.6

0.78

0.96

g/l

0.75

572

Benign neoplasm of mouth and pharynx

108

601

1.82

7.83

2.0

1.6

0.76

0.81

g/l

0.17

454

Tinnitus

224

1500

1.50

7.76

1.6

0.76

0.79

g/l

0.20

162

1137

Respiratory tuberculosis

197

2.47

7.75

1.7

0.82

0.89

g/l

0.13

152

Respiratory tuberculosis, confirmed and not-confirmed

197

2.47

7.75

1.7

0.82

0.89

g/l

0.13

152

Childhood allergy (age < 16)

159

807

1.64

7.73

1.5

1.6

0.72

0.68

g/l

0.18

126

626

Calculus of kidney and ureter

266

1846

1.45

7.67

1.6

0.90

0.85

g/l

0.24

201

1400

Stenosis and insufficiency of lacrimal passages

448

1.94

7.66

1.5

1.6

0.60

0.79

g/l

1.02

338

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

400

2.00

7.65

1.4

1.6

0.65

0.77

g/l

0.22

301

AV-block

131

675

1.71

7.65

1.5

1.6

0.87

0.93

g/l

0.17

525

Scar conditions and fibrosis of skin

205

2.43

7.63

1.2

1.7

0.48

0.86

g/l

2.50

156

Amenorrhoea

387

2.01

7.61

1.9

1.7

0.53

0.63

g/l

0.45

292

Ulcer of oesophagus

274

2.22

7.61

1.3

1.5

0.72

0.90

g/l

0.85

209

Osteonecrosis due to drugs

3.92

7.60

1.3

1.7

0.65

0.88

g/l

0.30

Nail disorders

479

1.90

7.54

1.2

1.7

0.55

0.83

g/l

2.90

368

Oral lichen planus, including avohilmo , including avohilmo

355

2.06

7.53

1.5

1.7

0.58

0.76

g/l

1.11

265

Alzheimer disease, including avohilmo

1198

0.56

7.49

1.6

0.73

0.87

g/l

0.63

897

Ankylosing spondylitis, strict definition

270

2.23

7.49

1.7

1.8

0.64

0.85

g/l

0.62

211

Problems related to lifestyle

106

595

1.80

7.48

1.4

1.6

0.76

0.75

g/l

0.01

446

Prurigo nodularis

3.19

7.46

1.1

1.6

1.01

0.82

g/l

0.32

Alcohol abuse, main dg, excluding more controls

146

898

1.64

7.38

1.6

1.7

0.90

0.83

g/l

0.15

108

683

Infections with a predominantly sexual mode of transmission

400

2783

1.34

7.37

1.5

1.6

0.64

0.70

g/l

0.77

306

2103

Social phobias

519

1.85

7.34

1.7

1.8

0.71

0.82

g/l

0.48

391

Chronic suppurative otitis media, including avohilmo

442

1.92

7.30

1.8

1.7

0.66

0.85

g/l

1.06

342

Drug-induced neutropenia

373

2.01

7.29

1.4

1.6

0.63

0.78

g/l

0.56

280

Other disorders of patella

161

1017

1.59

7.29

1.3

1.6

0.68

0.78

g/l

0.85

126

766

Dementia

151

1644

0.63

7.28

1.5

0.72

0.87

g/l

0.79

111

1206

Thyrotoxicosis, other and/or unspecified

186

1215

1.54

7.27

1.5

1.6

0.82

0.72

g/l

0.45

136

909

Peritonsillar abscess

183

1191

1.55

7.26

1.3

1.6

0.59

0.76

g/l

2.16

134

893

Disorders of pituitary gland, other and/or unspecified

6.44

7.25

2.8

1.3

0.80

0.46

g/l

0.58

Other bacterial agents as the cause of diseases classified to other chapters

4.06

7.23

1.3

1.9

0.44

0.85

g/l

0.95

Other viral hepatitis

395

1.98

7.23

1.5

1.7

0.70

0.81

g/l

0.47

304

Viral hepatitis

451

1.91

7.22

1.5

1.7

0.73

0.81

g/l

0.30

348

Lesion of lateral popliteal nerve

236

2.28

7.18

1.5

1.7

0.66

0.87

g/l

0.63

183

Tubulo-interstitial nephritis, not specified as acute or chronic

301

2.12

7.15

1.5

1.6

0.86

0.82

g/l

0.06

231

Viral encephalitis, not elsewhere classified/unspecified

101

3.05

7.15

1.3

1.6

0.46

0.82

g/l

1.32

Other and unspecified glaucoma

288

2.14

7.14

1.6

0.69

0.89

g/l

0.64

218

Sacrococcygeal disorders, not elsewhere classified

134

2.74

7.13

2.1

1.8

0.68

0.85

g/l

0.43

Supplementary factors related to causes of morbidity and mortality classified elsewhere

302

2174

1.40

7.13

1.7

1.6

0.76

0.78

g/l

0.13

221

1645

Viral warts

217

1471

1.49

7.12

1.7

1.6

0.72

0.76

g/l

0.28

159

1126

Persistent mood disorders

183

1198

1.54

7.10

1.4

1.6

0.63

0.78

g/l

1.54

147

889

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

225

2.31

7.09

1.4

1.9

0.63

0.71

g/l

0.20

179

Alzheimer disease

1013

0.52

7.05

1.5

1.6

0.70

0.86

g/l

0.57

761

Seborrhoeic keratosis

185

1216

1.53

7.04

1.6

1.5

0.58

0.82

g/l

3.45

144

910

Fracture of foot, except ankle

243

1688

1.45

7.03

1.5

1.6

0.80

0.74

g/l

0.22

185

1281

Tuberculosis of other organs, strict

3.27

7.01

1.7

1.6

0.76

0.74

g/l

0.04

Other and unspecified diseases of blood and blood-forming organs

119

2.83

6.96

1.7

0.90

0.83

g/l

0.10

Diseases of appendix

730

5341

1.24

6.94

1.5

1.6

0.71

0.75

g/l

0.27

530

4036

Infective dermatitis

108

624

1.75

6.94

1.5

1.6

0.70

0.80

g/l

0.63

476

Lichen planus

115

677

1.71

6.91

1.8

1.5

0.64

0.76

g/l

0.66

508

Monoplegia

3.54

6.91

2.0

1.7

0.34

0.79

g/l

1.41

Hyperkinetic disorders

147

902

1.61

6.91

1.5

1.7

0.78

0.71

g/l

0.28

113

693

Abnormal blood-pressure reading, without diagnosis

196

2.38

6.90

1.6

1.7

0.50

0.88

g/l

2.83

153

Appendicitis, broad definition

725

5324

1.24

6.89

1.5

1.6

0.71

0.75

g/l

0.25

526

4021

Inflammation of lacrimal passages (acute and unspecified)

3.42

6.89

2.4

1.7

0.78

0.76

g/l

0.04

Unstable angina pectoris

279

1564

1.41

6.86

1.5

1.6

0.69

0.92

g/l

3.60

217

1141

Campylobacter enteritis

137

2.69

6.86

1.5

1.8

0.64

0.79

g/l

0.42

108

Spirochaetal infections, other/unspecified

467

1.86

6.82

1.3

1.6

0.57

0.79

g/l

2.12

346

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

163

1051

1.56

6.80

1.6

1.5

0.49

0.62

g/l

1.50

119

791

Papilloedema, unspecified

104

2.95

6.79

1.5

2.0

0.59

0.82

g/l

0.44

Other infective otitis externa

301

2.09

6.79

1.5

1.6

0.69

0.80

g/l

0.33

238

Urolithiasis

280

2008

1.40

6.78

1.6

0.89

0.86

g/l

0.15

207

1516

Dementia, including avohilmo

171

1782

0.66

6.78

1.6

1.5

0.74

0.86

g/l

0.66

125

1306

Visual field defects

404

1.93

6.77

1.7

1.6

0.64

0.83

g/l

1.07

305

Hordeolum and other deep inflammation of eyelid

315

2.06

6.76

1.7

1.6

0.56

0.82

g/l

1.90

241

Squamous cell neoplasms and carcinomas of the skin

281

2.12

6.75

1.5

1.8

0.87

1.01

g/l

0.28

215

Other superficial mycoses

3.00

6.75

1.8

1.5

0.87

0.75

g/l

0.22

Other congenital malformations, not elsewhere classified

3.88

6.75

1.7

1.6

0.84

0.65

g/l

0.20

Later onset COPD

185

971

1.52

6.74

1.3

1.6

0.90

g/l

0.02

140

728

Tuberculosis of other organs

3.36

6.73

1.7

0.79

0.80

g/l

0.01

Decubitus ulcer and pressure area

224

2.26

6.68

1.6

0.73

0.90

g/l

0.56

174

Symptoms and signs involving emotional state

157

2.53

6.64

1.5

1.8

0.70

0.83

g/l

0.22

125

Unspecified nephritic syndrome

100

2.97

6.64

2.1

1.7

0.59

0.77

g/l

0.39

DVT of lower extremities

162

1049

1.55

6.63

1.6

1.5

0.83

0.81

g/l

0.05

119

794

Superficial injury of wrist and hand

214

1470

1.47

6.61

1.6

0.95

0.73

g/l

0.84

165

1137

Hepatocellular carcinoma

3.40

6.59

1.7

0.46

1.26

g/l

2.39

Other disorders of the musculoskeletal system and connective tissue

137

856

1.61

6.56

1.5

1.6

0.67

0.78

g/l

1.04

645

Benign neoplasm: Sigmoid colon

161

1045

1.55

6.54

1.7

1.6

0.75

0.83

g/l

0.32

121

786

Dronedarone medication

112

2.82

6.52

1.2

1.5

0.56

0.85

g/l

0.96

Restless leg syndrome

126

773

1.64

6.50

1.8

1.6

0.64

0.76

g/l

0.90

102

579

Other problems related to primary support group, including family circumstances

129

774

1.64

6.50

1.6

1.7

0.73

0.74

g/l

0.05

105

603

Oral lichen planus

118

2.77

6.49

1.7

1.8

0.53

0.86

g/l

1.16

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

141

2.60

6.49

1.4

1.7

0.43

0.59

g/l

0.78

110

Poisoning by drugs, medicaments and biological substances

242

1707

1.43

6.48

1.5

1.6

0.67

0.71

g/l

0.32

185

1304

Degenerative diseases of the nervous system

1234

0.59

6.48

1.4

1.6

0.70

0.86

g/l

0.89

932

Hypercalcemia

196

2.33

6.46

1.6

1.8

1.26

0.86

g/l

0.39

146

Trigeminal neuralgia

287

2.08

6.45

1.9

1.6

0.66

0.82

g/l

0.70

221

Specific personality disorders

242

1709

1.42

6.44

1.4

1.6

0.73

0.71

g/l

0.12

178

1300

Agoraphobia

172

2.42

6.41

1.5

1.9

0.65

0.84

g/l

0.74

126

Superficial injury of hip and thigh

121

737

1.65

6.40

1.4

1.6

0.92

0.82

g/l

0.19

553

Other maternal disorders predominantly related to pregnancy

539

2662

1.27

6.40

1.4

1.5

0.56

0.61

g/l

0.81

420

2012

Cramp and spasm

255

2.15

6.39

1.7

0.82

0.86

g/l

0.09

199

Other specified and unspecified disorders of eyelid

3.67

6.37

2.1

1.9

0.62

0.92

g/l

0.55

Abdominal aortic aneurysm (AAA)

367

1.93

6.36

1.6

0.82

0.97

g/l

0.41

281

Excessive vomiting in pregnancy

478

1.82

6.35

1.4

1.6

0.54

0.64

g/l

0.57

356

Dialysis

204

2.29

6.35

1.3

1.8

0.44

0.87

g/l

2.70

158

Charcot foot

3.24

6.35

1.2

1.4

0.58

0.65

g/l

0.15

Complications following infusion, transfusion and therapeutic injection

3.54

6.34

1.5

1.3

1.31

0.75

g/l

0.28

Other sleep disorders

104

611

1.72

6.33

1.4

1.7

0.61

0.82

g/l

1.64

480

Lesion of ulnar nerve

137

864

1.60

6.33

1.6

0.73

0.81

g/l

0.41

108

668

Achalasia of cardia

3.32

6.33

1.2

1.4

0.41

0.69

g/l

0.97

Amyloidosis, other/unspecified

3.41

6.32

1.6

1.8

0.65

0.85

g/l

0.23

Abnormal findings in cerebrospinal fluid

8.46

6.32

2.2

1.4

0.71

0.50

g/l

—

Ptosis of eyelid

530

1.77

6.31

1.8

1.5

0.74

0.82

g/l

0.41

397

Hallux valgus (acquired)

268

1379

1.40

6.30

1.4

1.6

0.73

0.76

g/l

0.12

203

1059

Other disorders of veins

358

2686

1.33

6.29

1.5

0.72

0.74

g/l

0.12

266

2049

Mental and behavioural disorders due to alcohol

474

3569

1.28

6.26

1.4

1.7

0.78

0.82

g/l

0.27

340

2681

Extrapyramidal and movement disorders

317

2353

1.35

6.24

1.6

0.64

0.81

g/l

2.32

239

1767

Vitamin D deficiency

2.98

6.22

1.2

1.4

0.59

0.52

g/l

0.16

Anogenital herpesviral [herpes simplex] infection

368

1.93

6.17

1.5

1.7

0.74

0.70

g/l

0.11

279

Use of anticholinesterases

1255

0.59

6.16

1.6

0.72

0.87

g/l

0.70

931

N06DA Anticholinesterases

1255

0.59

6.16

1.6

0.72

0.87

g/l

0.70

931

Anogenital herpesviral [herpes simplex] infection

112

677

1.67

6.15

1.4

1.7

0.66

0.69

g/l

0.13

521

Acute appendicitis, no complications

545

4334

1.26

6.14

1.4

1.6

0.74

0.75

g/l

0.06

395

3273

Right bundle-branch block

139

2.55

6.14

1.2

1.8

0.80

0.88

g/l

0.13

106

Open wound of ankle and foot

105

625

1.70

6.12

1.4

1.6

0.90

0.82

g/l

0.18

472

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

499

1.78

6.10

1.6

0.49

0.63

g/l

1.08

377

Cerebrovascular diseases

639

3635

1.24

6.10

1.6

0.85

0.79

g/l

0.52

500

2693

299

2020

1.36

6.10

1.5

1.6

0.79

0.83

g/l

0.18

223

1494

Dissection of aorta

122

2.67

6.09

1.5

1.6

0.69

0.89

g/l

0.58

Disorders of refraction and accommodation

266

1922

1.39

6.08

1.3

1.6

0.56

0.74

g/l

4.10

197

1476

Other and unspecified psoriasis

335

1.96

6.08

1.5

1.6

0.78

0.80

g/l

0.03

254

Lichen ruber planus, wide definition including periferal and oral lichen planus

196

1347

1.46

6.08

1.8

1.6

0.64

0.75

g/l

1.03

148

1006

Striking against or struck by other objects

329

2465

1.34

6.07

1.6

0.79

0.81

g/l

0.06

237

1872

Lung transplant status

3.87

6.03

1.2

1.8

0.45

0.92

g/l

0.86

Lung transplantation

3.86

6.03

1.2

1.8

0.45

0.92

g/l

0.86

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

501

1.77

6.02

1.6

0.49

0.65

g/l

1.31

377

Disorders of lacrimal system and orbit in diseases classified elsewhere

106

2.79

6.00

1.7

1.3

0.61

0.68

g/l

0.20

Acne

109

658

1.67

5.99

1.5

1.7

0.63

0.72

g/l

0.55

502

Erosion of teeth , including avohilmo

249

1792

1.40

5.98

1.5

1.6

0.67

0.74

g/l

0.51

192

1357

Bacterial, viral and other infectious agents

584

1.71

5.98

1.3

1.6

0.64

0.78

g/l

1.02

450

Otitis externa, unspecified

111

675

1.66

5.97

1.3

1.6

0.59

0.74

g/l

1.52

517

Personal history of other diseases and conditions

116

710

1.64

5.97

1.4

1.6

0.56

0.70

g/l

1.21

560

Osteomyelitis

296

2.02

5.96

1.5

1.6

1.00

0.86

g/l

0.12

229

Other noninflammatory disorders of vagina

401

1.86

5.95

1.3

1.6

0.51

0.64

g/l

1.00

301

Other and unspecified aplastic anaemias

3.64

5.95

1.3

1.4

0.61

g/l

0.00

Other symptoms and signs involving general sensations and perceptions

172

2.36

5.93

1.2

1.8

0.53

0.92

g/l

2.35

130

Other misadventures during surgical and medical care

107

2.77

5.90

1.4

1.8

0.64

0.86

g/l

0.52

Perforation of tympanic membrane

519

1.75

5.89

1.6

1.06

0.77

g/l

0.49

405

Acute nephritic syndrome

2.88

5.88

2.0

1.5

0.82

0.72

g/l

0.17

Dislocation, sprain and strain of joints and ligaments of knee

590

4400

1.24

5.88

1.5

1.6

0.67

0.75

g/l

1.55

446

3304

Thyrotoxicosis

224

1588

1.42

5.88

1.6

0.80

0.69

g/l

0.63

164

1179

Other and unspecified vaccines and biological substances

5.14

5.86

2.1

1.4

0.43

0.44

g/l

0.01

Epilepsy

267

1944

1.38

5.86

1.5

1.7

0.70

0.82

g/l

0.86

205

1491

Atrophic disorders of skin

134

858

1.57

5.84

1.5

0.58

0.72

g/l

1.31

111

644

Immunodeficiency associated with other major defects

8.38

5.83

1.4

2.1

0.81

0.79

g/l

—

Disorders of tooth development and eruption

150

792

1.54

5.82

1.8

1.6

0.71

0.79

g/l

0.37

112

612

Benign neoplasm of eye and adnexa

529

1.74

5.80

1.6

0.85

0.80

g/l

0.06

406

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

273

2005

1.37

5.80

1.4

1.6

0.65

0.83

g/l

1.89

206

1503

Type of accident

274

2014

1.37

5.79

1.7

1.6

0.75

0.78

g/l

0.20

201

1531

Other disorders of bladder

589

1.69

5.79

1.4

1.6

0.83

0.91

g/l

0.28

448

Sequelae of injuries, of poisoning and of other consequences of external causes

225

1601

1.41

5.79

1.4

1.6

0.67

0.76

g/l

0.85

161

1220

Inflammatory disease of uterus

136

876

1.56

5.78

1.4

1.5

0.53

0.63

g/l

0.97

658

Gonarthrosis,primary

785

4013

1.21

5.77

1.5

1.6

0.74

0.78

g/l

0.45

601

2997

Localized scleroderma [morphea]

3.42

5.77

2.2

1.3

0.91

0.61

g/l

0.54

Bell's palsy

110

674

1.65

5.76

1.5

1.6

0.64

0.76

g/l

0.78

513

Strabismus

254

1842

1.38

5.75

1.6

1.5

0.62

0.74

g/l

1.47

186

1409

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

291

2163

1.35

5.73

1.4

1.6

0.65

0.71

g/l

0.54

212

1644

Any event in cancer register

901

4460

1.19

5.72

1.5

1.6

0.69

0.75

g/l

0.76

670

3380

Any dementia

126

1360

0.64

5.71

1.6

0.72

0.86

g/l

0.63

1010

Vulvovaginal ulceration/inflammation in other diseases

322

1.95

5.70

1.5

1.6

0.68

0.65

g/l

0.09

246

Cyst of kidney

315

1.96

5.69

1.4

1.6

0.80

0.86

g/l

0.15

239

Hydronephrosis

562

1.70

5.68

2.6

1.7

1.00

0.83

g/l

0.52

435

Conductive and sensorineural hearing loss

701

3895

1.22

5.67

1.6

1.5

0.75

0.77

g/l

0.17

502

2952

Use of memantine

929

0.53

5.67

1.6

1.5

0.72

0.84

g/l

0.41

698

Use of other anti-dementia drugs

929

0.53

5.67

1.6

1.5

0.72

0.84

g/l

0.41

698

Other shoulder lesions

488

1.76

5.67

1.5

1.7

0.58

0.81

g/l

1.67

372

Deficiency of other B group vitamins

3.16

5.65

1.4

1.6

1.60

0.78

g/l

0.43

Other disorders of central nervous system

3.49

5.64

1.5

1.6

0.47

0.66

g/l

0.49

Sleep disorders, other/unspecified

202

2.21

5.63

1.3

1.8

0.75

0.77

g/l

0.03

147

Other hammer toe(s) (acquired)

129

760

1.57

5.62

1.4

1.6

0.79

0.78

g/l

0.01

102

575

Acute appendicitis

670

5163

1.22

5.61

1.5

1.6

0.72

0.75

g/l

0.19

490

3911

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

371

2850

1.30

5.60

1.6

0.73

0.72

g/l

0.10

298

2160

Chronic suppurative otitis media

338

1.91

5.59

1.9

1.7

0.71

0.79

g/l

0.25

263

Testicular hypofunction

203

2.21

5.58

1.5

1.7

0.62

1.02

g/l

1.58

152

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

2.92

5.57

2.1

0.58

0.83

g/l

0.57

Endometriosis of rectovaginal septum and vagina

382

1.85

5.54

1.9

1.6

0.64

0.63

g/l

0.02

283

Pemphigoid

105

2.71

5.53

1.9

1.5

0.76

0.77

g/l

0.02

Arterial embolism and thrombosis

203

2.19

5.53

1.5

1.6

0.74

0.89

g/l

0.34

159

Skin changes due to chronic exposure to nonionizing radiation

274

1868

1.36

5.53

1.5

1.6

0.83

g/l

0.03

202

1371

Female infertility

261

1151

1.38

5.52

1.5

0.53

0.63

g/l

1.37

203

873

Other local infections of skin and subcutaneous tissue

575

1.68

5.51

1.7

1.6

0.69

0.81

g/l

0.63

444

Mixed and other personality disorders

523

1.72

5.50

1.5

1.7

0.86

0.78

g/l

0.27

406

Anti-inflammatory and antirheumatic products, non-steroids

259

940

1.39

5.47

1.7

0.85

0.84

g/l

0.05

196

730

Other and unspecified local infections of skin and subcutaneous tissue

539

1.70

5.45

1.7

1.6

0.68

0.82

g/l

0.70

420

Other keratitis

111

692

1.62

5.45

1.5

1.6

0.47

0.77

g/l

4.06

532

Valvular operations

110

684

1.62

5.44

1.6

1.7

0.87

0.95

g/l

0.27

535

Myeloid leukaemia

112

2.64

5.42

2.0

1.6

0.84

0.83

g/l

0.01

Chronic Coagulation defects

124

2.55

5.41

1.7

1.8

0.46

0.79

g/l

1.31

Artificial joint operation, meniscal resection

829

4522

1.19

5.41

1.5

1.6

0.76

0.78

g/l

0.23

614

3385

Hyperfunction of pituitary gland

273

2.00

5.39

1.3

1.7

0.62

0.74

g/l

0.37

206

Other otitis externa (chronic)

350

1.88

5.38

1.3

1.5

0.47

0.77

g/l

2.49

277

Other salmonella infections

206

2.16

5.37

1.7

1.6

0.62

0.88

g/l

1.27

158

Mature T/NK-cell lymphomas, hilmo

3.37

5.36

1.3

1.7

0.78

0.91

g/l

0.09

Chondrocostal junction syndrome [Tietze]

174

2.28

5.36

1.4

1.8

0.80

0.79

g/l

0.01

132

Other renal tubulo-interstitial diseases

107

2.67

5.35

2.2

1.8

0.59

0.78

g/l

0.41

Hemiplegia

233

2.08

5.34

1.5

1.6

0.66

0.82

g/l

0.43

175

Other female pelvic inflammatory diseases

143

950

1.52

5.31

1.3

1.5

0.67

0.64

g/l

0.07

101

707

Pleural plaque with presence of asbestos

295

1.95

5.31

1.3

1.5

0.91

1.04

g/l

0.30

222

Hypertensive Renal Disease

119

2.55

5.30

1.3

1.4

0.81

0.78

g/l

0.05

Other specified/unspecified hearing loss

402

1.81

5.30

1.5

1.6

0.65

0.85

g/l

1.30

314

Disorder of the sleep-wake schedule

102

2.71

5.30

1.3

1.8

0.57

0.81

g/l

0.67

Achilles tendinitis

551

1.68

5.30

1.8

1.6

0.60

0.86

g/l

2.00

421

Other/unspecified synovitis and tenosynovitis

597

1.65

5.28

1.6

0.46

0.78

g/l

4.41

454

Actinic keratosis

262

1795

1.36

5.28

1.5

1.6

0.84

g/l

0.01

192

1318

Urethritis and urethral syndrome

102

2.70

5.28

1.4

1.6

0.45

0.80

g/l

1.61

Monoamine oxidase A inhibitors

108

675

1.61

5.26

1.4

1.6

0.71

0.83

g/l

0.56

509

Poisoning by medicine

215

1546

1.40

5.26

1.5

1.6

0.63

0.72

g/l

0.82

161

1174

Malignant neoplasm of breast, HER2-negative

208

1893

0.72

5.25

1.3

1.5

0.56

0.64

g/l

1.14

149

1443

Carbimazole or st.post thyroidectomy, condition for graves disease

190

1338

1.43

5.24

1.8

1.6

0.82

0.68

g/l

0.69

138

996

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

127

825

1.55

5.24

1.5

1.6

0.90

0.82

g/l

0.18

628

Transport accidents

432

2943

1.27

5.24

1.6

0.73

0.77

g/l

0.19

330

2235

Thyrotropin deficiency

3.44

5.22

1.2

1.4

0.64

0.52

g/l

—

Spondylopathies in diseases classified elsewhere

3.57

5.22

1.3

1.9

0.67

1.10

g/l

0.61

Hypocalcemia

103

2.68

5.19

1.6

1.8

0.58

0.85

g/l

0.60

Acne vulgaris

494

1.72

5.18

1.4

1.8

0.64

0.70

g/l

0.26

375

Malignant neoplasm of breast

212

1912

0.72

5.16

1.3

1.5

0.55

0.64

g/l

1.38

155

1458

Respiratory tuberculosis, not confirmed

139

2.40

5.15

1.9

1.7

0.79

0.91

g/l

0.18

106

Sensorineural hearing loss

650

3646

1.21

5.14

1.6

1.5

0.72

0.78

g/l

0.52

461

2762

Other and unspecified injuries of lower leg

451

1.75

5.13

1.6

0.73

0.78

g/l

0.16

339

Dermatophytosis

556

4545

1.23

5.11

1.5

1.6

0.74

0.77

g/l

0.27

435

3438

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

422

1.77

5.11

1.7

1.5

0.44

0.65

g/l

2.27

319

Morphin

3.13

5.09

1.5

1.4

0.86

0.84

g/l

0.04

Degeneration of macula and posterior pole

346

2126

1.30

5.09

1.5

0.75

0.82

g/l

0.41

249

1599

MS-disease / Multiple Sclerosis

445

1.75

5.08

1.5

1.7

0.54

0.72

g/l

1.02

344

Heterophoria

475

1.72

5.07

1.7

0.74

0.78

g/l

0.12

356

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

144

970

1.49

5.02

1.3

1.7

0.86

0.85

g/l

0.03

735

Allergic contact dermatitis

124

810

1.54

5.01

1.4

1.6

0.68

0.72

g/l

0.10

612

Chronic periodontitis, including avohilmo

905

5174

1.17

5.00

1.5

1.6

0.68

0.77

g/l

2.22

689

3877

Residual foreign body in soft tissue

253

2.00

5.00

1.4

1.7

0.62

0.85

g/l

1.14

190

Congenital malformations of the urinary system

338

1.86

4.98

1.4

1.7

0.63

0.82

g/l

0.89

264

Other disorders of glucose regulation and pancreatic internal secretion

455

1.73

4.97

2.2

1.6

1.04

0.79

g/l

0.57

348

Other and unspecified mood [affective] disorders

418

1.76

4.97

1.2

1.8

0.70

0.76

g/l

0.27

317

Lichen simplex chronicus

148

2.33

4.96

1.3

1.7

0.87

0.86

g/l

0.02

114

Injuries to the neck

216

1572

1.38

4.94

1.4

1.6

0.60

0.76

g/l

2.58

174

1197

Injuries to the hip and thigh

386

2755

1.27

4.93

1.4

1.6

0.81

0.80

g/l

0.03

298

2065

Other abnormal uterine and vaginal bleeding

190

961

1.42

4.93

1.4

1.5

0.58

0.65

g/l

0.51

137

708

Benign neoplasm: Adrenal gland

390

1.79

4.92

1.4

1.6

0.54

0.83

g/l

2.79

296

Stroke, excluding SAH

482

2837

1.24

4.91

1.6

0.91

0.82

g/l

0.58

377

2097

Viral conjunctivitis

194

2.14

4.91

1.5

1.7

0.56

0.86

g/l

1.26

148

Intrahepatic Cholestasis of Pregnancy (ICP)

428

1.75

4.88

1.7

1.6

0.44

0.63

g/l

1.91

326

Benign neoplasm of meninges

518

1.67

4.88

1.6

0.67

0.77

g/l

0.46

382

Biguanides

889

4620

1.18

4.88

1.6

0.73

0.76

g/l

0.40

668

3489

Gluteal tendinitis

175

2.20

4.86

1.5

1.7

0.55

0.80

g/l

0.97

132

Superficial injury of ankle and foot

121

792

1.54

4.86

1.5

1.6

0.76

g/l

0.01

603

Hypersplenism

6.09

4.86

1.3

2.4

0.52

1.04

g/l

—

Female infertility, cervical, vaginal, other or unspecified origin

236

1125

1.37

4.84

1.5

0.52

0.64

g/l

1.78

184

851

Melanocytic naevi

273

2066

1.33

4.84

1.6

0.61

0.74

g/l

1.23

216

1558

Other eating disorders

291

1.91

4.84

1.5

1.8

0.70

0.65

g/l

0.21

214

Acute nasopharyngitis (common cold)

109

693

1.57

4.83

1.6

1.7

0.76

0.88

g/l

0.31

516

Eustachian salpingitis and obstruction

543

1.66

4.83

1.9

1.7

0.74

0.76

g/l

0.04

417

Other peripheral vertigo

467

1.71

4.82

1.7

1.6

0.58

0.81

g/l

1.98

353

Scoliosis

437

1.73

4.81

1.3

1.7

0.60

0.80

g/l

1.02

330

Acute epiglottitis

3.22

4.80

1.9

2.2

0.75

1.00

g/l

0.34

Amputation

415

1.75

4.79

1.3

1.6

1.20

0.93

g/l

0.30

317

Postmenopausal bleeding

216

830

1.39

4.77

1.3

1.5

0.58

0.67

g/l

0.80

162

613

Congenital malformations of the urinary system

365

1.80

4.76

1.4

1.7

0.69

0.82

g/l

0.48

286

Graves ophthalmopathy, strict

108

2.55

4.75

1.7

1.5

0.62

0.67

g/l

0.12

Oligomenorrhoea

177

2.18

4.74

1.8

1.6

0.54

0.60

g/l

0.20

138

Chondropathies

148

1016

1.47

4.73

1.6

0.75

g/l

0.01

109

766

Hypertrophic disorders of skin

315

1.86

4.73

1.5

1.7

0.59

0.78

g/l

0.95

242

Paralytic strabismus

344

1.82

4.71

1.7

0.65

0.87

g/l

1.27

261

Use of pramipexole

181

1291

1.41

4.69

1.7

1.6

0.64

0.78

g/l

1.33

136

963

Other contact dermatitis

433

1.72

4.69

1.5

1.7

0.67

0.77

g/l

0.39

333

Dementia in Alzheimer disease

568

0.46

4.68

1.1

1.5

0.67

0.87

g/l

0.35

419

Other and unspecified erythematous conditions

146

2.30

4.67

1.6

1.7

0.61

0.84

g/l

0.80

117

Suicide or other Intentional self-harm

234

1743

1.35

4.65

1.5

1.6

0.65

0.73

g/l

0.79

173

1328

Testicular dysfunction

233

2.01

4.63

1.5

1.6

0.59

0.97

g/l

1.66

176

Periodontitis

903

5185

1.17

4.63

1.5

1.6

0.68

0.77

g/l

2.20

689

3880

Ischaemic Stroke, excluding all haemorrhages

442

2647

1.25

4.63

1.6

0.91

0.82

g/l

0.56

342

1957

Benign lipomatous neoplasm of other sites/unspecified

406

1.74

4.59

1.4

1.7

0.61

0.84

g/l

0.93

312

Chronic mastoiditis

110

2.50

4.58

2.1

1.6

0.72

0.78

g/l

0.11

Peripheral artery operations in Hilmo

536

1.63

4.53

1.4

1.7

1.21

0.91

g/l

0.41

412

Other salmonella infections

161

2.20

4.52

1.4

1.6

0.66

0.82

g/l

0.47

123

Alcohol use disorder, ICD-based

370

2941

1.26

4.52

1.4

1.6

0.73

0.85

g/l

1.34

261

2206

Convalescence

270

1.91

4.51

1.6

1.7

0.69

0.77

g/l

0.31

202

Malnutrition

2.57

4.50

1.6

0.65

0.76

g/l

0.23

Other and unspecified nail disorders

105

2.52

4.50

1.1

1.8

0.54

0.91

g/l

1.06

Fracture of shoulder and upper arm

307

2384

1.29

4.49

1.4

1.6

0.67

0.79

g/l

1.48

237

1785

Neovascular glaucoma

168

2.17

4.48

1.5

1.6

0.36

0.79

g/l

3.19

130

Diseases of male genital organs

488

1998

1.24

4.47

1.6

1.7

0.84

0.93

g/l

0.92

358

1515

Impetigo

257

1.93

4.46

1.6

0.83

0.74

g/l

0.18

198

Plantar fascial fibromatosis

493

1.66

4.45

1.5

1.6

0.73

0.77

g/l

0.14

373

Dislocation, sprain and strain of joints and ligaments at neck level

146

1013

1.45

4.44

1.5

1.6

0.59

0.72

g/l

1.65

119

757

Other dialysis

156

2.22

4.43

1.3

1.8

0.56

0.85

g/l

1.13

121

Diabetic maculopathy, excluding more controls

595

1.59

4.41

1.5

1.6

0.97

0.83

g/l

0.18

459

Brain meningioma, including Hilmo

251

1.93

4.41

1.4

1.7

0.46

0.88

g/l

3.95

191

Malignant neoplasm of breast, including Hilmo

226

1952

0.75

4.41

1.3

1.5

0.56

0.64

g/l

1.11

164

1490

Malignant neoplasm of breast, HER2-negative, including Hilmo

226

1952

0.75

4.41

1.3

1.5

0.56

0.64

g/l

1.11

164

1490

Hypertrophic cardiomyopathy

203

2.05

4.40

1.5

1.7

0.55

0.89

g/l

1.65

159

Disorders of iron metabolism

2.79

4.39

1.4

1.9

0.58

0.72

g/l

0.26

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

4.41

4.39

1.2

2.0

1.14

1.09

g/l

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

183

2.10

4.38

2.3

1.6

0.77

0.83

g/l

0.12

139

Sub-endpoint used in defining T1D endpoints

261

1960

1.31

4.38

1.7

1.6

0.69

0.81

g/l

0.49

194

1505

Exposure to other and unspecified inanimate mechanical forces

450

1.68

4.38

1.8

1.7

0.87

0.83

g/l

0.05

349

Other erythematous conditions

170

2.15

4.37

1.6

1.7

0.63

0.83

g/l

0.78

129

Contusion of toe(s) without damage to nail

125

2.36

4.37

1.1

1.6

0.45

0.68

g/l

0.91

Excessive attrition of teeth

527

4366

1.21

4.37

1.5

1.6

0.69

0.74

g/l

0.64

396

3315

Any dementia, excluding more controls

120

1220

0.67

4.36

1.6

0.74

0.90

g/l

0.71

904

Schizophrenia

1117

0.60

4.36

1.3

1.7

0.48

0.78

g/l

2.10

852

Pleural plaque without asbestos

125

2.35

4.36

1.6

0.60

1.05

g/l

1.78

Use of glatiramer acetate

2.64

4.35

1.4

1.7

0.70

0.62

g/l

0.13

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

398

1.73

4.35

1.3

1.7

0.60

0.76

g/l

0.77

304

Other endocrine disorders

324

1.79

4.34

1.4

1.7

0.75

0.82

g/l

0.17

266

Nonischemic cardiomyopathy

473

1.66

4.34

1.5

1.7

0.85

0.87

g/l

0.06

371

Malignant neoplasm of breast, HER-positive

147

1626

0.70

4.34

1.3

1.5

0.62

0.66

g/l

0.30

100

1239

Hypertrophy of tongue papillae

3.03

4.32

1.8

1.7

0.99

0.85

g/l

0.12

Lateral epicondylitis

113

750

1.52

4.30

1.5

1.6

0.63

0.77

g/l

1.04

568

Speech and linguistic disorders, excluding more controls

453

1.65

4.30

1.2

1.8

0.58

0.85

g/l

2.57

356

Mantle cell lymphoma, including Hilmo

3.11

4.28

1.8

1.7

0.42

1.02

g/l

—

Follicular cysts of skin and subcutaneous tissue

163

1165

1.41

4.23

1.6

0.60

0.79

g/l

2.44

123

884

Brain meningioma

241

1.93

4.22

1.4

1.7

0.46

0.90

g/l

4.05

184

Statin medication

680

3229

1.19

4.21

1.5

1.6

0.75

0.74

g/l

0.09

505

2416

All dysplastic lesions of the vagina

121

2.35

4.20

1.5

1.6

0.52

0.73

g/l

0.54

Malignant neoplasm of small intestine, including Hilmo

121

2.35

4.20

1.5

1.8

0.92

1.00

g/l

0.09

Familial hypercholesterolemia, with ischemic heart disease

372

1.73

4.19

1.9

1.6

0.80

0.98

g/l

0.65

288

Glaucoma secondary to other eye disorders

173

2.10

4.19

1.5

0.36

0.77

g/l

3.03

130

Artificial joint re-operation

299

1.82

4.18

1.4

1.7

1.02

0.90

g/l

0.35

231

Bacterial, viral and other infectious agents

549

1.60

4.17

1.4

1.6

0.64

0.80

g/l

1.03

420

Haemorrhage in early pregnancy

248

1844

1.31

4.17

1.4

1.5

0.52

0.62

g/l

1.67

191

1394

Glaucoma-related operations

235

1.93

4.17

1.6

0.73

0.87

g/l

0.32

181

Nonpyogenic thrombosis of intracranial venous system

3.18

4.14

1.4

1.3

0.50

0.74

g/l

—

Other congenital malformations of skin

222

1.96

4.13

1.3

1.7

0.69

0.78

g/l

0.24

172

Melanocytic naevi of lower limb, including hip

236

1.93

4.13

1.7

1.6

0.62

0.77

g/l

0.45

177

Speech disturbances, not elsewhere classified

404

1.70

4.13

1.8

1.5

0.84

0.80

g/l

0.08

306

Alcohol abuse, main dg

146

1029

1.43

4.12

1.6

0.90

0.80

g/l

0.25

108

777

Propionic acid derivatives

248

940

1.33

4.10

1.7

0.77

0.84

g/l

0.39

188

730

Transient ischemic attack

404

2648

1.24

4.10

1.5

0.70

0.81

g/l

1.53

305

1971

Corneal ulcer

167

1206

1.39

4.09

1.7

1.6

0.71

0.78

g/l

0.43

125

927

Certolizumab pegol

2.55

4.08

1.5

1.7

0.61

0.65

g/l

0.08

Superficial injury of head

198

1469

1.35

4.08

1.6

0.72

0.74

g/l

0.07

160

1111

Injuries to unspecified part of trunk, limb or body region

576

1.57

4.07

1.6

1.7

0.60

0.82

g/l

1.37

442

Other and unspecified mononeuropathies of lower limb

123

2.31

4.06

1.3

1.7

0.51

0.90

g/l

1.44

Medicines for HER+ breast cancer

180

2309

0.74

4.06

1.4

1.5

0.59

0.64

g/l

0.46

129

1755

Stroke, including SAH

509

3060

1.21

4.06

1.6

0.88

0.81

g/l

0.49

400

2258

Benign neoplasm: Cerebral meninges

475

1.63

4.06

1.7

1.6

0.71

0.78

g/l

0.28

353

Type 1 diabetes, wide definition

204

1522

1.34

4.04

1.6

0.66

0.80

g/l

0.47

154

1180

Iron deficiency

143

2.20

4.02

1.3

1.8

0.41

0.74

g/l

1.38

106

Flat foot [pes planus] (acquired)

484

1.62

4.01

1.2

1.7

0.66

0.80

g/l

0.58

371

Left ventricular outflow tract obstruction (LVOTO), broad definition

101

666

1.53

4.01

1.7

1.6

0.88

0.81

g/l

0.23

522

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

197

2.01

4.00

1.5

1.8

0.64

0.74

g/l

0.24

149

Benign neoplasm: Tongue

124

2.29

3.99

2.3

1.7

0.83

0.86

g/l

0.03

Other diseases of spinal cord

131

2.24

3.95

1.3

1.8

0.55

0.85

g/l

1.07

105

Endometriosis ASRM stages 1,2

162

1172

1.39

3.95

1.5

0.62

0.63

g/l

0.04

106

881

Glaucoma

440

3110

1.22

3.94

1.5

1.6

0.64

0.81

g/l

2.85

305

2357

Kyphosis

2.95

3.93

1.2

1.8

0.69

0.96

g/l

0.45

Normotensive glaucoma

357

1.72

3.93

1.3

1.6

0.68

0.86

g/l

0.81

274

Mental and behavioural disorders due to alcohol, excluding acute intoxication

390

3157

1.23

3.93

1.4

1.7

0.73

0.86

g/l

1.65

276

2374

Use of donepezil

763

0.55

3.92

1.8

1.5

0.73

0.83

g/l

0.27

574

Malignant neoplasm of endocrine gland

380

1.70

3.92

1.8

1.7

0.74

0.79

g/l

0.11

288

Injury of muscle and tendon at forearm level

2.55

3.91

1.5

1.8

0.77

0.92

g/l

0.20

Other benign neoplasms of skin

305

2416

1.27

3.90

1.7

1.5

0.70

0.78

g/l

0.62

228

1809

Alzheimer’s disease, strict definition

845

0.60

3.89

1.4

1.6

0.55

0.84

g/l

1.89

636

Malignant neoplasm of breast, ER-positive, including Hilmo

155

1648

0.72

3.89

1.3

1.5

0.62

0.66

g/l

0.28

108

1255

Mental and behavioural disorders due to sedatives or hypnotics

419

1.66

3.89

1.3

1.7

0.62

0.83

g/l

1.03

327

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

220

1.93

3.89

1.9

1.6

0.53

0.82

g/l

1.54

176

Medical abortion

557

2526

1.20

3.89

1.4

1.5

0.61

g/l

0.03

422

1900

Meralgia paraesthetica

165

2.09

3.89

1.6

1.7

0.90

0.86

g/l

0.07

127

Disorders of eyelid in diseases classified elsewhere

145

2.17

3.88

1.6

1.5

1.35

0.81

g/l

0.31

113

Acute myeloid leukaemia and myelodysplastic syndromes

2.81

3.87

1.4

1.6

0.58

0.87

g/l

0.51

Female genital prolapse

234

1002

1.32

3.87

1.5

0.57

0.64

g/l

0.70

164

748

Perioral dermatitis

107

2.38

3.86

1.5

1.6

0.54

0.67

g/l

0.36

Lichen planus, including avohilmo

157

1135

1.39

3.85

1.8

1.6

0.64

0.75

g/l

0.85

119

849

Solid cancers, helper endpoint

772

3924

1.16

3.85

1.4

1.6

0.70

0.76

g/l

0.83

580

2973

Spasmodic torticollis

159

2.11

3.85

1.5

1.8

0.54

0.81

g/l

0.75

118

Fall on and from stairs and steps

218

1658

1.32

3.83

1.6

1.5

0.87

0.76

g/l

0.40

162

1254

Graves ophthalmopathy

120

2.29

3.83

1.7

1.5

0.62

0.73

g/l

0.27

Degenerative macular diseases

506

1.59

3.82

1.5

0.68

0.84

g/l

0.50

380

Benign neoplasm: Rectosigmoid junction

173

2.05

3.81

1.3

1.7

0.80

0.88

g/l

0.18

135

Palmar fascial fibromatosis [Dupuytren]

104

698

1.50

3.80

1.3

1.7

0.77

1.00

g/l

1.32

529

Myeloproliferative diseases

376

1.69

3.79

1.7

1.6

0.78

0.84

g/l

0.18

283

Desensitization to allergens

354

1.71

3.78

1.5

1.8

0.63

0.70

g/l

0.36

268

Other specified/unspecified dorsopathies

140

2.17

3.78

1.6

1.9

0.62

0.89

g/l

0.76

105

Discitis, unspecified

2.78

3.78

1.3

1.8

0.84

0.93

g/l

0.10

Other secondary gonarthrosis

258

1.84

3.78

1.7

1.8

0.83

0.80

g/l

0.05

202

Respiratory tuberculosis, confirmed

2.68

3.75

1.3

1.7

0.77

0.83

g/l

0.09

Biomechanical lesions, not elsewhere classified

230

1.89

3.75

1.1

1.7

0.66

0.83

g/l

0.65

176

Benign neoplasm: Skin, unspecified

195

1.97

3.74

1.2

1.6

0.49

0.86

g/l

2.10

144

Other specified and unspecified personality disorders

557

1.56

3.73

1.3

1.7

0.74

0.78

g/l

0.16

427

Peripheral arterial reconstruction

110

750

1.47

3.72

1.3

1.6

0.86

0.96

g/l

0.15

569

Other disorders starting during childhood or adolecense, excluding more controls

297

1.76

3.72

1.4

1.8

0.56

0.79

g/l

1.34

242

Deep endometriosis

534

1.57

3.71

1.8

1.6

0.61

0.60

g/l

0.03

402

Retinal vascular occlusion

510

1.58

3.71

1.5

0.69

0.84

g/l

0.49

382

Papillary adenocarcinoma of thyroid gland

267

1.82

3.71

2.0

1.7

0.79

g/l

0.00

207

Eating disorder

565

1.55

3.70

1.4

1.6

0.62

0.65

g/l

0.11

433

Other surgical follow-up care

162

2.06

3.67

1.4

1.7

0.49

0.84

g/l

1.68

122

Eating disorders

100

671

1.50

3.66

1.4

1.6

0.58

0.66

g/l

0.55

509

Seronegative juvenile rheumatoid arthritis

110

2.32

3.65

1.2

1.5

0.44

0.58

g/l

0.55

Other/unspecified disorders of vestibular function

183

1.99

3.65

1.1

1.7

0.76

0.82

g/l

0.09

141

Explicit fungal Sepsis

4.15

3.65

1.5

2.1

1.24

1.04

g/l

—

Osteitis due to dental implant

4.14

3.64

1.3

2.1

0.51

0.89

g/l

—

Hyperaldosteronism

123

2.23

3.63

2.0

1.8

1.27

0.93

g/l

0.35

Dislocation, sprain and strain of joint and ligaments of hip

156

2.08

3.63

1.2

1.7

0.62

0.89

g/l

0.88

116

Malignant neoplasm of thyroid gland, including Hilmo

412

1.64

3.62

2.0

1.6

0.78

0.77

g/l

0.02

315

Other other unspecified disorders of the circulatory system

170

2.02

3.61

1.9

1.6

0.63

0.86

g/l

0.73

130

Benign neoplasm of middle ear and respiratory system

374

1.67

3.61

2.0

1.6

0.91

0.88

g/l

0.05

280

Malignant neoplasm of thyroid gland

359

1.69

3.61

1.9

1.7

0.75

0.80

g/l

0.12

272

Pain associated with micturition

634

1.51

3.60

1.5

1.6

0.63

0.78

g/l

1.18

478

Thyrotoxicosis with diffuse goitre

120

839

1.44

3.59

1.6

0.88

0.70

g/l

0.62

638

Adenomyosis (Endometriosis of uterus)

107

732

1.47

3.58

1.3

1.5

0.70

0.67

g/l

0.16

541

Presbycusis

517

1.56

3.58

1.8

1.5

0.56

0.84

g/l

2.24

393

Congenital malformations of ovaries, fallopian tubes and broad ligaments

322

1.72

3.58

1.4

1.6

0.41

0.64

g/l

2.48

247

Dermatitis herpetiformis

2.49

3.58

1.6

1.7

0.92

0.79

g/l

0.24

Background retinopathy and retinal vascular changes

2.48

3.57

1.8

1.9

0.54

0.88

g/l

0.64

Respiratory tuberculosis, bacteriologically and histologically confirmed

2.61

3.57

1.3

1.6

0.77

0.81

g/l

0.06

Salpingitis and oophoritis

152

1109

1.38

3.56

1.5

0.64

0.65

g/l

0.03

118

829

Other acquired deformities of musculoskeletal system and connective tissue

249

1.83

3.55

1.9

1.7

0.65

0.83

g/l

0.81

186

Other strabismus

201

1525

1.32

3.54

1.6

0.62

0.73

g/l

1.29

144

1161

Fracture at wrist and hand level

319

2568

1.24

3.53

1.5

1.6

0.75

0.80

g/l

0.26

226

1943

Diabetic neuropathy

642

1.50

3.52

1.5

1.7

0.64

0.84

g/l

1.55

466

Retinal vascular disorders

517

1.56

3.51

1.5

0.69

0.84

g/l

0.48

388

Other condition

130

928

1.41

3.48

1.6

0.74

0.79

g/l

0.27

104

711

Endometriosis of ovary

136

955

1.40

3.45

1.5

0.63

g/l

0.03

104

715

Psychotic depression

318

1.71

3.45

1.2

1.8

0.53

0.86

g/l

2.06

242

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

155

1105

1.37

3.44

1.4

1.7

0.73

0.81

g/l

0.45

120

864

Other superficial mycoses

641

1.49

3.44

1.6

1.7

0.72

0.75

g/l

0.09

490

Other and unspecified disorders of skin and subcutaneous tissue

296

1.74

3.43

2.1

1.7

0.94

0.87

g/l

0.14

226

Bipolar affective disorders

173

1296

1.34

3.43

1.5

1.6

0.77

0.74

g/l

0.16

138

971

Prolonged pregnancy

930

0.64

3.43

1.3

1.6

0.63

g/l

0.00

702

Suppurative otitis media, unspecified

113

2.24

3.43

1.5

1.9

0.68

0.74

g/l

0.10

Disorders of optic nerve, not elsewhere classified

2.43

3.42

1.2

1.7

0.61

0.76

g/l

0.33

Benign neoplasm of urinary organs

209

1.88

3.40

1.8

1.6

0.73

0.93

g/l

0.39

153

Dermatitis due to ingested food

214

1.86

3.40

1.6

1.7

1.42

0.76

g/l

1.03

179

Benign lipomatous neoplasm

241

1892

1.28

3.39

1.3

1.6

0.57

0.80

g/l

3.85

169

1424

Other facial nerve disorders

127

2.15

3.37

2.3

1.7

0.64

0.92

g/l

0.70

Ménière disease

483

1.56

3.37

1.8

1.6

0.68

0.81

g/l

0.70

360

Other menopausal disorders

224

972

1.30

3.36

1.8

1.5

0.60

0.64

g/l

0.28

167

727

Other noninflammatory disorders of uterus, except cervix

164

817

1.36

3.35

1.6

1.5

0.67

0.65

g/l

0.09

127

602

Unspecified urinary incontinence

437

1.59

3.33

1.4

1.6

0.64

0.78

g/l

0.62

321

Molar incisor enamel hypoplasia

245

1.79

3.33

2.2

1.5

0.72

0.70

g/l

0.03

206

Localized skin eruption due to drugs and medicaments

2.98

3.33

2.1

2.0

0.41

0.92

g/l

—

Single spontaneous delivery

224

1523

0.78

3.32

1.6

1.5

0.70

0.62

g/l

0.48

154

1171

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

162

1172

1.35

3.32

1.4

1.7

0.76

0.79

g/l

0.17

124

913

Excessive earwax

454

3725

1.19

3.31

1.7

1.6

0.71

0.81

g/l

1.37

322

2830

L02BG Aromatase inhibitors

141

1908

0.73

3.31

1.4

1.5

0.60

0.64

g/l

0.20

100

1432

Somnolence, stupor and coma

190

1.91

3.30

1.4

1.8

0.42

0.90

g/l

3.07

147

Primary hyperparathyroidism

558

1.52

3.29

1.5

0.74

0.75

g/l

0.01

406

Cardiac arrest

204

1.81

3.28

1.1

1.5

0.40

1.00

g/l

4.25

160

Use of antiglaucoma preparations and miotics

300

1.71

3.28

1.4

1.5

0.51

0.86

g/l

2.78

227

Paraplegia, diplegia of upper limbs

109

2.24

3.28

1.3

1.8

0.59

0.88

g/l

0.73

Mental and behavioural disorders due to opioids

234

1.82

3.27

1.4

1.9

0.44

0.78

g/l

1.87

176

Alopecia areata

129

2.12

3.26

1.9

1.8

0.54

0.85

g/l

1.03

Hyperprolactinaemia

184

1.92

3.26

1.3

1.7

0.67

0.75

g/l

0.20

138

Vertical strabismus

170

1.97

3.26

1.3

1.7

0.55

0.87

g/l

1.56

131

Cardiomyopathy, Hypertrophic obstructive

2.42

3.25

1.3

1.8

0.47

0.76

g/l

0.68

179

1181

1.32

3.24

1.3

1.6

0.81

0.87

g/l

0.21

125

880

Ingrowing nail

317

1.69

3.23

1.2

1.7

0.57

0.79

g/l

1.48

244

Fall on same level involving ice and snow

500

4251

1.18

3.23

1.6

0.74

0.76

g/l

0.11

385

3202

Other epidermal thickening

206

1.86

3.22

1.4

1.6

0.56

0.87

g/l

1.29

166

Mixed conductive and sensorineural hearing loss

626

1.48

3.21

1.5

0.72

0.82

g/l

0.48

475

Other symptoms and signs involving the urinary system

537

1.52

3.21

1.6

0.56

0.87

g/l

3.74

409

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

263

2104

1.25

3.18

1.3

1.6

0.62

0.74

g/l

1.65

207

1603

Varicella [chickenpox]

296

1.71

3.18

1.3

1.7

0.99

0.90

g/l

0.10

231

Other nonscarring hair loss

3.33

3.17

1.6

0.27

0.54

g/l

—

Torsion of ovary, ovarian pedicle and fallopian tube

111

2.19

3.14

1.1

1.7

0.38

0.65

g/l

1.28

Other and unspecified epidermal thickening

131

2.09

3.14

1.3

1.7

0.49

0.86

g/l

1.10

102

Contusion of other and unspecified parts of foot

297

1.70

3.14

1.5

1.6

1.00

0.76

g/l

0.37

226

Myelodysplastic syndrome

3.50

3.13

1.2

2.0

0.60

1.21

g/l

—

Hypertrophy of breast in women and men

173

1316

1.32

3.13

1.4

1.5

0.66

g/l

0.03

123

989

Embedded teeth, including avohilmo

573

1.49

3.12

1.7

0.73

0.71

g/l

0.09

437

Alzheimer disease, excluding more controls

551

0.61

3.12

1.6

1.5

0.72

0.89

g/l

0.43

394

Benign neoplasm: Skin of eyelid, including canthus

120

863

1.40

3.12

1.8

1.5

0.81

0.75

g/l

0.18

643

Disorders of psychological development

116

768

1.41

3.11

1.3

1.7

0.60

0.79

g/l

1.74

597

Recurrent dislocation of patella

275

1.72

3.11

1.3

1.9

0.81

0.73

g/l

0.16

206

Emotionally unstable personality disorder

117

839

1.40

3.10

1.5

1.6

0.72

0.71

g/l

0.03

640

Superficial injury of forearm

607

1.48

3.09

1.6

1.7

0.84

0.79

g/l

0.10

464

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

462

1.55

3.09

1.3

1.8

0.64

0.80

g/l

0.77

353

Disorders of porphyrin and bilirubin metabolism

2.74

3.09

2.1

1.8

0.73

0.79

g/l

0.08

Event of undetermined intent

391

1.60

3.09

1.3

1.7

0.75

0.81

g/l

0.17

303

Herpesviral keratitis and keratoconjunctivitis

202

1.85

3.08

1.9

1.7

1.61

0.84

g/l

0.51

154

Respiratory conditions due to other external agents

2.41

3.08

1.6

0.42

0.86

g/l

1.52

Myeloproliferative diseases (CML excluded)

337

1.64

3.07

1.7

1.6

0.86

0.84

g/l

0.04

252

L01XX Other antineoplastic agents

239

1.77

3.06

1.3

1.6

0.52

0.90

g/l

2.63

183

Cholesteatoma of middle ear

217

1.81

3.06

2.0

1.5

0.49

0.81

g/l

1.54

167

Other predominantly sexually transmitted diseases, not elsewhere classified

160

1208

1.33

3.06

1.6

0.66

0.71

g/l

0.26

124

913

Persons encountering health services in circumstances related to reproduction

563

3258

1.17

3.05

1.5

1.6

0.71

0.75

g/l

0.44

416

2477

Disorders of male genital organs in diseases classified elsewhere

3.67

3.03

1.1

1.3

0.56

0.85

g/l

—

Other predominantly sexually transmitted diseases, not elsewhere classified

191

1480

1.30

3.03

1.5

1.6

0.65

0.69

g/l

0.26

145

1121

Amputation of toe

300

1.68

3.02

1.2

1.5

1.27

0.88

g/l

0.31

226

Blepharochalasis

209

1638

1.28

3.02

1.6

1.5

0.66

0.77

g/l

1.00

162

1226

Hypoglycaemia, other or unspecified

362

1.61

3.01

2.4

1.6

1.00

0.79

g/l

0.35

278

Chronic periodontitis, complicated

457

3847

1.18

3.01

1.5

1.6

0.69

0.79

g/l

1.31

346

2890

Congenital ovarian cysts

256

1.74

2.99

1.5

1.6

0.43

0.62

g/l

1.37

196

Secondary thrombocytopenia

2.60

2.99

1.8

0.16

0.90

g/l

2.51

Viral agents as the cause of diseases classified to other chapters

134

2.04

2.98

1.3

1.9

0.64

0.83

g/l

0.58

107

Congenital malformations of genital organs

633

1.45

2.98

1.4

1.7

0.50

0.71

g/l

2.14

494

Other disorders of Eustachian tube

134

2.04

2.97

1.4

1.6

0.74

0.68

g/l

0.13

104

Tobacco use

279

1.70

2.97

1.5

1.7

0.74

0.83

g/l

0.24

214

Other congenital malformations of skin

475

1.53

2.96

1.3

1.7

0.78

0.75

g/l

0.10

363

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

443

1.55

2.96

1.3

1.6

0.60

0.79

g/l

1.19

332

Acidosis

2.31

2.95

1.3

1.7

0.56

0.89

g/l

1.03

Insulin, fast-acting (human)

122

889

1.38

2.95

1.5

1.7

0.71

0.78

g/l

0.11

674

Renal tubulo-interstitial disorders in diseases classified elsewhere

2.90

2.95

1.2

1.4

0.26

0.61

g/l

—

Heart failure and hypertrophic cardiomyopathy

2.36

2.94

1.3

1.7

0.67

0.85

g/l

0.28

Radial styloid tenosynovitis [de Quervain]

280

1.69

2.93

1.6

1.7

0.34

0.78

g/l

5.98

217

Hypertrophic scar

288

1.68

2.92

1.6

0.59

0.78

g/l

0.79

221

Open wound of head

460

3777

1.18

2.92

1.6

0.85

0.81

g/l

0.18

340

2813

Muscle strain

135

2.02

2.91

1.3

1.6

1.10

0.88

g/l

0.24

106

Sixth [abducent] nerve palsy

149

1.97

2.91

1.8

0.57

0.89

g/l

1.31

114

Follicular lymphoma, hilmo

199

1.83

2.91

1.7

0.43

0.87

g/l

1.55

151

Injury of nerves at forearm level

2.48

2.91

1.6

1.9

0.31

0.85

g/l

2.08

Primary open-angle glaucoma, strict

172

1319

1.31

2.90

1.4

1.6

0.71

0.84

g/l

0.81

114

976

Other congenital malformations of the digestive system

317

1.64

2.90

1.8

1.6

0.78

0.77

g/l

0.02

251

Cauda equina syndrome

2.55

2.90

1.3

1.8

0.74

0.81

g/l

0.08

Pustulosis palmaris et plantaris

214

1.79

2.89

1.2

1.6

0.54

0.82

g/l

1.40

162

Other diseases of peritoneum

214

1.79

2.89

1.4

1.6

0.47

0.83

g/l

2.23

162

Fracture of lower leg, including ankle

476

4031

1.17

2.88

1.5

1.6

0.71

0.77

g/l

0.81

377

3028

Mantle cell lymphoma

3.24

2.88

1.8

0.41

1.01

g/l

—

Coxarthrosis, primary

450

3240

1.18

2.88

1.4

1.6

0.71

0.82

g/l

1.42

357

2420

Oesophageal obstruction

122

2.07

2.88

1.2

1.4

0.84

0.91

g/l

0.12

Aortic valve malfunction, age under 60 years

601

1.46

2.87

1.8

1.7

0.91

0.83

g/l

0.25

469

Secondary polycythaemia

109

2.14

2.86

2.1

1.7

0.92

0.83

g/l

0.13

Obsessive-compulsive disorder

375

1.58

2.86

1.5

1.8

0.56

0.80

g/l

1.57

282

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

155

1178

1.32

2.86

1.6

0.64

0.74

g/l

0.81

111

890

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

505

3432

1.17

2.86

1.5

0.59

0.68

g/l

1.58

368

2628

Endometriosis ASRM stages 3,4

188

1467

1.29

2.85

1.6

1.5

0.64

0.60

g/l

0.25

146

1090

All dysplastic lesions of the vulva

230

1.76

2.85

1.5

1.6

0.80

0.67

g/l

0.31

178

1.86

2.84

1.9

1.5

0.97

0.77

g/l

0.31

129

Complications of cardiac and vascular prosthetic devices, implants and grafts

2.37

2.83

1.7

1.5

0.82

0.73

g/l

0.17

Necrosis of pulp, including avohilmo

528

4552

1.16

2.81

1.4

1.6

0.75

g/l

0.01

385

3456

Sequelae of cerebrovascular disease

246

1708

1.25

2.81

1.6

0.88

0.80

g/l

0.42

193

1261

Thiazolidinediones

587

1.46

2.80

1.6

0.74

0.88

g/l

0.70

441

121

834

1.37

2.80

1.2

1.6

0.87

0.85

g/l

0.05

627

Impacted cerumen

481

1.51

2.80

1.3

1.6

0.67

0.83

g/l

0.96

371

Separation of retinal layers (serosa)

209

1.79

2.80

2.0

1.7

0.85

g/l

0.01

164

Embedded and impacted teeth

249

1657

1.24

2.79

1.7

1.6

0.68

0.73

g/l

0.44

203

1270

Abrasion of teeth

294

2420

1.22

2.78

1.5

1.6

0.58

0.73

g/l

2.58

218

1834

Periodontal disease, other/unspecified

124

2.04

2.78

1.3

1.7

0.53

0.84

g/l

0.85

100

Malignant neoplasm of mesothelium and soft tissue

166

1.89

2.77

1.3

1.8

0.75

1.00

g/l

0.60

132

Occupational exposure to risk-factors

159

1.91

2.77

1.7

1.6

0.89

0.86

g/l

0.05

120

Dissociative [conversion] disorders

195

1.81

2.77

1.4

1.7

0.71

0.82

g/l

0.28

138

Diabetic retinopathy, excluding more controls

219

970

1.27

2.76

1.4

1.7

0.71

0.76

g/l

0.13

141

697

Bruxism

111

2.11

2.75

1.3

1.7

0.57

0.70

g/l

0.25

Dilated cardiomyopathy

631

1.43

2.75

1.7

1.6

0.88

0.93

g/l

0.15

480

Injury of unspecified body region

403

1.55

2.74

1.5

1.7

0.63

0.84

g/l

0.92

312

Malignant neoplasm of small intestine

2.27

2.72

1.7

1.8

1.17

1.14

g/l

0.02

Malignant neoplasm of prostate, including Hilmo

124

991

0.74

2.71

1.3

1.7

1.23

1.01

g/l

0.41

744

Entropion and trichiasis of eyelid

310

1.62

2.70

1.3

1.6

0.86

0.93

g/l

0.09

237

Leisure time condition

152

1163

1.31

2.69

1.9

1.6

0.77

g/l

0.00

106

883

Alzheimer’s disease (Late onset)

755

0.66

2.69

1.4

1.5

0.57

0.83

g/l

1.42

562

Acute alcohol intoxication, ICD10

171

1331

1.29

2.67

1.5

1.6

0.87

0.80

g/l

0.21

121

1014

Effects of foreign body entering through natural orifice

213

1703

1.26

2.67

1.3

1.7

0.66

0.83

g/l

2.02

150

1293

Organic, including symptomatic, mental disorders

254

2215

0.81

2.66

1.6

1.5

0.70

0.86

g/l

1.51

192

1636

Embolic stroke

154

1.89

2.65

1.7

1.3

0.94

0.80

g/l

0.18

113

Complications of genitourinary prosthetic devices, implants and grafts

2.17

2.62

1.6

1.3

0.77

0.79

g/l

0.04

Arterial embolism and thrombosis of lower extremity artery

120

2.02

2.61

1.1

1.5

0.64

0.85

g/l

0.51

Other and unspecified vascular occlusions

368

1.56

2.61

1.6

1.7

0.73

0.90

g/l

0.39

282

Pustular psoriasis

244

1.70

2.61

1.3

1.7

0.53

0.82

g/l

1.45

184

Primary open-angle glaucoma

206

1590

1.26

2.60

1.5

1.6

0.72

0.86

g/l

1.04

138

1175

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

378

1.55

2.59

1.4

1.7

0.58

0.71

g/l

0.70

305

Primary coxarthrosis, bilateral

198

1576

1.26

2.58

1.5

1.6

0.68

0.86

g/l

1.71

159

1164

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

2.79

2.57

1.4

2.0

0.31

0.96

g/l

—

Sudden idiopathic hearing loss

533

1.45

2.55

1.9

1.6

0.78

0.82

g/l

0.11

411

Short stature, not elsewhere classified

179

1.79

2.54

1.4

1.7

0.53

0.74

g/l

1.23

161

Glucosamine medication

345

2317

1.19

2.54

1.4

1.5

0.65

0.82

g/l

3.05

253

1743

Carcinoma in situ of skin of other and unspecified parts of face

300

1.61

2.53

1.3

1.5

0.67

0.88

g/l

0.58

229

Glucagon-like peptide-1 (GLP-1) analogues

243

1985

1.23

2.52

1.4

1.6

0.68

0.83

g/l

1.74

182

1486

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

243

1985

1.23

2.52

1.4

1.6

0.68

0.83

g/l

1.74

182

1486

Malignant neoplasm, without specification of site, including Hilmo

157

1.86

2.52

1.3

1.7

0.74

1.05

g/l

0.69

122

Other specified disorders of muscle

115

2.02

2.52

1.5

1.8

0.59

0.88

g/l

0.77

Dysplasia of cervi uteri

187

1070

1.27

2.49

1.4

1.5

0.55

0.63

g/l

0.79

139

813

Hallux rigidus

686

1.39

2.49

1.6

1.7

0.75

0.80

g/l

0.21

522

Panniculitis affecting regions of neck and back

158

1.85

2.49

2.1

1.8

0.73

0.95

g/l

0.56

116

Complications of other internal prosthetic devices, implants and grafts

158

1.85

2.48

2.0

1.4

0.96

0.77

g/l

0.16

122

Convergence insufficiency and excess

2.42

2.48

1.3

1.4

0.59

0.60

g/l

—

Primary gonarthrosis, bilateral

385

2811

1.18

2.46

1.5

1.6

0.73

0.82

g/l

1.04

303

2114

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

210

1.73

2.46

1.5

1.9

0.53

0.79

g/l

0.82

167

Bicipital tendinitis

203

1.74

2.45

1.3

1.7

0.72

0.91

g/l

0.49

149

Left hemicolectomy

2.11

2.44

1.7

1.5

0.77

0.84

g/l

0.06

Benign neoplasm: Conjunctiva

152

1.86

2.44

2.3

1.7

0.46

0.79

g/l

1.55

116

Medial epicondylitis

174

1.80

2.43

1.3

1.7

0.72

0.85

g/l

0.33

132

Tuberculosis of nervous system

6.78

2.42

1.6

1.05

0.43

g/l

—

Other congenital malformations of circulatory system

131

1.93

2.42

2.1

1.7

0.50

0.88

g/l

1.35

102

Congenital malformations of the circulatory system

130

961

1.32

2.41

1.6

1.7

0.76

0.79

g/l

0.11

746

Assault

122

922

1.33

2.41

1.4

1.7

0.64

0.79

g/l

1.24

704

Postprocedural musculoskeletal disorders, not elsewhere classified

344

1.55

2.41

1.4

1.7

0.65

0.83

g/l

1.02

264

Fracture of skull and facial bones

181

1440

1.26

2.40

1.4

1.6

0.61

0.80

g/l

2.49

119

1090

malignant neoplasm of male genital organs

129

1030

0.76

2.40

1.4

1.7

1.19

1.00

g/l

0.36

100

776

Pneumoconiosis due to dust containing silica

6.44

2.39

1.2

1.5

2.01

0.58

g/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

149

1158

1.29

2.39

1.6

0.88

0.80

g/l

0.25

121

884

Other congenital malformations of the digestive system

272

1.62

2.39

1.8

1.6

0.78

0.79

g/l

0.02

216

Volvulus

2.08

2.38

1.4

1.5

0.51

0.69

g/l

0.80

Malignant neoplasm of prostate

120

949

0.75

2.38

1.5

1.7

1.31

0.99

g/l

0.60

710

Malignant neoplasm of oral cavity, including Hilmo

190

1.75

2.38

1.2

1.7

1.05

0.98

g/l

0.05

146

Blood alcohol or alcohol intoxication level

132

1.92

2.37

1.2

1.8

0.84

0.76

g/l

0.17

104

Emotional disorders starting during childhood or adolecense, excluding more controls

252

1.64

2.37

1.4

1.8

0.67

0.76

g/l

0.27

201

D07AA Corticosteroids, weak (group I)

137

1053

1.30

2.37

1.5

1.6

0.78

0.73

g/l

0.25

106

817

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

385

2865

1.17

2.37

1.4

1.5

0.54

0.61

g/l

1.52

298

2179

Sequelae of injuries of upper limb

600

1.41

2.37

1.3

1.7

0.73

0.81

g/l

0.31

462

Delivery

237

1524

0.82

2.33

1.6

1.5

0.68

0.62

g/l

0.34

168

1171

Disturbances of smell and taste

199

1.72

2.33

1.3

1.8

0.86

0.87

g/l

0.01

146

Oral leukoplakia, including avohilmo

133

1.90

2.33

1.4

1.8

0.48

0.90

g/l

1.55

102

Other and unspecified injuries of shoulder and upper arm

162

1.81

2.32

1.2

1.8

0.90

g/l

0.01

126

Other spirochaetal diseases

250

2068

1.21

2.32

1.6

0.70

0.77

g/l

0.51

200

1558

Moderate visual impairment, binocular

2.06

2.32

1.3

1.5

0.44

0.75

g/l

0.86

Other specified disorders of kidney and ureter

155

1.82

2.31

1.7

1.6

0.78

0.80

g/l

0.03

119

Other spirochaetal diseases

253

2097

1.21

2.30

1.6

0.70

0.77

g/l

0.53

202

1581

Wet age-related macular degeneration

658

1.38

2.30

1.4

1.6

0.98

0.81

g/l

0.29

505

Cerebral aneurysm, nonruptured

470

1.46

2.30

1.4

1.5

0.68

0.69

g/l

0.03

342

Recurrent and persistent haematuria

2.81

2.29

1.0

1.5

0.57

0.59

g/l

—

Melanoma in situ of other and unspecified parts of face

2.80

2.29

1.2

1.4

0.39

0.74

g/l

—

!Aliquae complicationes praecoces traumatis

223

1.67

2.28

1.4

1.8

0.53

0.89

g/l

1.13

176

Early complications of trauma

223

1.67

2.28

1.4

1.8

0.53

0.89

g/l

1.13

176

Fourth [trochlear] nerve palsy

2.05

2.27

1.9

1.6

0.66

0.83

g/l

0.44

Glaucoma suspect

264

2201

1.20

2.26

1.5

1.6

0.62

0.81

g/l

2.69

174

1669

Seborrhoeic dermatitis

505

1.43

2.26

1.4

1.7

0.69

0.84

g/l

0.78

394

Contraceptive management

387

2329

1.17

2.26

1.5

1.6

0.64

0.72

g/l

0.93

287

1769

Injuries to the elbow and forearm

624

4873

1.13

2.26

1.5

1.6

0.76

0.75

g/l

0.07

474

3700

Open wound of wrist and hand

397

3349

1.16

2.24

1.5

1.6

0.76

0.81

g/l

0.42

310

2528

Disorders of synovium and tendon in diseases classified elsewhere

2.12

2.24

1.3

1.9

1.27

0.89

g/l

0.41

Inflammatory diseases of prostate (prostatitis)

700

1.36

2.24

1.5

1.7

0.83

1.01

g/l

0.78

534

Maltreatment syndromes

327

1.54

2.22

1.2

1.8

0.89

0.74

g/l

0.35

257

Colitis due to radiation

2.91

2.22

1.8

2.0

0.65

1.26

g/l

—

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

100

2.02

2.21

2.1

1.7

0.68

0.92

g/l

0.50

Contact with and exposure to communicable diseases

283

2370

1.19

2.21

1.6

0.65

0.70

g/l

0.55

170

1828

Diabetic nephropathy, excluding more controls

117

731

1.32

2.21

1.4

1.7

0.71

0.81

g/l

0.57

527

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

233

1.64

2.20

1.3

1.8

0.54

0.81

g/l

1.37

176

Delivery, wide proxy

185

1220

0.80

2.20

1.6

1.5

0.65

0.63

g/l

0.11

137

920

Acute alcohol intoxication

205

1673

1.23

2.20

1.5

1.7

0.84

0.86

g/l

0.05

148

1271

Other and unspecified abdominal hernia

165

1.77

2.20

1.4

1.5

0.81

0.75

g/l

0.12

131

Tooth eruption problems

131

989

1.30

2.19

1.7

0.74

0.73

g/l

0.06

102

770

Specific development disorders of scholastic skills

308

1.55

2.19

1.4

1.8

0.57

0.76

g/l

1.19

241

Injury of muscle and tendon at shoulder and upper arm level

274

2302

1.19

2.18

1.5

1.7

0.72

0.88

g/l

1.88

201

1718

Sequelae of injuries of head

297

1.56

2.17

1.4

1.7

0.58

0.84

g/l

1.31

226

Benign neoplasm: Anus and anal canal

122

1.90

2.17

2.0

1.7

0.88

0.90

g/l

0.02

Other disorders of binocular movement

115

1.94

2.17

1.5

1.8

0.61

0.77

g/l

0.34

Other disorders of bone density and structure

115

1.93

2.17

1.6

1.8

0.54

0.82

g/l

0.74

Hypoplasia of dental enamel , including avohilmo

235

1.63

2.16

2.4

1.5

0.57

0.72

g/l

0.57

202

Contusion of ankle

219

1.66

2.16

1.4

1.6

1.08

0.85

g/l

0.21

164

Psoriasis (vulgaris), strict definition

166

1.76

2.16

1.3

1.7

0.64

0.81

g/l

0.56

133

False labour

265

1378

1.20

2.15

1.4

1.5

0.57

0.60

g/l

0.21

202

1052

Retinal detachments and breaks

257

2150

1.20

2.14

1.8

1.5

0.83

g/l

0.01

202

1630

Varicella [chickenpox]

363

1.50

2.12

1.3

1.7

0.92

0.86

g/l

0.07

288

Foreign body in respiratory tract

283

1.57

2.12

1.4

1.7

0.56

0.84

g/l

1.76

219

Infective bursitis

116

1.91

2.12

1.2

1.8

1.00

0.97

g/l

0.04

Impacted teeth

178

1277

1.24

2.12

1.7

1.6

0.67

0.72

g/l

0.35

146

979

Sequelae of injuries of neck and trunk

145

1.81

2.11

1.8

1.6

1.13

0.79

g/l

0.60

113

Contact with other hot fluids

175

1.73

2.11

1.4

1.7

0.63

0.77

g/l

0.41

134

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

2.30

2.09

1.4

1.7

0.72

0.69

g/l

—

Routine general health check-up of defined subpopulation

2.15

2.09

1.4

0.48

0.54

g/l

0.16

Other benign neoplasms of connective and other soft tissue

547

1.40

2.09

1.5

1.6

0.50

0.82

g/l

3.13

414

Delirium, not induced by alcohol and other psychoactive substances

512

1.41

2.09

1.6

0.61

0.89

g/l

2.02

391

Other disorders starting during childhood or adolescence

361

1.49

2.09

1.4

1.7

0.56

0.74

g/l

1.08

290

Postprocedural disorders of ear and mastoid process, not elsewhere classified

2.76

2.09

1.0

1.3

0.31

0.67

g/l

—

Chromosomal abnormalities, not elsewhere classified

153

1.79

2.08

1.5

1.6

0.75

0.69

g/l

0.07

126

Sequelae of infectious and parasitic diseases

414

1.46

2.08

1.5

1.7

0.64

0.82

g/l

0.91

314

Sequelae of injuries of lower limb

573

1.39

2.08

1.5

1.6

0.59

0.78

g/l

1.37

439

Pregnancy with abortive outcome

552

2544

1.13

2.07

1.4

1.5

0.64

0.61

g/l

0.27

414

1915

Disorders of breast

402

3173

1.15

2.07

1.4

1.5

0.57

0.62

g/l

0.53

305

2392

110

1.93

2.07

1.4

1.6

0.50

0.59

g/l

0.19

Crossbite

444

1.42

2.07

1.5

1.7

0.97

0.83

g/l

0.25

355

Anorexia (incl.atypical)

334

1.51

2.03

1.1

1.8

0.46

0.68

g/l

1.80

239

Alzheimer’s disease (Atypical or mixed)

299

0.50

2.03

1.1

1.4

1.16

0.87

g/l

—

226

Malignant neoplasm of bronchus and lung, including Hilmo

132

864

1.28

2.03

1.2

1.7

0.73

0.86

g/l

0.64

655

Alcohol dependence

210

1736

1.21

2.01

1.4

1.7

0.75

0.89

g/l

0.97

152

1318

Scabies

263

1.57

2.01

1.6

1.7

0.59

0.82

g/l

0.99

199

Alzheimer’s disease (Early onset)

145

0.34

2.01

1.2

1.7

0.39

0.97

g/l

—

109

Lactose intolerance

155

1.76

2.01

1.1

1.8

0.74

0.86

g/l

0.27

119

Female infertility, associated with anovulation

459

1.42

2.00

1.6

0.56

0.60

g/l

0.17

349

Hypertrophy of breast

145

1153

1.26

2.00

1.4

1.5

0.61

g/l

0.00

103

863

Emotional disorders and disorders of social functioning with onset specific to childhood

322

1.51

1.99

1.4

1.7

0.81

0.70

g/l

0.36

256

Carcinoma in situ of breast, intraductal

476

0.61

1.98

1.2

1.5

0.63

0.66

g/l

0.07

352

Speech and linguistic disorders

604

1.36

1.98

1.4

1.8

0.57

0.82

g/l

2.78

481

Gonococcal infection

156

1.75

1.97

1.4

2.0

0.79

0.95

g/l

0.28

119

Other specified/unspecified deforming dorsopathies

2.05

1.97

1.2

1.9

0.52

0.97

g/l

1.12

Alcoholic gastritis

2.22

1.96

1.1

1.3

0.87

0.84

g/l

—

Vitreous haemorrhage

512

1.39

1.95

1.8

1.7

0.89

0.82

g/l

0.11

391

Myopia

110

848

1.30

1.95

1.3

1.7

0.60

0.75

g/l

1.25

648

Left bundle-branch block

305

1.52

1.95

1.5

0.81

0.89

g/l

0.21

231

Benign neoplasm of other and unspecified sites

157

1.74

1.93

1.4

1.7

0.66

0.86

g/l

0.49

122

L02BB Anti-androgens

373

0.56

1.93

1.8

1.5

1.93

1.01

g/l

0.50

281

Female infertility, tubal origin

274

1.54

1.93

1.3

1.6

0.66

g/l

0.00

212

Fitting and adjustment of other devices

238

1804

1.19

1.92

1.5

1.6

0.72

0.83

g/l

0.58

204

1333

Other articular cartilage disorders

1.94

1.91

2.2

2.1

1.03

1.02

g/l

0.01

Corns and callosities

323

1.49

1.91

1.2

1.7

0.53

0.83

g/l

2.35

254

Pilonidal cyst

574

1.37

1.91

1.4

1.7

0.68

0.80

g/l

0.52

446

Corneal scars and opacities

128

1.81

1.91

2.3

1.8

0.54

0.87

g/l

1.19

Exposure to other and unspecified forces of nature

2.71

1.88

1.7

2.1

0.80

1.11

g/l

—

Macular pucker

739

1.32

1.88

1.9

1.6

0.76

0.85

g/l

0.36

554

Gonarthrosis, primary, with knee surgery

424

2966

1.14

1.88

1.5

1.6

0.74

0.82

g/l

0.78

315

2224

Overexertion and strenuous or repetitive movements

610

1.35

1.88

1.2

1.7

0.82

g/l

0.01

462

LSIL lesion of the cervix uteri, vagina or vulva

119

933

1.28

1.87

1.5

0.60

0.62

g/l

0.10

694

Traumatic subdural haemorrhage

552

1.36

1.87

1.5

1.6

0.80

0.87

g/l

0.21

410

Anxious personality disorder

100

1.92

1.86

1.4

2.1

0.55

0.88

g/l

0.93

L02BA Anti-estrogens

999

0.74

1.86

1.3

1.5

0.52

0.64

g/l

1.19

741

Dependent personality disorder

1.96

1.86

1.5

1.9

0.67

0.96

g/l

0.57

Other and unspecified injuries of ankle and foot

229

1.58

1.85

2.1

1.6

0.77

g/l

0.00

172

Viral haemorrhagic fevers, not elsewhere classified/unspecified

128

1014

1.27

1.84

1.6

0.95

0.78

g/l

0.61

103

783

Presence of other devices

151

1215

1.24

1.84

1.5

1.6

0.77

0.78

g/l

0.07

119

950

Gonococcal infection

175

1.67

1.83

1.3

2.0

0.79

0.93

g/l

0.25

134

Other appendicitis

493

1.39

1.83

1.3

1.7

0.59

0.78

g/l

0.90

375

Other conjunctival vascular disorders and cysts

108

1.87

1.83

1.5

1.8

0.55

0.89

g/l

1.04

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

261

1.54

1.82

1.5

0.72

0.73

g/l

0.03

195

Impotence

286

1.51

1.82

1.5

1.7

0.80

1.02

g/l

0.90

215

Melanocytic naevi of trunk

726

1.31

1.82

1.5

1.7

0.54

0.76

g/l

2.37

555

Retinal haemorrhage

101

1.90

1.81

1.4

1.8

0.66

0.87

g/l

0.38

Polyp of the female genital tract

227

1091

1.20

1.81

1.4

1.5

0.56

0.63

g/l

0.73

172

813

Bursitis of shoulder

1.93

1.81

1.4

2.1

0.38

1.03

g/l

2.52

Haemangioma, any site

478

1.39

1.80

2.0

1.5

0.63

0.78

g/l

0.86

358

Benign neoplasm: Long bones of lower limb

184

1.65

1.79

2.3

1.7

1.02

0.82

g/l

0.36

139

Amputation of foot

109

1.85

1.78

1.6

2.79

0.90

g/l

0.71

Leiomyoma of uterus

512

2583

1.13

1.78

1.5

0.62

g/l

0.03

374

1972

Other abnormal findings in urine

2.12

1.77

2.1

1.3

1.39

0.72

g/l

—

617

1.34

1.76

1.2

1.5

0.45

0.60

g/l

1.66

462

Alzheimer’s disease (Early onset), excluding more controls

129

0.36

1.76

1.2

1.3

0.39

0.74

g/l

—

Essential (haemorrhagic) thrombocythaemia

162

1.68

1.75

1.3

1.8

1.13

0.99

g/l

0.21

129

Neuroendocrine tumor and carcinoma of small intestine

2.25

1.75

1.5

2.1

1.24

1.26

g/l

—

Hypermetropia

421

1.41

1.75

1.4

1.6

0.58

0.80

g/l

1.29

325

Unspecified event, undetermined intent

132

1.76

1.75

1.4

1.7

0.35

0.80

g/l

2.48

107

Alzheimer’s disease (Atypical or mixed), excluding more controls

227

0.52

1.74

1.1

1.3

1.16

0.77

g/l

—

162

Malignant neoplasm of respiratory system and intrathoracic organs

128

849

1.26

1.73

1.3

1.6

0.76

0.85

g/l

0.38

642

Chalazion

671

1.32

1.73

1.7

1.6

0.70

0.75

g/l

0.21

508

Melanoma in situ

194

1.61

1.72

1.7

0.73

0.93

g/l

0.38

148

Graves disease, strict definition

620

1.33

1.71

1.5

1.7

0.94

0.71

g/l

0.51

476

Major anomalies of jaw size

148

1.71

1.5

1.8

0.71

0.80

g/l

0.16

113

Other degenerative diseases of the nervous system

181

1119

1.21

1.70

1.5

0.64

0.81

g/l

1.48

132

825

Other secondary coxarthrosis

156

1.68

1.70

1.7

1.04

0.86

g/l

0.18

116

Haemangioma and lymphangioma, any site

527

1.35

1.68

1.9

1.6

0.65

0.76

g/l

0.58

399

Perineal laceration during delivery

964

0.77

1.68

1.7

1.6

0.48

0.60

g/l

1.09

716

Lyme disease

240

2048

1.17

1.68

1.6

0.70

0.77

g/l

0.62

194

1539

Early lumbar disc prolapse, operated

631

1.32

1.67

1.3

1.7

0.55

0.82

g/l

3.03

487

Schizoaffective disorder

490

0.65

1.66

1.0

1.7

0.36

0.79

g/l

5.89

374

Status epilepticus

157

1.67

1.66

1.3

1.7

0.63

0.85

g/l

0.54

126

Other and unspecified trigeminal disorders

2.05

1.65

1.1

1.5

0.99

0.57

g/l

—

Benign neoplasm: Choroid

293

1.48

1.65

1.3

1.7

1.29

0.85

g/l

0.30

221

Injury of nerves at ankle and foot level

2.43

1.63

1.2

2.1

0.30

0.81

g/l

—

Malignant neoplasm of eye, brain and central nervous system

197

1.58

1.63

1.6

1.7

0.55

0.95

g/l

1.48

158

Pregnancy examination and test

138

692

1.24

1.63

1.6

0.55

0.58

g/l

0.17

104

530

Retinoschisis and retinal cysts

1.85

1.62

2.1

1.6

1.44

0.81

g/l

0.41

Intentional self-harm by sharp object

143

1.69

1.62

1.3

1.8

0.83

0.80

g/l

0.06

108

Bitten or struck by other mammals

740

1.29

1.62

1.4

1.6

0.58

0.73

g/l

1.20

562

Vestibular neuronitis

471

1.37

1.61

1.3

1.7

0.67

0.81

g/l

0.67

364

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

471

1.36

1.61

1.6

1.7

0.66

0.85

g/l

1.03

348

Dislocation, sprain and strain of joints and ligaments of head

254

1.51

1.61

1.5

1.8

0.59

0.76

g/l

0.63

192

Dyshidrosis [pompholyx]

2.09

1.60

1.2

1.9

0.39

0.79

g/l

—

Additional codes for the location of defect, injury or illness

295

1.47

1.60

1.4

1.6

0.66

0.83

g/l

0.53

227

Benign neoplasm of bone and articular cartilage

515

1.35

1.59

2.3

1.7

1.07

0.76

g/l

0.89

397

Recurrent dislocation and subluxation of joint

404

1.39

1.59

1.6

1.7

0.67

0.84

g/l

0.72

301

Spirochaetal infections, other/unspecified

241

2068

1.17

1.59

1.6

0.70

0.77

g/l

0.59

195

1559

Autism spe, excluding more controls

144

1.68

1.58

1.3

1.9

0.46

0.72

g/l

1.66

117

Car occupant injured in other and unspecified transport accidents

154

1271

1.22

1.58

1.7

1.6

0.66

0.76

g/l

0.83

126

969

Allergic contact dermatitis due to drugs in contact with skin

1.84

1.58

1.3

1.8

0.61

0.83

g/l

—

Fracture of femur

160

1201

1.21

1.57

1.4

1.6

0.63

0.80

g/l

2.03

120

904

Other disorders of pigmentation

207

1.56

1.57

1.5

1.7

0.48

0.83

g/l

2.02

159

Gestational [pregnancy-induced] hypertension

205

1736

1.18

1.55

1.5

0.55

0.60

g/l

0.64

156

1310

Malignant melanoma, including Hilmo

115

922

1.25

1.55

1.5

1.6

0.60

0.82

g/l

2.28

704

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

107

1.79

1.55

1.5

1.8

0.50

0.83

g/l

—

Family history of other conditions

1.95

1.55

1.3

1.9

0.40

0.68

g/l

—

Other maltreatment syndromes

192

1.58

1.55

1.3

1.8

0.65

0.79

g/l

0.44

153

Superficial injury of thorax

110

878

1.26

1.55

1.8

1.6

0.64

0.82

g/l

1.06

677

Benign neoplasm: Skin of trunk

216

1.54

2.0

1.7

0.60

0.84

g/l

0.52

166

Coxarthrosis, primary, with hip surgery

326

2682

1.14

1.53

1.4

1.6

0.67

0.83

g/l

2.08

258

1998

Primary ovarian failure

1.85

1.52

2.2

1.6

0.39

0.71

g/l

—

Ovarian dysfunction

425

1.37

1.52

1.8

1.6

0.35

0.60

g/l

3.14

321

Cystic kidney disease

162

1.62

1.50

1.3

1.8

0.61

0.84

g/l

0.69

123

Pregnancy hypertension

338

2672

1.13

1.50

1.5

0.56

0.61

g/l

0.72

263

2029

Status post-ami

154

972

1.21

1.49

1.3

1.6

0.97

g/l

0.01

128

731

Other disorders of the genitourinary system

661

1.29

1.49

1.4

1.6

0.60

0.72

g/l

0.71

476

L01XE Protein kinase inhibitors

251

1.48

1.4

1.6

0.97

0.88

g/l

0.11

190

Urethral stricture

235

1.50

1.47

1.3

1.4

0.90

g/l

0.01

185

Pediculosis, acariasis and other infestations

360

1.40

1.46

1.5

1.7

0.56

0.81

g/l

1.52

273

Right hemicolectomy

236

1.49

1.44

1.4

1.6

0.91

0.86

g/l

0.10

178

Gilbert syndrome

2.35

1.44

1.8

1.9

0.71

0.92

g/l

—

Pregnancy, childbirth and the puerperium

161

1006

0.83

1.44

1.5

0.64

0.65

g/l

0.06

119

755

Granulomatous disorders of skin and subcutaneous tissue

110

1.74

1.43

1.7

0.44

0.86

g/l

1.48

Lactose intolerance, other/unspecified

133

1.67

1.43

1.1

1.8

0.83

0.88

g/l

0.08

103

Endometriosis diagnosis and infertility diagnosis occurring together

710

1.27

1.42

1.5

0.62

0.63

g/l

0.06

533

Malignant melanoma

755

1.26

1.41

1.6

0.60

0.81

g/l

1.81

572

Assault by bodily force

535

1.31

1.41

1.4

1.7

0.64

0.80

g/l

0.96

412

Long labour

142

1458

0.83

1.39

1.5

0.69

0.59

g/l

0.67

115

1101

Melanocytic naevi of other and unspecified parts of face

313

1.41

1.39

1.8

1.5

0.92

0.74

g/l

0.30

234

Malignant neoplasm of oral cavity

142

1.63

1.38

1.3

1.7

0.71

1.03

g/l

0.92

112

Redundant prepuce, phimosis and paraphimosis

169

1414

1.19

1.38

1.5

1.7

0.92

0.93

g/l

0.06

128

1080

Carcinoma in situ of skin

364

1.38

1.9

1.5

0.86

0.83

g/l

0.05

278

Cystic kidney disease

174

1.56

1.38

1.3

1.7

0.74

0.84

g/l

0.19

135

Diabetic nephropathy

118

953

1.23

1.36

1.4

1.7

0.70

0.78

g/l

0.40

689

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

223

1.49

1.36

1.3

1.7

0.50

0.86

g/l

1.51

171

Malignant neoplasm of stomach, including Hilmo

215

1.49

1.35

1.5

1.7

0.63

0.96

g/l

1.33

169

Malignant neoplasm of bladder, including Hilmo

492

1.32

1.34

2.0

1.7

0.97

0.90

g/l

0.15

382

Nontoxic multinodular goitre

129

1067

1.21

1.34

1.6

1.5

0.69

0.70

g/l

0.03

791

Foreign body in ear

105

1.73

1.34

1.2

1.7

0.44

0.75

g/l

0.74

Congenital deformities of feet

216

1.49

1.33

1.4

1.7

0.91

0.78

g/l

0.32

170

Anisometropia and aniseikonia

152

1.59

1.32

1.3

1.7

0.59

0.87

g/l

0.73

120

Disorders of speech understanding and production

278

1.42

1.31

1.4

1.7

0.80

0.78

g/l

0.04

231

Varicose veins of other sites

360

1.37

1.30

1.9

1.6

1.08

0.89

g/l

0.28

281

Lichen sclerosus et atrophicus

535

1.29

1.28

1.7

1.5

0.70

0.73

g/l

0.10

393

Calcific tendinitis of shoulder

285

1.41

1.27

1.2

1.6

0.65

0.82

g/l

0.73

214

Chronic viral hepatitis

336

1.38

1.27

1.2

1.8

0.77

0.84

g/l

0.17

256

Fracture of neck

260

1.43

1.27

1.2

1.7

0.53

0.97

g/l

2.49

202

Impacted maxillary molar

362

1.36

1.26

1.8

1.6

0.57

0.64

g/l

0.26

275

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

146

1.59

1.26

1.2

1.7

0.79

0.80

g/l

0.02

115

Anankastic personality disorder

219

1.47

1.26

1.3

1.7

0.69

0.80

g/l

0.28

163

LSIL lesion of the cervix uteri

741

1.25

1.26

1.5

0.54

0.61

g/l

0.39

556

Infectious mononucleosis

563

1.28

1.26

1.9

1.7

0.57

0.72

g/l

1.00

427

Schizophrenia or delusion

201

2317

0.87

1.25

1.3

1.6

0.67

0.75

g/l

0.54

137

1736

Injury of muscle and tendon at lower leg level

116

958

1.21

1.25

1.9

1.6

0.91

0.85

g/l

0.11

731

Arthropod-borne viral fevers and viral haemorrhagic fevers

537

1.29

1.25

1.8

1.6

0.71

0.82

g/l

0.39

410

Injuries involving multiple body regions

195

1.50

1.24

1.3

1.8

0.81

0.83

g/l

0.02

150

Sequelae of other accidents

1.88

1.24

1.2

1.8

0.56

0.84

g/l

—

Schizophrenia, schizotypal and delusional disorders

202

2326

0.87

1.24

1.3

1.6

0.67

0.75

g/l

0.56

138

1743

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

345

2093

1.12

1.24

1.7

1.6

0.70

0.81

g/l

0.94

261

1578

Juvenile osteochondrosis

179

1.52

1.24

1.9

0.74

0.83

g/l

0.18

141

Other benign neoplasm of uterus: Other parts/unspecified

139

1.59

1.23

1.2

1.6

0.55

0.76

g/l

0.66

109

Other and unspecified injuries of wrist and hand

212

1.47

1.23

1.4

1.7

0.80

0.83

g/l

0.04

169

Premature rupture of membranes

125

1072

0.83

1.23

1.5

0.63

0.61

g/l

0.07

812

Non-small cell lung cancer, squamous

139

1.59

1.23

1.5

1.6

0.70

1.08

g/l

1.44

106

Malignant neoplasm of bronchus and lung

106

720

1.22

1.2

1.7

0.73

0.85

g/l

0.41

550

Other blood glucose lowering drugs, excl. Insulins

105

861

1.22

1.3

1.6

0.68

0.87

g/l

1.35

642

Other puerperal infections

496

1.30

1.21

1.5

1.6

0.68

0.60

g/l

0.37

378

Malignant neoplasm of bladder

238

1.43

1.19

2.2

1.7

1.01

1.03

g/l

0.02

185

Myocardial infarction, with ST-elevation

103

845

1.22

1.19

1.6

0.87

0.95

g/l

0.14

647

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

289

1.39

1.19

2.0

1.7

0.40

0.79

g/l

3.31

215

Other benign neoplasms of uterus

197

1.48

1.19

1.2

1.5

0.61

0.72

g/l

0.36

153

Open wound of abdomen, lower back and pelvis

173

1.51

1.18

1.1

1.8

0.81

0.84

g/l

0.05

132

Crushed, pushed or stepped on by crowd or human stampede

498

1.29

1.18

1.3

1.7

0.67

0.76

g/l

0.45

384

Transient global amnesia

464

0.71

1.18

2.0

1.6

0.65

0.82

g/l

0.59

342

Laparoscopic right hemicolectomy

248

1.42

1.17

1.5

1.6

1.01

0.89

g/l

0.23

190

Preterm labour and delivery

200

1742

1.15

1.16

1.4

1.5

0.53

0.61

g/l

0.81

143

1313

Pathological resorption of teeth

182

1.49

1.16

1.8

1.7

0.88

0.84

g/l

0.08

138

Injury of muscle and tendon at hip and thigh level

588

1.26

1.16

1.5

1.7

0.83

0.81

g/l

0.04

444

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

473

1.29

1.15

1.3

1.7

0.90

0.91

g/l

0.02

364

Non-small cell lung cancer

417

1.31

1.15

1.3

1.7

0.65

0.89

g/l

1.48

319

Malignant neoplasm of ovary

235

0.59

1.15

1.9

1.7

0.38

0.73

g/l

—

176

Hereditary corneal dystrophies

150

1.54

1.15

2.0

1.8

0.99

0.87

g/l

0.19

111

Other and unspecified mononeuropathies, also in other diseases

134

1.58

1.15

1.6

1.7

0.76

0.81

g/l

0.08

104

Astigmatism

386

1.33

1.14

1.2

1.7

0.45

0.84

g/l

4.05

299

Congenital malformations of eye, ear, face and neck

396

1.32

1.13

1.3

1.6

0.84

0.76

g/l

0.17

302

Cicatricial alopecia [scarring hair loss]

2.03

1.13

1.5

0.49

0.62

g/l

—

Malignant neoplasm of other and ill-defined sites, including Hilmo

1.91

1.12

2.0

1.7

1.83

0.92

g/l

—

Diffuse brain injury

159

1.52

1.12

1.1

1.7

0.59

0.85

g/l

0.86

125

Disorder of external ear, unspecified

151

1.53

1.12

1.8

1.5

0.75

g/l

0.00

116

Injury of eye and orbit

114

953

1.20

1.11

1.4

1.7

0.69

0.80

g/l

0.72

719

Benign neoplasm of ovary

117

981

1.20

1.11

1.2

1.5

0.63

0.66

g/l

0.07

724

Bacterial meningitis

176

1.49

1.10

1.9

1.8

0.95

0.93

g/l

0.03

130

Alzheimer’s disease (Late onset), excluding more controls

422

0.76

1.10

1.5

0.61

0.91

g/l

1.16

291

Abnormal findings in secretions and smears from cervix uteri vagina vulva

398

2735

1.10

1.4

1.5

0.54

0.61

g/l

1.21

300

2087

Congenital deformities of hip

104

1.65

1.10

1.8

1.5

0.65

0.50

g/l

0.30

Non-small cell lung cancer, including Hilmo

668

1.23

1.09

1.2

1.7

0.82

0.86

g/l

0.11

506

Viral haemorrhagic fevers, not elsewhere classified/unspecified

425

1.30

1.08

1.9

1.6

0.73

0.83

g/l

0.25

325

Cysts of oral region, not elsewhere classified

312

1.35

1.08

1.9

1.8

0.86

0.84

g/l

0.05

241

Follow-up examination after treatment for malignant neoplasms

355

1.33

1.08

1.2

1.5

0.68

0.84

g/l

0.68

238

Exposure to other and unspecified animate mechanical forces

169

1.49

1.07

1.4

1.8

0.58

0.76

g/l

0.63

135

Other malignant neoplasms of skin (=non-melanoma skin cancer)

312

1926

1.11

1.05

1.7

1.6

0.69

0.83

g/l

1.25

237

1447

Malignant neoplasm of head and neck

366

1.32

1.04

1.2

1.6

1.04

0.89

g/l

0.18

283

Superficial injury of shoulder and upper arm

678

1.23

1.04

1.9

1.7

0.70

0.83

g/l

0.83

521

Foreign body entering into or through eye or natural orifice

490

1.27

1.04

1.4

1.6

0.73

0.81

g/l

0.29

385

Malignant neoplasm of breast, HER-negative

1099

0.83

1.04

1.3

1.5

0.56

0.69

g/l

1.06

826

Asymptomatic human immunodeficiency virus [HIV] infection status

2.09

1.04

1.3

1.9

0.64

0.68

g/l

—

Other disorders of cornea

517

1.26

1.03

1.6

0.79

0.81

g/l

0.07

398

Postpartum haemorrhage due to retained placenta

823

0.80

1.03

1.4

1.5

0.71

0.61

g/l

0.58

634

Persistent delusional disorders

417

0.72

1.03

1.1

1.6

0.58

0.80

g/l

0.92

316

Non-small cell lung cancer, squamous, helper endpoint

146

1.51

1.03

1.5

0.70

0.96

g/l

0.87

114

Mental disorders, not otherwise specified

509

1.26

1.02

1.5

1.7

0.62

0.76

g/l

0.89

388

Foreign body in alimentary tract

281

1.36

1.02

1.4

1.6

0.78

0.83

g/l

0.12

221

Mental and behavioural disorders due to cannabinoids

188

1.45

1.02

1.1

2.0

0.60

0.76

g/l

0.34

149

Other disorders of penis

581

1.24

1.01

2.3

1.7

0.96

0.95

g/l

0.03

462

In situ neoplasms

265

2378

1.12

1.00

1.7

1.5

0.76

0.74

g/l

0.11

186

1785

Melanocytic naevi, other sites/unspecified

449

1.27

0.99

1.6

0.53

0.79

g/l

1.03

346

Sequelae of other and unspecified infectious and parasitic diseases

335

1.32

0.99

1.5

1.7

0.60

0.82

g/l

1.11

254

Benign leiomyoma with endometriosis

106

893

1.19

0.98

1.4

1.5

0.61

0.63

g/l

0.10

651

Pediculosis, acariasis and other infestations

132

1133

1.17

0.98

1.6

0.70

0.77

g/l

0.46

104

868

Malignant neoplasm of other and ill-defined digestive organs

0.00

0.98

0.0

2.1

—

1.07

—

Polymorphous light eruption

1.97

0.97

1.0

1.4

0.44

0.43

g/l

—

Femoral hernia

173

1.45

0.97

2.1

1.5

0.53

0.80

g/l

0.95

139

Varicose veins

454

3159

1.09

0.97

1.6

1.5

0.74

0.76

g/l

0.18

317

2396

Convergent concomitant strabismus

380

1.30

0.97

1.6

1.8

0.55

0.80

g/l

1.89

292

Malignant neoplasm of breast, ER-negative, including Hilmo

109

1223

0.85

0.96

1.3

1.5

0.55

0.67

g/l

1.20

922

Benign neoplasm: Kidney

157

1.47

0.96

1.7

0.76

0.92

g/l

0.18

117

Failed attempted abortion

1.79

0.95

1.9

1.5

0.22

0.53

g/l

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

191

1.42

0.95

1.6

1.8

0.77

0.92

g/l

0.29

154

Macular hole

242

1.37

0.94

1.1

1.7

0.41

0.93

g/l

4.66

188

Traumatic subarachnoid haemorrhage

125

1.53

0.94

1.3

1.4

0.69

0.78

g/l

0.24

Use of rivastigmine

544

0.77

0.94

1.4

1.5

0.76

0.87

g/l

0.22

406

Inguinal hernia

466

2878

1.08

0.93

1.8

1.6

0.97

0.84

g/l

0.82

351

2142

Other disorders of breast

789

1.19

0.92

1.3

1.5

0.50

0.63

g/l

1.38

589

Malignant neoplasm of ovary, including Hilmo

315

0.70

0.92

1.7

1.6

1.14

0.70

g/l

0.23

236

Malignant neoplasm of skin

352

2204

1.10

0.92

1.6

0.64

0.81

g/l

2.62

268

1668

Anomalies of dental arch relationship, including avohilmo

167

1322

1.14

0.92

1.3

1.6

0.70

0.75

g/l

0.29

125

1017

Wide developmental disorders, excluding more controls

206

1.39

0.92

1.3

1.8

0.48

0.73

g/l

1.62

164

Emotional disorders starting during childhood or adolescence

319

1.31

0.91

1.4

1.7

0.67

0.71

g/l

0.11

258

Foreign body on external eye

114

975

1.17

0.91

1.3

1.7

0.72

0.84

g/l

0.81

744

HSIL lesion of the cervix uteri

108

1264

0.85

0.90

1.4

1.5

0.55

0.62

g/l

0.43

960

Carcinoma in situ of cervix uteri

575

0.78

0.90

1.6

0.54

0.60

g/l

0.26

437

Infections of genitourinary tract in pregnancy

564

1.23

0.90

1.3

1.6

0.53

0.66

g/l

0.81

412

Use of interferon beta-1a

135

1.49

0.89

1.4

1.6

0.47

0.68

g/l

0.52

Complications of the puerperium, not elsewhere classified

245

1.35

0.89

1.6

0.55

0.60

g/l

0.15

184

Other and unspecified corneal deformities and disorders

160

1.45

0.89

1.3

1.7

0.51

0.83

g/l

1.08

123

Labour and delivery complicated by umbilical cord complications

280

1.33

0.88

1.3

1.6

0.52

0.66

g/l

0.74

209

Other sexually transmitted chlamydial diseases

413

1.26

0.87

1.4

1.8

0.61

0.71

g/l

0.49

303

Single delivery by forceps and vacuum extractor

690

0.84

0.87

1.4

1.5

0.67

0.61

g/l

0.36

539

Congenital malformations of great arteries

175

1.41

0.86

1.6

1.8

0.68

0.77

g/l

0.19

147

Ectopic pregnancy

131

1139

1.15

0.86

1.5

0.66

0.62

g/l

0.19

857

Aneurysms, operations, SAH

107

916

1.17

0.86

1.5

0.68

0.74

g/l

0.32

680

Amblyopia ex anopsia

221

1.36

0.85

1.6

1.5

1.26

0.69

g/l

0.40

176

Atlantoaxial subluxation

1.96

0.85

1.2

1.5

0.50

0.74

g/l

—

Malignant neoplasm of rectum, including Hilmo

614

0.80

0.85

1.3

1.6

1.00

0.87

g/l

0.19

466

Specific development disorders of speech and language

391

1.26

0.84

1.4

1.8

0.69

0.79

g/l

0.27

314

Post-traumatic wound infection, not elsewhere classified

137

1.47

0.84

1.1

1.8

0.39

0.98

g/l

3.39

106

Malignant neoplasm of stomach

179

1.40

0.84

1.5

1.7

0.67

0.99

g/l

1.03

139

Postmenopausal atrophic vaginitis

178

869

1.13

0.83

1.7

1.5

0.68

0.66

g/l

0.08

140

644

Liposarcoma, including Hilmo

1.76

0.83

1.1

2.5

0.78

1.20

g/l

—

Injury of other and unspecified intrathoracic organs

310

1.29

0.82

1.3

1.6

0.60

0.88

g/l

1.60

241

Glaucoma, exfoliation

390

1.26

0.82

1.6

1.5

0.83

0.86

g/l

0.05

302

Benign neoplasm: Skin of upper limb, including shoulder

1.58

0.81

2.1

1.7

0.51

0.77

g/l

—

Other disorders of iris and ciliary body

130

1.47

0.81

1.5

1.6

0.60

0.80

g/l

0.55

100

Presbyopia

400

1.25

0.81

1.4

1.6

0.56

0.80

g/l

1.87

304

Toxic effects of substances chiefly nonmedicinal as to source

709

1.19

0.81

1.8

1.6

0.60

0.78

g/l

1.44

538

All dysplastic lesions of the cervix uteri, vagina or vulva

224

1995

1.11

0.79

1.4

1.5

0.57

0.60

g/l

0.21

170

1517

139

1.45

0.79

2.1

1.8

0.75

0.83

g/l

0.12

107

Intermittent heterotropia

365

1.26

0.79

1.4

1.7

0.51

0.80

g/l

2.27

278

Autism spe

173

1.40

0.79

1.3

1.7

0.46

0.71

g/l

1.61

137

Open wound of hip and thigh

173

1.39

0.79

1.3

1.8

0.83

0.75

g/l

0.08

136

0.00

0.78

0.0

1.3

—

0.39

—

Contact with heat and hot substances

322

1.28

0.78

1.5

1.7

0.73

0.85

g/l

0.30

248

Obstructed labour due to maternal pelvic abnormality

112

972

1.15

0.78

1.4

1.5

0.54

0.61

g/l

0.65

730

Focal epilepsy

153

1356

1.13

0.77

1.5

1.6

0.75

0.80

g/l

0.15

116

1038

Focal epilepsy, mode (most common among epilepsy diagnosis)

132

1159

1.14

0.77

1.6

0.78

g/l

0.01

102

883

Hyperplasia of prostate

245

1261

1.10

0.77

1.5

1.7

0.92

0.95

g/l

0.09

181

950

Congenital deformities of hip

115

1.49

0.77

1.8

1.5

0.65

0.53

g/l

0.22

Calculus of lower urinary tract

217

1.34

0.77

1.4

1.7

0.58

1.00

g/l

1.65

168

Parkinson's disease

715

0.82

0.76

2.1

1.5

0.58

0.88

g/l

2.49

538

Behavioural disorders, excluding more controls

116

1.47

0.74

1.6

1.8

1.26

0.79

g/l

—

Focal epilepsy, strict definition

140

1240

1.13

0.73

1.5

1.6

0.66

0.79

g/l

0.88

106

947

Benign neoplasm of other and unspecified female genital organs

202

1.34

0.72

1.4

1.7

0.64

0.72

g/l

0.17

156

Complications of labour and delivery

501

2611

1.07

0.72

1.4

1.5

0.61

g/l

0.07

383

1964

Other fall from one level to another

171

1534

1.12

0.72

1.5

1.6

0.87

0.80

g/l

0.26

129

1181

HSIL lesion of the cervix uteri, vagina or vulva

122

1385

0.88

0.72

1.4

1.5

0.53

0.61

g/l

0.72

1056

Certain conditions originating in the perinatal period

547

1.19

0.71

1.3

1.7

0.62

0.79

g/l

0.82

436

Inguinal hernia, bilateral

544

1.20

0.71

1.5

1.6

0.82

0.91

g/l

0.35

422

Polycystic ovarian syndrome

300

1.27

0.70

1.4

1.6

0.28

0.64

g/l

5.90

219

Inguinal or femoral hernia, bilateral

554

1.19

0.70

1.5

1.6

0.80

0.90

g/l

0.41

429

Autism

178

1.36

0.69

1.3

1.7

0.46

0.74

g/l

1.90

138

Bulimia nervosa (incl. atypical)

187

1.34

0.68

1.2

1.8

0.67

0.61

g/l

0.19

134

Other and unspecified nonorganic psychotic disorders

124

1399

0.88

0.68

1.4

1.6

0.67

0.76

g/l

0.46

1051

Struck by thrown, projected or falling objec

302

1.26

0.68

1.4

1.7

0.78

0.79

g/l

0.04

233

Postpartum care and examination

611

0.86

0.67

1.5

1.6

0.46

0.59

g/l

1.35

465

Non-small cell lung cancer, adenocarcinoma

242

1.28

0.64

1.1

1.7

0.55

1.00

g/l

2.26

190

Motorcycle rider injured in other and unspecified transport accidents

377

1.22

0.64

1.7

0.55

0.86

g/l

2.40

290

Alcohol withdrawal state with delirium

377

1.22

0.64

1.4

1.7

0.71

0.95

g/l

0.90

294

Nontoxic single thyroid nodule

377

1.22

0.64

1.9

1.6

0.61

0.77

g/l

0.68

289

Abnormal spermatozoa

644

0.84

0.63

1.5

1.6

1.09

0.98

g/l

0.15

496

Intracerebral haemorrhage

552

1.18

0.62

1.4

0.82

0.85

g/l

0.07

412

Postpartum haemorrhage

163

1516

0.90

0.62

1.4

1.5

0.63

0.59

g/l

0.39

121

1149

Other mental disorders due to brain damage and dysfunction and to physical disease

534

1.18

0.62

1.3

1.6

0.60

0.87

g/l

2.44

403

Placenta praevia

279

1.26

0.62

1.4

1.6

0.60

0.66

g/l

0.14

202

Conductive hearing loss, unspecified

461

1.20

0.62

1.4

1.6

0.98

0.80

g/l

0.17

359

Toxic effect of contact with venomous animals

226

1.29

0.61

1.1

1.6

0.58

0.81

g/l

1.31

171

Postpartum hemorraghe, all women as controls

163

1769

0.91

0.61

1.4

1.5

0.63

0.60

g/l

0.30

121

1347

Ependymoma

0.00

0.61

0.0

1.3

—

0.54

—

Benign neoplasm of thyroid gland

156

1.35

0.61

2.4

1.6

0.83

0.82

g/l

0.01

118

Syndactyly

0.00

0.60

0.0

1.4

—

0.63

—

Fall on and from ladder

389

1.21

0.60

1.5

1.6

1.14

0.89

g/l

0.60

303

Keratoconus

122

1.40

0.60

1.4

1.9

0.89

0.81

g/l

0.15

Other and unspecified injuries of head

371

1.22

0.60

1.4

1.7

0.84

0.83

g/l

0.03

279

Pre-eclampsia or poor fetal growth

231

2122

1.09

0.60

1.4

1.5

0.57

0.60

g/l

0.27

175

1610

Congenital malformations of heart and great arteries

100

855

1.14

0.59

1.4

1.7

0.78

0.80

g/l

0.07

668

Lesion of plantar nerve

308

1.24

0.59

1.7

1.6

0.71

0.77

g/l

0.16

229

Melanoma in situ of trunk

1.54

0.59

1.8

1.7

0.81

0.88

g/l

—

Unspecified maternal hypertension

1.57

0.59

1.1

1.4

0.67

0.55

g/l

—

Traumatic amputation of wrist and hand

220

0.72

0.59

1.7

1.8

0.79

0.93

g/l

0.23

170

Supervision of high-risk pregnancy

165

900

1.10

0.58

1.5

0.53

0.59

g/l

0.53

131

690

Rubella [German measles]

202

1.29

0.57

2.3

1.7

0.79

0.95

g/l

0.43

155

Deep bite

693

1.14

0.57

1.3

1.7

0.62

0.81

g/l

2.04

546

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

493

1.18

0.57

1.4

1.5

0.63

0.64

g/l

0.05

377

Type 1 diabetes, strict (exclude DM2)

715

1.15

0.57

1.5

1.8

0.66

0.76

g/l

0.39

567

Type 1 diabetes, definitions combined

715

1.15

0.57

1.5

1.8

0.66

0.76

g/l

0.38

567

Congenital malformations of the nervous system

141

1.36

0.56

1.2

1.8

1.45

0.76

g/l

0.76

113

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

146

1306

1.11

0.56

1.2

1.6

0.81

0.86

g/l

0.18

106

984

Benign mammary dysplasia

802

1.14

0.56

1.4

1.5

0.53

0.65

g/l

1.04

586

Other vitreous opacities

194

1.29

0.56

1.5

1.6

0.63

0.87

g/l

0.56

149

Unspecified lump in breast

106

944

1.12

0.56

1.5

0.54

0.63

g/l

0.63

701

Otorrhagia

1.64

0.56

1.5

0.29

0.54

g/l

—

malignant neoplasm of female genital organs

748

0.86

0.55

1.3

1.5

0.53

0.70

g/l

1.28

552

Unspecified abortion

284

1.24

0.55

1.6

1.5

0.51

0.64

g/l

0.60

210

Slow fetal growth and fetal malnutrition

1.53

0.55

1.9

1.6

0.42

0.70

g/l

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

121

0.65

0.55

1.9

1.5

1.03

0.68

g/l

—

102

Pedal cyclist injured in transport accident

142

1565

0.91

0.55

1.6

0.74

0.77

g/l

0.06

109

1193

Benign neoplasm: Skin of other and unspecified parts of face

523

1.17

0.55

1.6

0.62

0.79

g/l

0.96

397

Lesion of radial nerve

177

1.30

0.54

2.4

1.7

2.05

0.84

g/l

0.74

135

Diabetic retinopathy

253

1464

1.08

0.54

1.4

1.6

0.72

0.75

g/l

0.07

164

1078

Abnormal findings on antenatal screening of mother

525

0.84

0.54

1.6

0.58

0.64

g/l

0.16

401

Personal history of risk-factors, not elsewhere classified

1.50

0.53

1.1

1.9

0.62

0.80

g/l

0.31

Diabetes mellitus in pregnancy

254

1511

1.08

0.53

1.4

1.5

0.56

0.61

g/l

0.47

208

1160

Lesion of sciatic nerve

160

1.32

0.53

1.6

1.08

0.93

g/l

0.11

123

Nontoxic goitre/thyroid nodule

196

1808

1.09

0.53

1.9

1.5

0.72

0.68

g/l

0.22

148

1340

Retinal breaks without detachment

107

958

1.12

0.52

2.3

1.6

0.92

0.81

g/l

0.39

732

Contact with sharp glass

232

1.25

0.52

1.3

1.9

0.66

0.82

g/l

0.26

180

Outcome of delivery

105

725

0.89

0.51

1.4

1.5

0.59

g/l

0.00

553

Injury of muscle and tendon at wrist and hand level

875

1.12

0.51

1.4

1.7

0.64

0.82

g/l

1.00

683

Other disorders of male genital organs

224

1.25

0.51

2.1

1.7

0.87

0.93

g/l

0.11

178

Parkinson's disease, strict definition

639

0.86

0.50

2.2

1.5

0.58

0.90

g/l

2.33

479

Memory loss

398

1.18

0.50

1.7

1.5

0.79

0.83

g/l

0.10

301

Generalized epilepsy, mode (most common among epilepsy diagnosis)

171

1.29

0.50

1.3

1.7

0.52

0.84

g/l

1.21

131

Toxic effect of ethanol

234

1.24

0.49

2.8

1.8

0.65

0.82

g/l

0.55

184

Parkinson's disease, including avohilmo

744

0.87

0.49

2.2

1.5

0.59

0.88

g/l

2.54

559

Other osteochondropathies

427

1.17

0.49

1.6

0.69

0.81

g/l

0.55

324

Endovascular or surgical operations to intracerebral aneurysms

298

1.21

0.49

1.6

1.5

0.60

0.72

g/l

0.51

219

Inguinal of femoral hernia, unilateral

110

1.37

0.49

2.6

1.6

0.70

0.79

g/l

—

Femoral hernia, unilateral

110

1.37

0.49

2.6

1.6

0.70

0.79

g/l

—

Inguinal hernia, unilateral

110

1.37

0.49

2.6

1.6

0.70

0.79

g/l

—

Malignant neoplasm of rectum

432

0.83

0.48

1.4

1.7

0.73

0.92

g/l

0.37

331

Traumatic ischaemia of muscle

1.46

0.48

1.7

1.8

1.06

0.83

g/l

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

357

1978

1.06

0.48

1.5

0.64

0.60

g/l

0.48

290

1508

399

0.83

0.48

1.2

1.6

1.11

0.94

g/l

0.33

305

Conduct disorder

128

1.33

0.48

1.6

1.7

1.26

0.73

g/l

—

101

Foreign body or object entering through skin

373

1.18

0.47

1.4

1.7

0.44

0.82

g/l

4.10

293

Pedestrian injured in transport accident

373

1.18

0.47

1.3

1.7

0.87

0.80

g/l

0.11

286

Non-small cell lung cancer, adenocarcinoma, helper endpoint

254

1.22

0.47

1.1

1.7

0.55

0.93

g/l

1.74

197

Open wound of forearm

560

1.15

0.47

1.2

1.7

0.67

0.84

g/l

0.89

425

Primary angle-closure glaucoma

182

1.27

0.46

3.0

1.6

0.75

0.85

g/l

0.12

137

Tibial collateral bursitis [Pellegrini-Stieda]

1.44

0.46

1.0

2.0

0.39

0.98

g/l

—

Type 1 diabetes, strict definition

609

0.87

0.45

1.5

1.8

0.70

0.73

g/l

0.04

483

Hydrocele

628

1.13

0.45

2.0

1.7

0.71

0.96

g/l

1.35

494

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

449

0.84

0.44

1.3

1.7

1.18

0.92

g/l

0.32

347

Universal erythroderma, KELA reimbursement

1.46

0.44

1.1

1.7

0.69

0.92

g/l

—

Periapical abscess

359

3409

1.05

0.44

1.5

1.6

0.71

0.80

g/l

0.61

264

2596

Pedal cyclist injured in noncollision transport accidents

747

0.88

0.44

1.5

1.6

0.56

0.77

g/l

2.14

567

Peripheral retinal degeneration

139

1.30

0.43

1.3

1.6

0.42

0.87

g/l

—

105

Other and unspecified disorders of adult personality and behaviour

1.63

0.43

1.2

1.6

0.38

0.67

g/l

—

Other superficial injuries of ankle and foot

1.63

0.43

3.2

1.2

0.79

0.63

g/l

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

527

1.14

0.43

1.1

1.6

0.49

0.66

g/l

1.05

387

Migraine with aura, drug-induced

1.44

0.43

2.4

1.8

0.51

0.76

g/l

—

Burn and corrosion of hip and lower limb, except ankle and foot

122

1.32

0.42

1.9

1.7

1.15

0.75

g/l

0.41

Non-seminoma of testis, including Hilmo

1.57

0.42

1.4

1.3

0.37

0.92

g/l

—

Liposarcoma

1.57

0.42

1.0

2.3

0.59

1.03

g/l

—

Fracture of forearm

435

3811

1.05

0.41

1.4

1.6

0.77

0.73

g/l

0.25

330

2879

Bicornuate uterus

1.48

0.40

1.0

1.4

0.21

0.49

g/l

—

Foreign body granuloma of skin and subcutaneous tissue

0.00

0.40

0.0

1.8

—

0.71

—

Other deformities of toe(s)

159

1.26

0.40

1.1

1.8

0.66

0.80

g/l

0.26

117

Other disorders of amniotic fluid and membranes

897

0.90

0.40

1.7

1.6

0.52

0.64

g/l

0.98

680

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

844

1.10

0.40

1.3

1.6

0.49

0.79

g/l

3.19

643

Previous suicide attempt

1.32

0.39

1.1

1.9

0.75

0.79

g/l

—

Left ventricular outflow tract obstruction, narrow definition

306

1.18

0.39

1.6

1.7

0.86

0.84

g/l

0.06

239

Congenital varicose veins

1.44

0.39

1.6

1.7

0.45

0.67

g/l

—

Alzheimer’s disease (undefined), excluding more controls

0.00

0.39

0.0

1.3

—

1.19

—

Other and unspecified injuries of forearm

1.44

0.39

1.0

2.2

0.26

1.01

g/l

—

Renal cell carcinoma of kidney

106

0.66

0.39

1.3

1.6

0.62

1.07

g/l

—

Dementia in other diseases classified elsewhere

187

1.23

0.39

1.2

1.5

0.47

0.85

g/l

1.86

142

Otosclerosis

391

1.15

0.38

1.2

1.7

0.77

0.78

g/l

0.02

297

Thyrotoxicosis with toxic single thyroid nodule

1.39

0.38

1.8

1.4

0.85

0.55

g/l

—

Other abortion

1.39

0.38

1.2

1.4

0.39

0.58

g/l

—

Spontaneous abortion

346

2222

1.05

0.38

1.3

1.5

0.58

0.60

g/l

0.17

262

1683

Complications predominantly related to the puerperium

195

1830

1.07

0.38

1.5

0.61

0.62

g/l

0.12

150

1383

Contact with machinery

637

1.12

0.38

1.3

1.6

0.69

0.90

g/l

1.00

499

Other abnormal products of conception

248

1550

1.06

0.38

1.6

1.5

0.54

0.59

g/l

0.51

190

1186

Scabies

105

962

1.09

0.38

1.7

1.6

0.76

0.77

g/l

0.05

735

Malignant neoplasm of colon, including Hilmo

894

1.10

0.37

1.6

1.02

0.82

g/l

0.72

671

Contact with other sharp object(s)

451

0.86

0.37

1.6

1.7

0.58

0.78

g/l

1.08

346

severe traumatic brain injury, does not include concussion

133

1232

1.08

0.37

1.4

1.6

0.75

0.89

g/l

0.92

936

LeFortI or BSSO operation

246

0.81

0.37

1.4

1.7

0.54

0.77

g/l

0.82

184

Congenital malformations of aortic and mitral valves

253

1.19

0.36

1.6

1.7

0.90

0.85

g/l

0.09

199

Marfan's syndrome

1.48

0.36

1.2

1.5

0.57

0.54

g/l

—

Nontraumatic intracranial haemmorrhage

110

1012

1.09

0.36

1.6

1.5

0.77

0.79

g/l

0.09

749

Acute myeloid leukaemia, helper endpoint

1.47

0.36

1.8

0.54

0.88

g/l

—

Acute myeloid leukaemia, including Hilmo

1.47

0.36

1.8

0.54

0.88

g/l

—

Acute myeloid leukaemia

1.47

0.36

1.8

0.54

0.88

g/l

—

Vascular dementia

271

1.18

0.36

1.8

1.4

0.68

0.90

g/l

1.13

204

Supervision of normal pregnancy

149

914

0.93

0.36

1.3

1.5

0.64

0.58

g/l

0.45

119

702

Benign neoplasm: Parathyroid gland

1.44

0.35

1.0

1.8

0.43

0.88

g/l

—

Coronary artery bypass grafting

134

926

1.08

0.35

2.0

1.6

0.91

1.02

g/l

0.32

101

690

Basal cell carcinoma

282

1855

1.05

0.35

1.7

1.6

0.65

0.83

g/l

2.03

216

1392

Early lumbar disc prolapse operation

775

1.10

0.35

1.3

1.6

0.75

0.77

g/l

0.04

585

Type1 diabetes, definitions combined, early onset

488

0.88

0.35

1.6

1.8

0.72

0.70

g/l

0.04

384

Family history of certain disabilities and chronic diseases leading to disablement

287

0.83

0.34

1.3

1.7

0.61

0.75

g/l

0.42

226

Wide developmental disorders

245

1.18

0.34

1.3

1.7

0.48

0.70

g/l

1.39

196

Malignant melanoma of skin, including Hilmo

757

1.10

0.34

1.7

1.6

0.57

0.81

g/l

2.46

579

Seminoma of testis, including Hilmo

1.34

0.34

4.2

2.3

1.12

1.18

g/l

—

Medical treatment for female infertility

155

1445

1.07

0.33

1.5

0.55

0.60

g/l

0.43

125

1099

Multiple gestation

606

1.11

0.33

1.5

1.6

0.57

0.64

g/l

0.36

454

Burn and corrosion of trunk

155

1.23

0.32

1.3

1.8

0.61

0.90

g/l

1.10

121

Adenocarcinoma and papilloma adenocarcinoma of rectum

423

0.87

0.32

1.4

1.7

1.17

0.90

g/l

0.32

324

Mandibular retrognathia

416

1.13

0.31

1.4

1.7

0.55

0.75

g/l

1.11

320

1.30

0.30

1.9

1.7

0.23

0.86

g/l

—

Generalized epilepsy, strict definition

120

1.25

0.30

1.3

1.6

0.46

0.81

g/l

—

Conotruncal defects

102

1.28

0.30

1.3

1.5

0.95

0.69

g/l

—

Aggressive periodontitis

102

1.28

0.30

1.2

1.7

0.36

0.92

g/l

—

Postpartum hemorraghe, parous women as controls

163

1470

0.94

0.30

1.4

1.5

0.63

0.58

g/l

0.54

121

1125

All dysplastic lesions of the cervix uteri

189

1777

1.06

0.29

1.4

1.5

0.55

0.60

g/l

0.46

137

1356

Obstructed labour due to malposition and malpresentation of fetus

151

1494

0.94

0.29

1.4

1.5

0.61

0.60

g/l

0.10

117

1136

Dislocation, sprain and strain of joints and ligaments of elbow

401

1.12

0.29

1.7

0.67

0.81

g/l

0.74

311

Divergent concomitant strabismus

461

0.89

0.29

1.6

1.7

0.47

0.79

g/l

2.89

350

Use of galantamine

238

0.84

0.28

1.4

1.5

0.71

0.93

g/l

0.44

179

Diabetic retinopathy, strict definition

121

1000

1.07

0.28

1.5

1.7

0.90

0.78

g/l

0.19

731

Combinations of oral blood glucose lowering drugs

185

1756

1.05

0.28

1.7

1.6

0.80

0.89

g/l

0.46

140

1310

Other lesions of median nerve

103

1.27

0.28

1.2

1.8

0.38

0.89

g/l

—

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

1.30

0.28

2.4

2.2

0.32

0.93

g/l

—

Malignant neoplasm of testis, including Hilmo

1.28

0.28

2.7

2.0

0.72

1.12

g/l

0.78

Kela-code for severe mental illness

258

2693

0.96

0.28

1.3

1.6

0.62

0.75

g/l

1.58

188

2013

Bilateral sagittal split ramus osteotomy operation

194

0.82

0.27

1.4

1.8

0.56

0.80

g/l

0.65

144

Behavioural disorders

140

1.22

0.27

1.6

1.26

0.73

g/l

—

115

Car occupant injured in noncollision transport accident

196

1.18

0.27

1.3

1.9

0.63

0.86

g/l

0.66

149

Other disorders of breast and lactation associated with childbirth

1.28

0.26

1.3

1.5

0.45

0.47

g/l

—

Hydatidiform mole

0.70

0.26

1.4

1.5

0.88

0.49

g/l

—

Colorectal neuroendocrine tumor and carcinoma

0.69

0.26

1.0

2.0

0.85

0.97

g/l

—

Diabetic maculopathy

753

1.08

0.25

1.6

1.03

0.79

g/l

0.29

553

Open bite

358

1.12

0.25

1.4

1.7

0.95

0.79

g/l

0.31

275

Twin gestation

588

1.09

0.25

1.5

1.6

0.58

0.64

g/l

0.29

438

Crowding of teeth, including avohilmo

526

1.09

0.25

1.4

1.7

0.60

0.81

g/l

1.61

407

Short Achilles tendon (acquired)

105

1.24

0.25

2.2

2.0

1.40

0.99

g/l

—

Pre-eclampsia

144

1366

1.06

0.24

1.5

0.55

0.62

g/l

0.79

111

1021

Basal cell carcinoma, including avohilmo

296

1967

1.04

0.23

1.7

1.6

0.69

0.82

g/l

1.17

227

1480

Other noninflammatory disorders of cervix uteri

237

1.14

0.23

1.7

1.5

0.73

0.69

g/l

0.10

176

Contact with blunt object, undetermined intent

1.29

0.23

1.4

2.0

0.64

0.94

g/l

—

Pedal cyclist injured in collision with pedestrian or animal

1.29

0.23

1.6

1.5

0.54

0.71

g/l

—

Calcaneal spur

1.22

0.22

2.4

2.5

0.62

1.12

g/l

—

Other perinatal haematological disorders

0.00

0.21

0.0

1.2

—

0.74

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

182

1.16

0.21

1.1

2.0

0.82

g/l

0.00

142

Accidental poisoning by and exposure to pesticides

0.00

0.21

0.0

1.8

—

0.50

—

Chondrosarcoma

0.00

0.21

0.0

3.8

—

1.18

—

Intracranial nontraumatic haemorrhage of fetus and newborn

0.00

0.21

0.0

1.6

—

0.68

—

Cholera

0.00

0.21

0.0

1.4

—

0.59

—

Complications following abortion and ectopic and molar pregnancy

173

1.16

0.21

1.4

1.6

0.55

0.65

g/l

0.26

127

Generalized epilepsy

249

1.13

0.20

1.3

1.7

1.08

0.81

g/l

0.19

192

Other and unspecified mononeuropathies of upper limb

145

1.17

0.20

1.4

1.7

0.59

0.83

g/l

0.59

110

Ectropion of eyelid

117

1.20

0.20

1.3

1.5

0.70

1.09

g/l

—

Congenital malformations of cardiac septa

436

1.09

0.20

1.3

1.7

0.68

0.78

g/l

0.38

352

Overjet

186

0.85

0.20

1.5

1.6

0.71

0.67

g/l

—

155

Bicuspidal aortic valve syndrome

202

1.14

0.20

1.7

1.01

0.81

g/l

0.40

160

Postpartum haemorrhage due to anatomy

645

0.93

0.20

1.5

0.61

0.57

g/l

0.23

494

Colorectal adenocarcinoma

930

0.94

0.19

1.5

1.6

0.95

0.84

g/l

0.24

700

Pedestrian injured in collision with pedal cycle

146

1.17

0.19

1.2

1.7

1.16

0.90

g/l

—

113

Caught, crushed, jammed or pinched in or between objects

308

1.11

0.19

2.0

1.7

0.73

0.82

g/l

0.22

238

Torsion of testis

137

1.17

0.19

1.6

1.8

2.59

0.85

g/l

0.48

109

Bacterial sepsis of newborn

1.13

0.19

1.5

1.7

1.09

0.59

g/l

—

Malignant neoplasm of urinary organs

424

1.09

0.18

1.3

1.7

1.04

0.92

g/l

0.17

328

Pre-eclampsia or eclampsia

154

1478

1.04

0.18

1.4

1.5

0.56

0.63

g/l

0.74

121

1110

Polycystic ovarian syndrome, broad definition

686

1.07

0.18

1.5

1.6

0.49

0.61

g/l

0.76

532

Malignant neoplasm of corpus uteri, including Hilmo

415

1.09

0.18

1.1

1.6

0.53

0.68

g/l

0.91

304

Male infertility

310

1.10

0.17

1.3

1.7

0.90

0.92

g/l

0.02

235

Contact with nonpowered hand tool

243

1.11

0.17

1.3

1.7

0.65

0.87

g/l

0.89

187

Cellulitis of external ear

1.11

0.17

2.9

1.7

0.92

0.76

g/l

—

Other congenital malformations of male genital organs

0.72

0.17

1.2

1.5

0.32

0.76

g/l

—

Malignant neoplasm of kidney, except renal pelvis

388

1.08

0.16

1.3

1.7

1.08

0.93

g/l

0.20

303

Other sexually transmitted chlamydial diseases

661

1.06

0.16

1.5

1.7

0.52

0.67

g/l

1.21

490

Respiratory and cardiovascular disorders specific to the perinatal period

182

0.88

0.16

1.7

1.6

0.53

0.76

g/l

0.88

158

Colorectal cancer

111

1133

0.96

0.15

1.4

1.6

0.92

0.86

g/l

0.14

842

Malignant neoplasm of testis

1.21

0.15

3.1

2.1

0.81

1.12

g/l

—

Puerperal sepsis

780

1.05

0.15

1.6

1.5

0.58

0.66

g/l

0.46

577

Uterine polyps

536

1.06

0.15

1.4

1.5

0.50

0.66

g/l

1.01

406

Single delivery by caesarean section

140

834

0.96

0.15

1.5

0.60

0.59

g/l

0.03

104

658

Myocardial infarction, unclassifiable

896

0.96

0.15

1.5

1.6

0.82

0.92

g/l

0.41

675

Injury of nerves at wrist and hand level

207

1.11

0.15

1.4

1.9

0.51

0.92

g/l

1.76

165

Respiratory distress of newborn

129

0.86

0.14

2.0

1.5

0.55

0.73

g/l

0.37

113

Malignant neoplasm of corpus uteri

343

1.08

0.14

1.1

1.6

0.57

0.67

g/l

0.38

256

Congenital musculoskeletal deformities of head, face, spine and chest

1.19

0.14

1.6

1.9

1.33

0.80

g/l

—

Malignant cancer of tonsil and base of tongue, including Hilmo

103

1.17

0.13

1.1

1.6

0.66

0.94

g/l

—

Benign neoplasm: Skin of lower limb, including hip

132

1.14

0.13

1.7

1.8

0.48

0.87

g/l

—

Other complications of labour and delivery, not elsewhere classified

702

1.05

0.13

1.3

1.6

0.59

0.63

g/l

0.17

525

Pedal cyclist injured in other and unspecified transport accidents

703

0.95

0.12

1.4

1.6

0.99

0.77

g/l

0.26

534

Focal brain injury

297

1.08

0.12

1.6

1.5

0.90

0.82

g/l

0.15

228

Multiple delivery

569

0.95

0.12

1.6

1.4

0.53

0.58

g/l

0.24

447

Maternal care for other known or suspected fetal problems

176

1084

1.03

0.12

1.3

1.5

0.59

g/l

0.01

132

835

Inflammatory disorders of breast

356

1.07

0.12

1.7

1.6

0.45

0.61

g/l

0.75

264

Maternal care for known or suspected abnormality of pelvic organs

183

1214

1.03

0.11

1.4

1.5

0.51

0.60

g/l

1.23

133

921

Burns and corrosions

936

1.04

0.11

1.7

1.6

0.67

0.79

g/l

0.74

714

Tooth agenesis EXCLUDE clefts and syndromes

250

0.92

0.11

1.7

1.8

0.51

0.76

g/l

1.00

201

Abnormalities of forces of labour

708

0.96

0.10

1.3

1.5

0.56

0.61

g/l

0.29

536

Birth asphyxia

1.09

0.09

1.0

1.5

0.38

0.67

g/l

—

Accidental poisoning by and exposure to alcohol

1.15

0.09

2.0

1.9

0.60

0.80

g/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

330

1.06

0.09

1.4

1.7

0.65

0.83

g/l

0.67

251

Tarsal tunnel syndrome

1.04

0.09

1.0

1.8

1.41

0.79

g/l

—

Antepartum haemorrhage, not elsewhere classified

587

1.04

0.08

1.3

1.6

0.47

0.64

g/l

1.27

443

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

1.03

0.08

1.0

1.4

0.83

0.54

g/l

—

Prominent ears

0.82

0.08

1.4

1.7

1.52

0.72

g/l

—

Unspecified mental disorder

309

3047

1.01

0.08

1.3

1.6

0.62

0.75

g/l

2.12

230

2297

Schizophrenia or delusion, excluding more controls

201

1957

1.02

0.07

1.3

1.7

0.67

0.78

g/l

0.85

137

1477

Other specified disorders of external ear

167

1.08

0.07

1.6

0.70

0.85

g/l

0.41

128

Polyhydramnios

275

0.94

0.06

1.6

0.74

0.63

g/l

0.21

202

Family history of malignant neoplasm

690

0.97

0.06

1.3

1.6

0.46

0.67

g/l

2.19

541

Retained placenta and membranes, without haemorrhage

770

0.97

0.06

1.5

0.57

0.62

g/l

0.20

567

Malignant neoplasm of colon

671

1.03

0.06

1.5

1.6

0.81

0.84

g/l

0.10

507

Manic episode

139

1.08

0.05

2.0

1.9

0.57

0.96

g/l

—

105

Gestational diabetes (for exclusion)

275

1892

1.01

0.05

1.3

1.5

0.57

0.59

g/l

0.11

222

1441

Maternal care for known or suspected malpresentation of fetus

127

936

0.98

0.05

1.5

0.53

0.60

g/l

0.63

718

Acute and transient psychotic disorders

777

0.98

0.05

1.3

1.6

0.68

0.76

g/l

0.26

586

Malignant melanoma of skin

555

1.03

0.04

1.7

1.6

0.55

0.84

g/l

2.49

419

Use of disulfiram, acamprosate or naltrexone

585

0.97

0.04

1.4

1.7

0.73

0.86

g/l

0.47

450

Erectile dysfunction

387

1.03

0.04

1.6

1.83

0.94

g/l

0.80

299

Atrial septal defect

237

1.05

0.04

1.2

1.7

0.63

0.78

g/l

0.40

195

Benign neoplasm: Larynx

140

1.07

0.04

1.8

1.5

0.61

0.77

g/l

—

107

Antenatal screening

165

938

0.99

0.04

1.4

1.5

0.57

0.59

g/l

0.15

142

718

Malignant neoplasm of brain

160

1.06

0.04

1.4

1.7

0.48

0.91

g/l

1.42

128

Type 1 diabetes, strict definition, subgroup 1

506

1.03

0.04

1.6

1.7

0.69

0.70

g/l

0.02

405

Inflammatory disease of cervix uteri

319

1.03

0.03

1.4

0.70

0.69

g/l

0.02

237

Ill-defined and unknown causes of mortality

331

0.97

0.03

1.1

1.6

0.66

0.89

g/l

0.85

251

Subarachnoid haemorrhage

482

0.97

0.03

1.9

1.5

0.68

0.79

g/l

0.47

359

Other ill-defined and unspecified causes of mortality

290

1.03

0.03

1.1

1.6

0.71

0.89

g/l

0.55

222

Sulfonylureas

182

1462

0.99

0.03

1.4

1.6

0.83

0.90

g/l

0.35

140

1078

Congenital musculoskeletal deformities of head, face, spine and chest

1.09

0.03

1.6

1.9

1.33

0.78

g/l

—

Retinal detachment with retinal break

678

1.02

0.03

1.8

1.6

0.93

0.84

g/l

0.17

517

Orchitis and epididymitis

511

0.98

0.03

1.6

1.7

0.66

0.97

g/l

2.37

400

Acute appendicitis, with complications

125

1264

0.99

0.03

1.8

1.6

0.61

0.80

g/l

1.67

974

Pedestrian injured in collision with car, pick-up truck or van

112

1.07

0.03

1.4

1.6

0.81

0.73

g/l

—

Maternal care for known or suspected fetal abnormality and damage

111

944

1.01

0.02

1.5

0.61

0.62

g/l

0.09

711

Distal bite

260

1.03

0.02

1.6

1.7

0.74

0.83

g/l

0.17

205

Other and/or unspecified nontoxic goitre

419

0.98

0.02

2.8

1.6

0.93

0.74

g/l

0.57

310

Thyrotoxicosis with toxic multinodular goitre

282

1.03

0.02

1.8

1.7

0.70

0.80

g/l

0.25

216

Failed induction of labour

358

0.98

0.01

1.5

1.6

0.40

0.60

g/l

1.71

268

Personal history of malignant neoplasm

368

0.98

0.01

1.6

0.66

0.74

g/l

0.21

288

Pedal cyclist injured in collision with motor vehicle

153

1.05

0.01

2.1

1.8

0.70

0.87

g/l

0.56

120

Parkinson's disease, strict definition, excluding more controls

517

1.01

0.01

2.2

1.5

0.58

0.88

g/l

1.91

372

Benign neoplasm of breast

697

0.99

0.01

1.4

1.5

0.99

0.63

g/l

0.69

520

Malignant neoplasm of brain, including Hilmo

236

0.97

0.00

1.3

1.8

0.43

0.91

g/l

2.77

187

Hydrocephalus

326

0.98

0.00

1.7

1.6

0.71

0.86

g/l

0.49

252

Clear cell adenocarcinoma of kidney

195

1.03

0.00

1.5

1.8

1.43

1.02

g/l

0.31

157

Colon adenocarcinoma

511

1.00

0.00

1.6

1.7

0.76

0.88

g/l

0.43

389

Use of levodopa decarboxylase inhibitor

605

0.99

0.00

1.9

1.5

0.55

0.90

g/l

3.22

454

Septal defects

416

1.01

0.00

1.3

1.7

0.66

0.79

g/l

0.49

343

Parkinson's disease, excluding more controls

553

1.00

0.00

2.1

1.5

0.58

0.91

g/l

2.42

400

Noise effects on inner ear

214

0.98

0.00

1.3

1.7

0.59

0.91

g/l

0.79

167

Spermatocele

384

0.99

0.00

1.4

1.7

0.74

0.98

g/l

0.49

293

Burns and corrosions of external body surface, specified by site

706

1.01

0.00

1.6

1.7

0.77

0.80

g/l

0.08

538

Maternal care for cervical incompetence

188

1.01

0.00

1.4

1.6

0.69

0.71

g/l

0.03

144

Other obstructed labour

458

1.00

0.00

1.2

1.5

0.59

0.63

g/l

0.17

344

Labour and delivery complicated by fetal stress [distress]

172

1128

1.00

0.00

1.4

1.5

0.59

0.58

g/l

0.06

132

857

Atrial septal defect, secundum type

194

0.98

0.00

1.1

1.7

0.26

0.73

g/l

4.73

157

Exposure to vibration

0.00

0.0

1.0

—

0.66

—

Degeneration of iris and ciliary body

0.00

0.0

1.6

—

0.33

—

Pemphigus foliaceus

0.00

0.0

1.8

—

0.55

—

Carcinoma in situ of oral cavity

0.00

0.0

1.5

—

0.78

—

Malignant neoplasm of larynx, including Hilmo

1.01

-0.00

1.0

1.7

1.08

1.24

g/l

—

Soft tissue disorders in diseases classified elsewhere

0.00

-0.00

0.0

5.8

—

2.62

—

Other sudden death, cause unknown

0.00

-0.00

0.0

1.3

—

0.64

—

General hospital and personal-use devices associated with adverse incidents

0.00

-0.00

0.0

1.3

—

0.55

—

Lichen nitidus

0.00

-0.00

0.0

1.1

—

0.54

—

Cholera

0.00

-0.00

0.0

1.5

—

0.55

—

Cutaneous autosensitization

0.00

-0.00

0.0

1.4

—

0.69

—

Delta-beta thalassaemia

0.00

-0.00

0.0

1.2

—

0.61

—

Subclinical iodine-deficiency hypothyroidism

0.00

-0.00

0.0

1.8

—

0.62

—

Amputation of ankle

0.00

-0.00

0.0

1.3

—

0.73

—

Drowning and submersion in swimming-pool or bath

0.00

-0.00

0.0

1.6

—

0.85

—

Malignant neoplasm of rectosigmoid junction

1.00

-0.00

1.2

1.8

2.74

1.03

g/l

—

Intentional self-harm by jumping or lying before moving object

0.00

-0.00

0.0

1.6

—

0.42

—

Injury of nerves at lower leg level

1.00

-0.00

1.4

2.3

1.68

1.18

g/l

—

Liveborn infants according to place of birth

0.91

-0.00

1.0

1.6

0.68

0.51

g/l

—

Exposure to noise

0.00

-0.00

0.0

1.0

—

0.47

—

Personality and behavioural disorders due to brain disease, damage and dysfunction

0.99

-0.00

2.5

1.8

0.44

0.84

g/l

—

Other and unspecified disorders of skin and subcutaneous tissue related to radiation

0.00

-0.00

0.0

1.2

—

0.82

—

Assault by unspecified chemical or noxious substance

0.00

-0.00

0.0

1.5

—

0.53

—

Choroidal detachment

0.00

-0.00

0.0

1.2

—

0.33

—

Birth injury to skeleton

0.00

-0.00

0.0

1.5

—

0.79

—

Varus deformity, not elsewhere classified

0.89

-0.00

2.0

0.79

g/l

—

Carcinoma in situ of lip

0.00

-0.00

0.0

1.0

—

0.66

—

Carcinoma in situ of penis

0.00

-0.00

0.0

6.2

—

3.15

—

Other inherited muscular atrophy

0.00

-0.00

0.0

1.3

—

0.62

—

Poor fetal growth

850

1.00

-0.00

1.3

1.5

0.59

0.60

g/l

0.03

654

Alcoholic myopathy

0.00

-0.00

0.0

1.5

—

0.72

—

Use of pergolide

0.00

-0.00

0.0

1.4

—

0.49

—

Phlebitis and thrombophlebitis of other sites, drug-induced

0.00

-0.00

0.0

1.3

—

0.56

—

Congenital malposition of the kidney

0.00

-0.00

0.0

1.0

—

0.81

—

Undescended testis, unilateral

1.00

-0.00

1.6

1.5

1.16

0.87

g/l

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

IgG subclass 4 [Mass/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS